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A b s t r a c t
Melatonin is present within various eye tissues, in particular the retina, o f  many 
species and evidence exists for a local synthetic capacity. Melatonin is also reported 
to  have several actions within the eye. The human ocular melatonin system, however, 
has previously been little studied. In these investigations, melatonin was quantified in 
human neural retina (NR) and choroid-retinal pigment epithelium (C-RPE) tissues o f  
46 post-mortem human eyes, using an existing radioimmunoassay which was fully 
validated for use in these tissues. Melatonin was present in 26 specimens in at least 
one tissue (range 10 to  486.8 pg/g wet weight tissue), but levels were not related to 
any donor parameter (sex; age; time, month and cause o f death; specimen age; and 
post-mortem interval).
Additional studies investigated 2-[^^^I]iodomelatonin binding sites within the 
eye. The quail displays a robust retinal melatonin rhythm under the control o f  an 
intra-ocular clock. Membrane radioreceptor assays indicated a single class o f  high 
affinity bindings sites in both NR and C-RPE tissues. Pharmacologically the sites in 
the two tissues were very similar. Characterisation studies indicated that binding was 
saturable, reversible and specific. Photoperiod duration had little effect on either 
binding site density or affinity in both tissues. Autoradiographic studies confirmed the 
existence o f a binding site in both tissues.
Using the methodology developed in the quail, 2-[^^^I]iodomelatonin binding 
sites were subsequently investigated in post-mortem human N R  and C-RPE 
membranes. Saturable, specific binding which could be Scatchard transformed was 
demonstrated in N R and/or C-RPE membranes o f only 3/18 specimens. 
Autoradiography confirmed this low occurrence o f binding (1/11). Preliminary 
evidence was also obtained for a melatonin binding site in human iris sphincter 
muscle.
This study has detected melatonin and its binding sites in a proportion o f  human 
eyes. It is likely that the data were influenced by the post-mortem nature o f  the 
specimens.
©Karenza James 1996
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C h a p t e r  1
R e v ie w  o f  t h e  l it e r a t u r e
1.1 Introduction
1.1.1 Biological rhythms
Eukaryotic organisms are highly ordered within the temporal dimension. N ot 
only are organisms directed through strictly organised stages o f development as part 
o f  their life cycle but also their biology is structured around a framework o f  rhythms. 
Most, if  not all, biochemical and physiological events occurring within living things 
display controlled fluctuations with time in order to optimise the internal milieu for 
function in the prevailing environmental conditions. Biological rhythmicity also 
confers anticipatory advantage to the organism allowing the required changes to 
occur in preparation for the expected alteration in environmental condition.
The most significant environmental variant is the daily light-dark cycle. 
Accordingly, most rhythms occur in synchrony with this 24 hour cycle (diurnal, or 
daily cycles). Such cycles may exist entirely as the product o f  the direct effects o f  
light and darkness or as is more frequently the case, may result from a combination o f  
these photoperiod effects and the output o f  an endogenous rhythm generator. Some 
diurnal rhythms are in fact circadian rhythms (Latin; circa about, dies day). True 
circadian rhythms are characterised by certain features. Firstly, they are o f 
endogenous origin, that is, in the absence o f any external time cues they are self- 
sustaining and free run with a repeating period approximating 24 hours. Secondly, 
they should be capable o f being synchronised in phase and period (entrained) by 
periodic stimuli o f the environment (Pittendrigh, 1981a). Principal among these 
entraining stimuli or zeitgehers (German; time-givers) is the daily light-dark cycle. 
Other non-photic cues include social interaction, temperature, and feeding time. The 
magnitude and direction o f the phase shift induced by light varies as a function o f 
subjective time. This rhythm o f sensitivity is a universal property o f  circadian 
systems: light exposure during the subjective day has little or no effect on the timing 
o f  the oscillator, however applied during the early or late subjective night it delays and 
advances, respectively the phase o f  the circadian oscillator. Through the action o f  the 
zeitgeber(s) the period o f the rhythm is set daily to 24 hours precisely. Many species 
also display circannual (seasonal) rhythms which have a period o f  approximately a 
year. The most obvious example o f such a rhythm is the reproductive cycle in 
seasonal breeders.
All circadian rhythms are the outward manifestation o f  an internal oscillator or 
clock which acts as the pacemaker. Within multicellular organisms the circadian 
system is generally in fact multi-oscillator in nature; that is, more than one circadian 
clock exists . Normally all the circadian rhythms displayed by an organism are in fixed 
phase relationships with each other implying that when multiple clocks exist in 
individual organisms they are physiologically coupled to one another in some way 
(Pittendrigh, 1981b). One oscillator may act as the pacemaker controlling the phase 
and period o f  the secondary oscillators, or they may be mutually coupled with each 
other such that they all contribute to the pacemaking function. The innate rhythmicity 
o f  biological oscillators is subsequently translated into neural and hormonal outputs 
for the genesis o f  circadian functions at distant sites.
In vertebrates, circadian oscillators have been located to several anatomical 
areas; the suprachiasmatic nuclei (SCN) o f the anterior hypothalamus (review, Klein
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et a l, 1991), the pineal gland (review, Underwood, 1989) and the lateral eyes 
(review, Cahill and Besharse, 1995). The relative contributions that these make to 
circadian control appears to be class dependent. In mammalian species, for example, 
there is much evidence to  suggest that the principal circadian oscillator, or master 
pacemaker, which drives the circadian rhythms is situated within the SCN (Moore, 
1983). N ot only does the SCN function to  generate circadian rhythms, however, but 
also, it subsequently acts to couple them with zeitgeber information in the process o f 
entrainment. In order for light to  act as a zeitgeber in mammals, it must be able to 
input at some level to the SCN. Light information is received by the retina and 
conveyed to  the SCN via the retinohypothalamic tract (RHT) which leaves the eyes 
within the optic nerves (M oore 1983). Anatomical evidence has been provided for 
the existence o f  such a tract in a large number o f species (Moore, 1973) including 
man (Sadun et a l , 1984).
1.1.2 Pineal melatonin
The 5-methoxyindole melatonin (Figure 1.1) has been demonstrated in the 
pineal glands o f all animals studied (Wurtman et a l, 1968).
Figure 1.1
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The production o f melatonin by the pineal is one o f the many physiological events 
under circadian control (Ralph et a l, 1971). Synthetic rate is higher during the dark 
phase. Circadian production o f melatonin may be under the control o f  a variety o f 
oscillators depending on the species. In avian species and several lower vertebrates 
the pineal gland is itself a circadian oscillator and displays autonomous rhythmicity 
(Underwood, 1989). In mammals, pineal melatonin production is entirely dictated by 
sympathetic input from the superior cervical ganglion. In addition to the circadian 
component o f production, in all animals, synthesis is a light-sensitive process 
(Illnerova et a l, 1978; Lewy et al, 1980), light being inhibitory.
The pineal gland has been termed a neurochemical transducer (Axelrod, 1974). 
It translates light:dark information into a chemical messenger, melatonin. Melatonin 
then conveys the photoperiodic message to the organ systems o f  the body. The highly 
lipophilic nature o f the molecule facilitates its passage into every fluid compartment 
and therefore essentially all cells. In this way, melatonin can be considered as 
representing the daily “chemical expression o f  darkness” (Reiter, 1991). Furthermore, 
the duration o f the nocturnal melatonin surge is directly related^îlark phase length and
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hence it is able to provide information to the organism about absolute day and night 
length. Long term, therefore, melatonin is able to indicate increasing or decreasing 
day length and in doing so acts as a seasonal cue, for example in the control o f 
reproduction. Consequently, the melatonin rhythm has been described as both a 
“clock and calendar” (Reiter, 1993). It has also been proposed that melatonin acts as 
an internal zeitgeber, its periodic nocturnal release serving to synchronise the internal 
rhythms and enabling adjustment o f  their phase (Armstrong, 1989). The 
demonstration o f  melatonin receptors in the mammalian SCN (Reppert et a l, 1988) 
lends support to this hypothesis.
1.1.3 Extra-pineal melatonin
Although once believed to be a product unique to the pineal gland, evidence has 
now accumulated for the synthesis o f  melatonin in several extra-pineal tissues. 
Currently these include the gastrointestinal tract (Bubenik et a l, 1977; Holloway et 
a l, 1980; and Raikhlin et a l, 1975); leukocytes (Finocchiaro et a l, 1988; 1991); the 
testis (Tijmes et al, 1996), Harderian gland (Vivien-Roels et al, 1981) and the eye. 
The first indication that the eye may be a site o f melatonin synthesis was provided six 
years after the discovery o f pineal melatonin. Quay (1965) demonstrated the capacity 
o f  retinal tissue, from several classes o f lower vertebrate, to synthesise melatonin from 
A-acetylserotonin. Thus the presence o f local hydroxyindole-O-methyltransferase 
(HIOM T) activity was confirmed. This enzyme, responsible for catalysis o f  melatonin 
formation from its precursor, had originally been localised in pineal tissue (Axelrod 
and Weissbach, 1960). The concept o f  the eye as an additional, independent source 
o f  melatonin is not an unlikely one given the many parallels, developmental, 
morphological, and functional, that exist between retinal and pineal tissue (reviewed in 
Flight, 1979; Wiechmann, 1986). Interest in ocular melatonin and its physiological 
relevance has since grown considerably. Discussion o f various aspects o f  the ocular 
melatonin system forms the basis o f  this review.
1.2 S tru c tu re  of the  eye
The structure o f the eye is shown in Figure 1.2. The globe o f  the eye consists 
o f  three concentric coats, the fibrous, uveal and retinal tunics, enclosing various 
transparent refractive media (Davson, 1980).
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Figure 1 .2  Structure o f the eye
The three tunics
1. fibrous: sclera and cornea
2. uveal: choroid, ciliary body and iris
3. retinal
Substructure o f the retina is shown in Figure 1.3 From Wheater, 1987.
1.4
The outermost fibrous tunic is comprised o f the tough, collagenous sclera and 
cornea. The choroid, ciliary body and iris together comprise the intermediate layer, 
the uvea. The choroid is highly vascularised and therefore serves a nutritive function. 
It contains large amounts o f the pigment melanin which is synthesised in cellular 
organelles termed melanosomes. Melanin serves to absorb light thus preventing 
stimulation o f  the retinal cells by light reflected within the eye. The ciliary body is 
responsible for accommodation and secretes aqueous humor. The iris, the third, and 
most anterior, component o f the uvea extends as a diaphragm across the front o f  the 
lens. It is suspended from the anterior surface o f  the ciliary body by means o f  a root 
(or ciliary border). It possesses a circular opening at it centre (the pupil) and thus 
forms an aperture through which light enters the eye. The iris contains two muscles; 
the sphincter pupillae muscle (circular, or constrictor muscle) and the dilator pupillae 
(radial, or dilator muscle). The posterior face o f the iris is lined with a layer o f  heavily 
pigmented epithelial cells.
The innermost tunic o f  the eye is the photosensitive retina which lines the 
posterior compartment o f the eye. The main organisation o f the retina is in the 
vertical plane. It is a laminar structure consisting o f 10 layers, the specific layering 
pattern being common to all vertebrates (Fig 1.3). Three basic cell types comprise 
the retina. These are neuron support cells (Müller cells), pigmented epithelial cells 
and neurons.
Müller cells are glial-like elements extending in their height the full thickness o f 
the retina having their cell bodies located in the inner nuclear layer. Their function is 
to provide structural support for the retinal neurons and they may also mediate 
essential metabolite transfer to the neurons.
The retinal pigment epithelium (RPE), a single layer o f pigmented epithelial cells 
represents the outermost layer o f the retina. This is an essential component o f  the 
vertebrate retina. The RPE cells possess long microvilli at their apical surface which 
project amongst the photoreceptor outer segments. Within the RPE cells and within 
their processes are found numerous melanosomes. In certain species, under specific 
environmental conditions, these granules move within the processes (section 1.7.2 ). 
The RPE is multifunctional. Its melanin content serves to reduce light scatter and it 
acts as an intermediary between the choroidal blood supply and the photoreceptors 
thus fulfils a nutritive and metabolic function. It also participates in the process o f 
photoreceptor renewal via intermittent phagocytosis o f  detached distal portions o f  
these structures (Young and Bok, 1969) (section 1.7.6) and is involved with the 
uptake, processing and transport o f  the visual retinoids (Dowling, 1960).
The neuronal component o f the retina (neural retina, NR) is subdivided 
functionally into three components placed one on another, and forming synapses in 
between. (Figure 1.3) The photoreceptors (rods and cones) are the visual cells 
(Figure 1.4). Interior to these are the integrating neurons (bipolar cells, horizontal 
cells and amacrine cells) which serve to integrate sensory input from the 
photoreceptors before its transmission to the various brain centres. At the innermost 
face o f  the retina, are the ganglion cells the axons o f  which leave the retina in the 
optic nerve.
The eye is well supplied with blood via two separate systems: the retinal vessels 
which supply the inner part o f  the retina, and the uveal, or ciliary, blood vessels, 
which supply the rest o f the eye.
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Figure 1. 3 Schema o f retinal components
1. RPE.
2. Photoreceptor layer - 2 layers comprising the outer (a) and inner segments (b) o f 
rods and cones. The outer segments project into the long microvilli o f  the RPE cells.
3. Outer limiting membrane - the line o f  intercellular junctions between Müller cells 
and the photoreceptors.
4. Outer nuclear layer - the photoreceptor cell bodies.
5. Outer plexiform layer - a zone o f synaptic interaction between the photoreceptors 
and integrating neurons (bipolar and horizontal cells). The photoreceptors also 
display lateral connections with each other.
6. Inner nuclear layer - the cell bodies o f the integrating neurons and the Müller 
cells.
7. Inner plexiform layer - a zone o f synaptic interaction between the integrating 
neurons and the retinal ganglion cells.
8. Ganglion cell layer - the cell bodies o f these cells.
9. Optic fibre (afferent fibre) layer - unmyelinated ganglion cell axons passing 
towards the optic disc to form the optic nerve.
Inner limiting membrane - a true membrane representing the basement membrane o f 
the Müller cells resting on the vitreous body. Müller cells are not shown.
From Wheater, 1987.
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Figure 1.4
Photoreceptor structure; (a) rod, (b) cone
Rods and cones share several features. The cells are bipolar in form. Their cell 
bodies lie in the outer nuclear layer and their synaptic terminals in the outer plexiform 
layer. An elongated portion o f the cell protrudes from the cell body. This is 
structurally divided into two portions, the outer and inner segments. The light 
sensitive outer segment is composed o f a stack o f  membranous discs which contain 
photopigment. The discs are continuously shed from the end o f  each photoreceptor 
and subsequently phagocytosed by the RPE cells. The discs are continuously replaced 
by the inner segment. Control o f the disc shedding process is discussed in section 
I.7.2.6.
From Wheater, 1987.
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The interior o f  the eye consists o f two fluid-filled cavities, the anterior and 
posterior compartments created by the combined partitioning effect o f  the lens, 
suspensory ligament and ciliary body. The posterior compartment is filled with a clear 
transparent hydrogel mass (the vitreous body). The anterior compartment contains a 
fluid, the aqueous humor. This is plasma-derived and secreted continuously by the 
cells o f the ciliary epithelium into the posterior chamber from where it subsequently 
passes into the anterior chamber via the pupil. The pressure exerted by the aqueous 
humor represents the intraocular pressure (lOP). lOP is a function o f  the relative 
rates o f  aqueous humor formation and drainage via the canal o f  Schlemm (Figure 
1.2).
1.3 Ocular melatonin
1.3.1 Quantification
Melatonin has been quantified in ocular tissue from members o f all the animal 
classes (Table 1.1). A variety o f analytical techniques have been employed. The 
earliest study demonstrating melatonin in ocular tissue (from Xenopus laevis) (Van de 
Veerdonk, 1967) used the bioassay developed by Bagnara (1960) in which melatonin 
is estimated on the basis o f it skin lightening ability. The bioassay has now been 
superseded by a variety o f more powerful analytical techniques. Many workers have 
utilised immunochemical techniques such as radioimmunoassay (RIA) and 
immunohistology. This latter poses special technical problems for the demonstration 
o f  melatonin. In particular the melatonin molecule is difficult to preserve as the 
commonly used fixatives (for example, formaldehyde) and dehydrating agents (for 
example, alcohol) solubilise it (Mennenga et al, 1991). Conversely, inadequate fixing 
results in poor tissue preservation thus allowing melatonin to  diffuse (Falcon and 
Collin, 1991). Immmunohistological studies provide semi-quantitative data only. 
However, their main advantage is that they enable localisation o f  the ligand. D ata 
generated by both RIA and immunohistology relate to  melatonin-like 
immunoreactivity and the possibility o f  interference by a cross-reactant cannot be 
excluded. Chromatographic techniques such as high pressure liquid chromatography 
(HPLC) (utilising electrochemical or fluorescence detection) and thin layer 
chromatography (TLC) allow more definite identification o f  endogenous melatonin by 
co-elution with authentic melatonin. The golden standard method for melatonin 
measurement, and that by which others are frequently validated, utilises the resolving 
capacity o f gas chromatography coupled with mass spectrometric detection (GC-MS). 
This technique offers a means o f unequivocal ligand identification.
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The disparate data units employed by research groups make inter-species 
comparison o f absolute ocular melatonin level difficult. Variations in experimental 
procedure, and animal age and breed differences, etc., contribute further problems. 
M oreover, it is likely that these factors are responsible for creating the apparent 
differences in data generated from the same species but by different groups (Table 
1.1). One such factor is that melatonin levels o f  individual animals are highly 
dependent on the lighting schedule they are maintained under, their photoperiodic 
history and on the precise time o f sacrifice. This is because melatonin levels within 
the eye do not remain constant across a 24 hour period: in a large number o f  species a 
diurnal rhythm o f  melatonin level has been demonstrated. In the majority o f  those 
species for which this is the case highest levels were demonstrated at night with 
lowest occurring during the light phase (Table 1.1). Hence ocular melatonin 
concentrations are in phase with melatonin synthesis in the pineal. The rhythms in 
ocular melatonin level and their genesis are described below.
1.3.2 Ocular distribution
1.3.2.1 N R an d R P E
Studies o f  ocular melatonin have focused predominantly upon the content o f 
NR, sometimes in association with the retinal pigment epithelium (RPE). Frequently 
it is not stated whether or not the RPE is included in the tissue termed “retina” . 
Melatonin appears to be present in both compartments, however. Isolated trout 
(Gem et a l, 1978), bovine (Hall et a l, 1985) and chicken (Hamm and Menaker, 
1980) N R tissues contain melatonin. Immunohistochemical studies in several species 
indicate that within the substructure o f the NR melatonin-like immunoreactivity is 
almost exclusively confined to the outer nuclear layer, that is, the cell bodies o f  the 
photoreceptors (Bubenik et a l, 1978; Vivien-Roels et a l, 1981 and M ennenga et a l,
1991). The specific cell type was not determined. In some instances, melatonin has 
been located in the inner nuclear layer (Vivien-Roels et a l, 1981) although these 
authors have attributed their own results to diffusion o f  the molecule. The studies o f  
Falcon and Collin (1991) showed that, in addition to the outer nuclear layer, pike 
retina contained melatonin-like immunoreactivity in both the outer plexiform layer and 
the cell bodies o f Müller cells. These authors acknowledged, however, that the 
methodology employed may have visualised the indole 5-methoxytryptamine as well 
as melatonin.
The small number o f studies which have investigated RPE only, found it to  
contain melatonin (for example, chicken Hamm and Menaker, 1980). Also, the 
melatonin content o f combined NR and RPE is higher than that o f  N R (Zawilska and 
luvone, 1989) further implying that the RPE contains melatonin.
1.3.2.2 Uveal tissue
One group have reported the presence o f  melatonin within rabbit choroidal 
tissue (Rohde et a l, 1993). Also in the rabbit, melatonin has been demonstrated in 
uveal tissue from the anterior eye, namely the iris and ciliary body (Aimoto et a l, 
1985; Rohde et a l, 1993a,b). Similarly, chicken iris and ciliary body contain
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melatonin (Aimoto et a l, 1985; Rohde and Chiou, 1987). The precise location o f 
melatonin within these areas has not been investigated.
1.3.2.3 Aqueous humor
Melatonin has been quantified in both human (Martin et a l, 1992) and rabbit 
(Yu et a l, 1990; Liu and Dacus, 1991) aqueous humor.
1.3.3 Origin
That melatonin which is quantified, within the eye may derive from three 
possible sources; local, de novo synthesis; active uptake o f melatonin originating in 
other, distant sites o f  melatonin synthesis, in practical terms the pineal gland; or it may 
simply represent that present within the ocular blood circulation. Available evidence 
favours the former. However, the possibility o f  the entrance o f  melatonin into the eye 
from the systemic circulation, that is, accumulation o f circulating pineal melatonin has, 
been neither proved nor disproved conclusively. Kopin and co-workers (1961) 
demonstrated that following intravenous administration o f radiolabelled melatonin to 
rats there was an extensive distribution o f melatonin throughout the body. Although 
the eye itself was not examined in this study it was shown that other organs, for 
example, the adrenal gland, were capable o f concentrating melatonin relative to 
plasma levels. Subsequently it was shown in similar experiments that this in fact was 
also the case for the eye: in the cat, the iris-choroid layer o f the eye was observed to 
concentrate the circulating hormone tenfold (Wurtman et a l, 1964). Bubenik and co­
workers (1978) have shown that following both melatonin injection and implant, the 
amount o f  melatonin in the outer nuclear layer o f  the rat retina is greatly increased and 
suggest that this may indicate some form o f  local uptake mechanism, for example, a 
receptor. However, because o f the supra-physiological levels o f  melatonin employed 
the physiological significance o f such findings is questionable. Similar studies were 
undertaken by Cassone et al (1986) who demonstrated that circulating exogenous 
melatonin was able to enter the chicken eye (NR and RPE). Yu and colleagues 
(1990) suggest that the melatonin content o f rabbit aqueous humor is derived from 
the circulating plasma pool but provide only circumstantial evidence.
No specific mechanism for accumulation o f melatonin by the eye, for example 
facilitated or active transport, has been reported. Furthermore bi-directional 
movement o f melatonin across the RPE has been demonstrated to occur as a result o f  
simple passive diffusion facilitated by the high permeability coefficient o f  the 
melatonin molecule (Pautler and Hall, 1987).
Melatonin content o f rabbit aqueous humor is not decreased following unilateral 
transection o f the cervical sympathetic trunk which would decrease night-time pineal 
melatonin synthesis (Liu and Dacus, 1991a). It is possible, therefore that in conflict 
with the proposals o f Yu and co-workers (1990) the melatonin content o f  aqueous 
humor does in fact derive from some intraocular source.
The most plausible explanation for the existence o f melatonin within the eye 
remains local synthesis. This is supported by many facts. Firstly, the appropriate 
precursor and inteimiediary molecules o f synthesis and anabolic enzymatic machinery 
have been shown to be present in ocular tissue. These aspects o f  synthesis are 
discussed in detail in section 1.4. Additional evidence is provided indirectly by studies
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on pinealectomised animals. Under these circumstances, ocular melatonin in various 
tissues remains demonstrable despite removal o f the primary source o f  circulating 
melatonin (rats: Yu et a l, 1981a, b; Reiter et a l, 1983; quail: Underwood et a l, 
1984; chicken: Reppert and Sagar, 1983; Rohde et a l, 1985; Hamm and Menaker,
1980).
1.4 Synthesis of ocular melatonin
The concept that the eye may be capable o f  de novo synthesis o f melatonin was 
originally not widely accepted. Later this view changed when evidence for retinal 
HIOM T in a number o f  species was offered (Quay, 1965) .
Numerous studies have since investigated the potential components o f  the 
retinal melatonin generating system. The elucidation o f  the metabolic pathway for 
ocular melatonin synthesis has been based on observations made regarding pineal 
melatonin synthesis. It is now apparent that the ocular pathway is extensively similar 
with that described for the pineal (review, Axelrod, 1974). Thus the synthetic 
precursor o f  melatonin is the essential amino acid L-tiyptophan which is supplied via 
dietary sources. The pathway o f intermediates and enzymes involved is shown in 
Figure 1.5.
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1.4.1 5-Hydroxytryptamine
In the first stage o f melatonin synthesis L-tryptophan is sequentially 
hydroxylated and decarboxylated by the enzymes tryptophan-5-hydroxylase (TPHT) 
and 5-hydroxytryptophan-decarboxylase (aromatic-L-amino acid decarboxylase, 
AADC), respectively, through the intermediate 5-hydroxytryptophan (5-HTP) to yield 
5-hydroxytryptamine (5-HT, serotonin).
The presence o f 5-HT in N R has now been confirmed in many species, both 
non-mammalian (Tomqvist et a l, 1983; Schütte and Witkovsky, 1990; Siuciak et a l,
1992) and mammalian (Ehinger et a l, 1981; Mitchell and Redbum, 1985; Wilhelm et 
a l, 1993; Steinlechner et a l, 1995) albeit at lower concentrations in the latter. 
Within the retina, endogenous 5-HT is reported to be found primarily in amacrine cell 
bodies and terminals situated in the inner plexiform layer, and bipolar cells (Osborne 
et a l, 1981; Schütte and Witkovsky, 1990; Wilhelm et a l, 1993). 5-HT has also been 
demonstrated in RPE and iris-ciliary body tissues (Bondy et a l, 1983; Klyce et al, 
1982 i; Uusitalo a/., 1982 Osborne, 1983 ), and in aqueous
humor (Martin et a l, 1988, 1992). All o f these sites o f  5-HT correspond with the 
reported ocular distribution o f melatonin.
Much evidence exists for the local synthesis o f  5-HT from tryptophan. Both 
TPH (Osborne, 1980; Osborne et al, 1984; Thomas and luvone, 1991; Wilhelm et 
a l, 1993 ) and AADC (Nguyen-Legros et a l, 1994) have been demonstrated
within the retina and isolated retina is able to synthesise radiolabelled 5-HT from 
tritiated tryptophan (for example, Osborne, 1980; 1981; 1984; Redbum  and Mitchell,
1989). A complementary DNA (cDNA) probe for TPH has been produced (Green 
and Besharse, 1994) and used to demonstrate that within the retina, mRNA encoding 
TPH is present in photoreceptors (Green et a l, 1995). Similarly, AADC
immunoreactivity has been localised to the photoreceptor cell inner segments 
(Nguyen-Legros et a l, 1994).
1.4.2 A-acetyltransferase (NAT)
Melatonin is subsequently synthesised from 5-HT in a tw o-step sequence. 
Firstly, it is acetylated in the presence o f  acetyl Co A by A-acetyltransferase (NAT; 
arylalkylamine A-acetyltransferase) to form A-acetyl-5-hydroxytryptamine {N- 
acetylserotonin; NAS).
Within the eye, the majority o f  studies demonstrating NAT activity have 
investigated homogenates o f  either N R alone or combined with the RPE (Table 1.2). 
As with several melatonin quantification studies, some authors have not stipulated 
whether the term “retina” they employ refers to N R  only or N R  combined with RPE. 
N R  and RPE tissue compartments have been investigated independently in the chicken 
however and activity has been demonstrated in both (Binkley et a l, 1979 and Hamm 
and Menaker, 1980 ). D ata concerning the precise localisation o f  NAT has not been 
available due to  the (initial) lack o f  specific probes: early studies investigated NAT 
activity by radioenzymatic assay in whole retina homogenate (Table 1.2). There is 
indirect evidence, however, that NAT activity is associated primarily with the 
photoreceptors. Firstly, NAT activity is maintained in the retina o f  chicken which 
have been treated with intravitreal kainic acid to destroy ganglion and integrating 
neurons (Zawilska and luvone, 1992). Secondly, NAT activity in chick retinal cell
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cultures is highly, positively correlated with their relative photoreceptor contents 
(luvone et a l, 1990). Additionally in these latter experiments, agents which 
stimulated NAT activity were more effective in those cultures containing the highest 
photoreceptor density.
Another possible location o f NAT activity includes rabbit iris-ciliary body 
(Rohde and Chiou, 1987) and in the chicken, both the iris and ciliary body have been 
demonstrated to  possess NAT activity (Aimoto et a l, 1985). Martin and co-workers
(1992) have also reported NAT activity in human ciliary body however, this finding is 
unconfirmed. .
In 1995 the cDNA encoding ovine pineal serotonin-NAT was cloned (Coon et 
a l, 1995) and subsequently NAT mRNA was found to be present in the ovine retina. 
Shortly afterwards, information concerning the human NAT gene was provided (Coon 
et a l, 1996) and NAT was found to be expressed in human retina also. It is 
envisaged that availability o f  the NAT cDNA clone will soon enable cellular 
distribution o f  NAT within the retina and other ocular tissues to be determined.
The product o f NAT action is the intermediate NAS. Evidence o f its 
occurrence provides some support for the presence o f  NAT. Accordingly, NAS-like 
immunoreactivity has been identified in retinal tissue from several avian species 
including quail, pigeon and chicken (Pang et a l, 1983) and rat (Pang et a l, 1977 and
1981), and NAS is synthesised by primary cultures o f guinea pig retina (Yu et a l,
1982). Also, NAS is produced following incubation o f  rat N R with radiolabelled 5- 
HT (Cardinali and Rosner, 1971b; Redburn and Mitchell, 1989).
1.4.3 Hydroxyindole-O-methyltransferase (HIOMT)
In the final stage o f melatonin synthesis, NAS is 0-methylated on the indole ring 
by hydroxyindole-O-methyltransferase (HIOMT). Discovery o f  this enzyme in ocular 
tissue by Quay (1965) was responsible for initiating investigations in the field o f 
retinal melatonin. As shown in Table 1.3, much evidence exists for the presence o f  
HIOM T activity, within the eye. As with NAT, measurements o f HIOM T activity 
have concentrated on NR or N R combined with RPE. Quay and co-workers (1969) 
reported that in trout, HIOMT was present in both NR and RPE but with greater 
amounts in the latter. In contrast, Eichler and M oore (1975) demonstrated that within 
the frog eye HIOMT was highly localised within the NR only. Other ocular tissues 
have been much less thoroughly investigated. Cardinali and Rosner (1971a) 
demonstrated the iris, sclerotic-choroid, lens and corneal tissue o f the rat to  be devoid 
o f  HIOM T activity, in contrast to their findings in retina. In conjunction with their 
studies on ciliary body in NAT, Martin and co-workers (1992) also reported HIOM T 
activity in human ciliary body.
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Unlike NAT, probes for HIOMT, both immunoreactive and molecular, have 
been available for some time. Much controversy has been associated with the former, 
however. Wiechmann and colleagues reported production o f a HIOMT-specific 
antiserum in 1985 which they subsequently used to study the occurrence and 
distribution o f HIOM T in several species (Wiechmann et a l, 1985; Wiechmann and 
Hollyfield, 1987 and 1989; Wiechmann and O ’Steen, 1990). Later these claims were 
retracted on the basis that the antiserum was not in fact HIOMT-specific as previously 
indicated (Wiechmann, 1993). Using a different antiserum however. Voisin and co­
workers (1988) have reported immunoprécipitation o f HIOMT activity in chicken 
retina homogenate.
M ore recently molecular techniques have been applied to the study o f  HIOMT. 
In the chicken retina, in situ hybridisation studies have localised HIOM T mRNA to 
the photoreceptor layer (Wiechmann and Craft, 1993). Using a highly sensitive 
technique (Southern blot analysis o f reverse transcriptase-polymerase chain reaction 
products), HIOM T mRNA has also been demonstrated at low level in human retina 
(Rodriguez et a l, 1994; Bernard et a l, 1995) although Bernard and co-workers 
(1995) were unable to detect HIOMT enzyme activity or immunoreactive protein in 
human retina. HIOMT mRNA has also been identified in rat retina (Gauer et a l, 
1996). An earlier study was unable to detect HIOM T mRNA in bovine retina (Ishida 
e ta l,  1987).
1.4.4 Studies o f melatonin synthesis in vitro
In addition to data concerning measurement o f  individual enzymes and 
precursor molecules involved in melatonin synthesis there is a large body o f  data 
which provides evidence for an intact, functional synthetic capacity o f various ocular 
tissues in vitro. The first evidence came from the isolated rat retina which when 
incubated with radiolabelled 5-HT produced both NAS and melatonin (Cardinali and 
Rosner, 1971b). This was later confirmed in trout NR by Gern and Ralph (1979) and 
subsequently in rat retina by Redburn and Mitchell (1989). Production o f  melatonin 
by isolated guinea pig retina has been demonstrated in the presence o f exogenous 
unlabelled 5-HT (Yu et a l, 1982). In rat retina also, synthesis o f melatonin from 
radiolabelled tryptophan is possible indicating the presence o f the full complement o f 
metabolic enzymes (Redburn and Mitchell, 1989). Melatonin production has also 
been observed in the absence o f exogenous substrate in eyecup preparations o f  the 
goldfish (Grace et a l, 1991); frog (Cahill and Besharse, 1990); hamster (Tosini and 
Menaker, 1996); and in isolated frog NR (Flight et a l, 1983). Supplementation o f  the 
culture medium with 5-HTP or indirectly with 5-HT, via the addition o f  the 
monoamine oxidase inhibitor (MAO) pargyline, does however enhance melatonin 
synthesis in the frog eyecup, although addition o f  the primary precursor tryptophan 
does not have the same effect (Cahill and Besharse, 1989 and 1990).
Inclusion o f TPH and HIOMT inhibitors in the rat N R incubation system results 
in the effective blockade o f 5-HT and melatonin synthesis, respectively, thus 
confirming the participation o f  these enzymes in melatonin synthesis (Redbum and 
Mitchell, 1989).
D ata obtained with whole eyecup preparations do not provide information 
regarding the precise area o f melatonin synthesis. However, culture o f  isolated N R 
indicates that this tissue specifically is capable o f melatonin synthesis (Redbum and
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Mitchell, 1989; Flight et a l, 1983). Within the NR it is unlikely that melatonin 
synthesis occurs in the cells o f  the inner retina. Xenopus eyecups in which the inner 
retina has been destroyed by detergent retain their capacity for melatonin synthesis 
from 5-HTP (Cahill and Besharse, 1992) . Similarly, if treated with kainic acid, a 
neurotoxic excitatory amino acid analogue, another agent which destroys inner retinal 
neurons, chicken NR-RPE is still able to synthesise melatonin from tryptophan 
(Thomas et a l, 1993). These findings combined with data regarding the cellular 
distribution o f the synthetic enzymes (sections 1.4.1 to 1.4.3) indicate that within the 
retina the photoreceptors are likely to be the principal site o f melatonin synthesis. 
Additional evidence supporting the hypothesis that melatonin is synthesised within the 
photoreceptors comes from studies performed on retinally degenerate chicken. In 
such birds there is a negative correlation between extent o f loss rods and cones and 
retinal melatonin content (Pang et a l, 1989).
Few other ocular tissues have been investigated individually for their ability to 
synthesise melatonin. Frog RPE was however shown not to  synthesise melatonin 
(Flight et a l, 1983) although no substrates were provided and in addition, the 
possibility o f rapid breakdown o f any melatonin which may have been produced 
cannot be excluded.
1.4.5 Release o f melatonin
Unlike most o f the classical neurotransmitters o f the retina, release o f  melatonin 
appears not to involve stimulus-coupled secretion requiring depolarisation: isolated 
rat retina does not release endogenously synthesised melatonin in response to 
potassium-induced depolarisation (Redburn and Mitchell, 1989). In this same 
experimental model, melatonin synthesis was associated with an immediate increase in 
melatonin release - there was no storage. This confirms the general assumption that 
melatonin simply diffuses from its site o f synthesis as a result o f its lipophilic nature. 
N ot all the available evidence is consistent with the theory o f immediate release 
however. In the quail, for example, despite the fact that the eyes contain more 
melatonin than the pineal, their contribution o f melatonin to the circulating level is less 
than 40 % (Underwood et al, 1984) suggesting either that melatonin is released 
immediately and degraded, or that some melatonin may be stored in the eye and not 
immediately secreted.
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1.5 R egulation of ocu lar m elatonin levels
1.5.1 Photic regulation
Melatonin levels within the retina o f several species display day/night 
differences, that is, they exhibit diurnal rhythmicity (Table 1.1). The ocular melatonin 
rhythms observed are independent o f those in the pineal as they persist following 
pinealectomy (for example, Yu et a l, 1981; Reppert and Sagar, 1983). In most 
instances, the maxima and minima occur in darkness and light, respectively: at the end 
o f  the light phase melatonin content increases reaching a peak around the middle o f 
the dark phase (for example. Pang et a l, 1983; quail, pigeon, chicken: Underwood et 
al, 1984). Similar patterns are apparent regardless o f  whether the animal is diumally 
or nocturnally active or exhibits crepuscular activity (Zawilska, 1992). Amongst the 
animal classes the magnitude o f nocturnal increase is generally lowest in mammals 
(Nowak et a l, 1989). Overall the cyclic changes o f retinal melatonin are not as 
robust as those o f the pineal, that is, the amplitude o f the rhythm, is much less (for 
example, Zawilsaka and luvone, 1989), but there are exceptions. The lizard, 
Dipsosaurus dorsalis, has a very distinct night day variation in retinal melatonin, 
whereas the pineal o f this species is reported to show no rhythm in its production o f 
melatonin (Menaker, 1985).
There are a number o f inconsistencies concerning retinal melatonin rhythms. 
For example, there has been a failure to demonstrate diurnally rhythmic ocular 
melatonin levels in the following species; Richardson’s ground squirrel (Reiter et a l,
1981), hamster Mesocricetus atiratiis (Beck and Pévet, 1984) and lizard Anolis 
carolinensis (Underwood, 1985). Also, in the trout, melatonin levels are out o f  phase 
with the light-dark cycle, that is, the melatonin peak occurs in the middle o f the light 
phase (Zachmann et a l, 1992; Gern et al, 1978).
These anomalous findings may be o f physiological relevance. The possibility 
exists however that they are in fact attributable to various aspects o f  methodology. In 
the rat, for example, Reiter and co-workers (1983) demonstrated an unusual 
melatonin rhythm consisting o f a short term rise two hours after lights on. These 
findings were not in agreement with other studies on the rat (for example. Pang et a l, 
1980) which demonstrated a more prolonged rise in melatonin occurring towards the 
end o f the dark phase. Consequently the authors postulated that the differences were 
related to the different photoperiods that the research groups had employed. As a 
further example. Pang and Allen (1986) have suggested that the irregular data 
reported by Gern et al (1978) and Reiter et al (1981) may in fact be artefactual and 
related to the antiserum used in both instances. M  auratus hamster retina has also 
recently been shown to synthesise melatonin rhythmically (Steinlechner, et a l, 1995; 
Tosini and Menaker, 1996) thus calling into question the significance o f  the findings 
o f  Beck and Pévet (1984).
The diurnal rhythm o f  retinal melatonin appears to be the product o f  a complex 
interaction o f  at least two factors. The first o f these involves the direct effects o f  light 
and darkness. When the guinea pig is subjected to an extended period o f  darkness, 
the corresponding level o f retinal melatonin is increased (Pang et a l, 1982). In 
contrast, light suppresses the dark associated increase in retinal melatonin content (Yu 
et al, 1982). Furthermore, as in the pineal (section 1.1.2), light acutely inhibits
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synthesis and melatonin content if applied during the dark phase (Hamm and 
Menaker, 1980; Hamm et a l, 1983; Reppert and Sagar, 1983; Wiechmann et al, 
1986). The melatonin increase associated with the onset o f darkness may therefore be 
the result o f release o f  the synthetic process from light inhibition. In the rat retina 
melatonin levels increase within minutes after exposure to darkness (Redbum and 
Mitchell, 1989). The second component o f the rhythm is contributed by an 
endogenous generator, implied by the fact that maximal nocturnal levels o f  melatonin 
are not achieved simply by the application o f  darkness during the animal’s subjective 
day (Hamm and Menaker, 1980; Reppert and Sagar, 1983; Wiechmann et a l, 1986; 
Cahill and Besharse, 1990). The relative contributions o f  photic and clock 
mechanisms to rhythmic melatonin control may vary among species.
1.5.1.1 Molecular basis o f melatonin rhythmicity
Melatonin is released immediately upon synthesis (Redburn and Mitchell, 1989), 
hence the nocturnal increases in melatonin levels observed must be accounted for by 
either an increase in its synthesis or decrease in its metabolic degradation. Regarding 
the latter, there is evidence o f retinal metabolism o f melatonin in some species 
(section 1.6) however there is no information concerning possible regulation o f  the 
enzymes involved. Available experimental evidence suggests that fluctuations in 
synthetic rate are o f particular importance in the control o f retinal melatonin. The 
synthetic enzymes and precursor molecules are obvious candidates for components 
which can be manipulated to effect changes in melatonin production. Fluctuating 
NAT activity plays an essential role in the regulation o f ocular melatonin synthesis. 
Other factors are also involved.
NAT activity levels parallel the diurnal fluctuations o f melatonin level occurring 
within the retina. The activity nadir occurs around the middle o f  the light phase. 
Activity subsequently increases just prior to the dark phase and reaches its maximum 
towards the middle o f the dark phase. Similar activity profiles have been 
demonstrated in many species, including mammals (for example, chicken; Hamm and 
Menaker, 1980; rabbit: Nowak et a l, 1988). The product o f NAT activity, NAS, can 
be measured and its levels follow the diurnal variation o f NAT acitivity, that is, high at 
night and low in the day (Pang et a l, 1983). It is likely therefore that NAT makes an 
important contribution to the regulation o f rhythmic melatonin biosynthesis: by 
increasing production o f NAS, melatonin production is subsequently increased 
through a mass action effect.
The effect o f acute exposure to light is also mediated through NAT: upon 
exposure to light during the dark phase NAT activity decreases (Binkley et a l, 1979). 
This sensitivity o f NAT to light is partially respsonsible for the low level o f  NAT 
activity during the day time. The period o f illumination required for effective 
inhibition o f  NAT acitivity to occur is short. In the chicken, for example, five minutes 
is sufficient (Hamm et a l, 1983). The decrease is rapid. In the chicken, the NAT 
halving time is about 10 minutes (Hamm and Menaker, 1980 and Hamm et a l, 1983). 
The effect o f  light on NAT activity is specific to that in the retina (and pineal) - 
activity in various areas o f the brain, for example the hypothalamus, is unaffected 
(Hamm e ta l,  1983). Monochromatic lights (blue, green or red ) are equally effective 
as white light in suppressing chick retina NAT activity (Zawilska et a l, 1995).
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1.5.1.2 Control o f NAT activity: Roles o f  cAMP, Ca^^ and protein synthesis
The surge in NAT activity which occurs in the dark phase is mediated by a 
cyclic AMP- and Ca^^-dependent mechanism. Protein synthesis may also play an 
important role. These same factors are also implicated in the suppressive effects o f 
light on NAT activity.
Agents which elevate intracellular cAMP levels in a variety o f  ways, for 
example, adenylate cyclase activators such as forskolin; phosphodiesterase inhibitors; 
and non-hydrolysable analogues (for example, dibutyryl cAMP) cause an increase in 
retinal NAT o f the chicken and hen in vivo when applied during the light phase 
(Nowak and Zurawska, 1989; Nowak and Wawrocka, 1993 and Zawilska et a l, 
1991). Similar effects have been demonstrated in chick retina cell culture (luvone, 
1990; luvone et a l, 1990). In contrast, in rat and Xenopus in vitro and rat and rabbit 
in vivo application o f  cAMP enhancing agents will only induce increases in retinal 
NAT activity if  applied during the dark phase (luvone and Besharse, 1983; Nowak, 
1990). Hence there may be some mechanism by which the endogenous rhythm 
generator can overcome the effect o f cAMP on NAT (Cahill et a l 1991). In 
accordance with the effects o f cAMP on retinal NAT in the rabbit, application o f 
topical forskolin in light also had no effect on iris-ciliary body NAT activity or 
melatonin level (Rohde and Chiou, 1987). Its effect in darkness was not investigated.
The effect o f cAMP is specific to this nucleotide: others such as adenosine and 
dibutyryl cyclic-GMP do not have similar effects on NAT activity (luvone and 
Besharse, 1983).
Both the natural night-time increase in NAT activity and the stimulation o f NAT 
activity induced by exogenous cAMP are inhibited by RNA and protein synthesis 
inhibitors (luvone and Besharse, 1983 and 1986; luvone et a l, 1990). It is likely 
therefore that the regulation o f NAT by cAMP occurs at the molecular level through 
activation o f  cAMP-dependent protein kinase and subsequent transcription o f  mRNA. 
W hether the increase in NAT occurs as a result o f  de novo synthesis o f  N AT or is 
stimulated via synthesis o f some NAT-activating protein is unknown. In the absence 
o f  a probe for NAT, as was until recently the case, these problems could not be 
addressed. It is anticipated that the newly cloned cDNA for NAT will enable many 
questions concerning the regulation o f  NAT gene expression to  be answered (Klein et 
al, 1996).
Calcium is another important factor involved in the control o f  NAT activity: 
transmembrane transport o f calcium into the cell appears to  play an important role in 
the induction o f  NAT activity. In Xenopus (luvone and Besharse, 1986), and rat 
(Nowak, 1990) retina, omission o f calcium medium or introduction o f  Ca^^-channel 
blockers can impede both the natural night-time rise in NAT activity and that induced 
pharmacologically. In cultured chick retinal cells the induction o f  NAT activity 
caused by K^-evoked depolarisation is blocked by calcium chelators and voltage- 
sensitive calcium channels (VSCC) antagonists (Avendano et a l, 1990). Influx o f 
calcium through the L-type VSCC is o f  particular importance - the dark induced 
increase in NAT activity is inhibited and potentiated by L-type VSCC antagonists and 
agonists, respectively (luvone and Besharse, 1986; Avendano et a l, 1990; Zawilska 
and Nowak, 1990).
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W hether the role calcium plays in the regulation o f NAT activity within the 
retina is in fact independent o f or related to any action involved with the cAMP 
mediated stimulation o f NAT activity is not clear at present. Accumulating evidence 
suggests that calcium may regulate NAT activity indirectly through its interactions 
with intracellular cAMP content. For example, the stimulatory effect o f  cAMP on 
NAT activity in rat and hen retina is highly dependent on Ca^^ concentration (Nowak, 
1990).
The photoreceptor has been established as the primary site o f  melatonin 
synthesis within the retina (section 1.4.4). Zawilska and Nowak (1992) propose the 
following hypothesis in explanation o f  the calcium-dependent night-time induction o f 
NAT which occurs in this cell type. During the hours o f darkness, photoreceptor 
intracellular calcium levels increase as a result o f  calcium entrance through the VSCC 
which open in darkness. Once a critical level o f  calcium is reached, this activates the 
cAMP generating system which, in turn induces NAT activity. Conversely, during the 
light phase, VSCC are closed and calcium levels are consequently too low to have any 
effect on cAMP. This system may also be responsible for part o f  the acute 
suppressive effects o f light on melatonin synthesis: light hyperpolarises
photoreceptors, causing closure o f the VSCC (for example, Corey et a l, 1984) thus 
inhibiting NAT activity.
1.5.2 Circadian regulation o f melatonin
Like the photic regulation o f melatonin, its circadian control also results, at least 
in part, from fluctuations in NAT activity. The first evidence that NAT was under 
circadian control came from in vitro studies with Xenopus eyecups. The NAT activity 
rhythm expressed by this preparation conformed to both the essential criteria o f  a 
circadian rhythm, that is the rhythm displayed a persistent period o f  24 hours in 
constant darkness (over a 3 day period), and could be phase reversed in response to a 
phase reversal o f the light dark cycle (re-entrained) (Besharse and luvone, 1983). 
Subsequently in the same model, corresponding circadian production o f  melatonin 
was also demonstrated: when Xenopus eyecups were maintained individually in 
superfusion culture systems, circadian overflow o f melatonin was observed for up to  5 
cycles in constant darkness (Cahill and Besharse, 1990; 1991).
Studies performed in vivo in the Japanese quail also provide very convincing 
evidence for a true circadian rhythm o f ocular melatonin production under the control 
o f a local circadian oscillator. The existence o f a melatonin rhythm in the quail retina 
is well documented (for example, Underwood et a l, 1984; 1990b). This is retained 
following pinealectomy (Underwood et a l, 1984) and optic nerve section 
(Underwood and Siopes, 1985). Exposure o f individual eyes o f  the same bird to 
oppositely phased light-dark cycles resulted in oppositely phased ocular melatonin 
rhythms (Underwood et a l, 1988). Furthermore, a similar effect is obtained despite 
optic nerve section and ablation o f ocular sympathetic innervation (Underwood et a l,
1990). Together these data provide evidence that an ocular circadian oscillator 
controlling melatonin synthesis exists in this species.
Studies performed on Xenopus have located the specific site o f  the ocular 
circadian oscillator regulating ocular melatonin synthesis to the photoreceptors. 
Cultured whole N R continue to produce melatonin, albeit at reduced levels, in a
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circadian manner, that is, independent o f influence from other regions o f the eye 
(Cahill and Besharse, 1993). Furthermore, in eyecups which had been lesioned by 
removal o f the inner retina, circadian melatonin production was maintained (Cahill and 
Besharse, 1992). Ultimate proof that the clock controlling melatonin production is 
actually within the photoreceptors o f the Xenopus eye was gained from studies on 
cultured isolated rod and cone photoreceptors (Cahill and Besharse, 1993). These 
preparations were found to rhythmically synthesise melatonin in constant darkness
For several years the Xenopus eyecup represented the only functional in vitro 
preparation for study o f  the ocular circadian clock. Very recently however, circadian 
rhythmicity o f  melatonin synthesis has been demonstrated in cultured N R  o f  a 
mammalian species, the golden hamster (Tosini and Menaker, 1996). Rhythmic 
melatonin production was maintained over a 5 day period o f  constant darkness. 
Furthermore, the rhythm was entrainable to particular light cycles. In the past, several 
researchers had experienced difficulty in demonstrating an ocular clock in mammalian 
species. The key factor in this hamster study appeared to be the much reduced 
culture temperature employed (27 compared with 37 °C previously). Although use o f 
this temperature was justified on the basis that the hamster is a hibernating species, 
the physiological relevance o f these findings should perhaps be questioned. However 
this aside the hamster model provides irrefutable proof for the first time that the 
mammalian retina does at least possess the intrinsic capacity for circadian production 
o f melatonin.
Circadian rhythms are characterised by their susceptibility to entrainment by 
external stimuli and, in accordance with classical circadian theory, in Xenopus 
eyecups, for example, the specific effect o f a light pulse (an entraining agent) on the 
subsequent phase o f the melatonin rhythm has been shown to be dependent on the 
circadian phase during which the pulse was applied (Cahill and Besharse, 1991). That 
entrainment o f  the retinal melatonin/NAT rhythms can occur in isolated eyecups 
indicates that the entrainment mechanism is itself located within the eye. In Xenopus 
this is actually within the photoreceptors themselves (Cahill and Besharse, 1993).
1.5.3 Involvement o f  HIOMT
Early studies with HIOMT indicated that like NAT, its activity followed a low 
amplitude diurnal rhythm with maximum activity occurring in the light phase (Nagle et 
a l, 1972; Cardinali et a l, 1972). Subsequent studies have failed to confirm these 
findings in a number o f species (Pévet et a l, 1980; Gern et a l, 1984; N ow ak et a l, 
1988; Falcon and Collin, 1991) and it is unlikely therefore that HIOM T contributes to 
the regulation o f melatonin levels as a result o f the effects o f light. However, Eichler 
and M oore, (1975) have demonstrated in frog retina, that is, in an ectothermic 
species, that HIOMT activity exhibits a diurnal rhythm which is engendered by diurnal 
temperature variation. The findings o f Delgado and Viven-Roels (1989) that a 
decrease in environmental temperature abolished the night-time ocular melatonin peak 
in the frog, lends support to this hypothesis.
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1.5.4 TPH
NAT activity may not be the sole rate-limiting factor o f retinal melatonin 
synthesis. Hamm and Menaker (1980) have demonstrated changes in chick retina 
melatonin content which were not correlated with changes in NAT activity. Rhythms 
in 5-HT exist and have been found to mirror those o f melatonin, that is, with higher 
levels at night (chicken Cassone et a l, 1986; Siuciak et a l, 1992 ). Availability o f
5-HT is a limiting factor for melatonin synthesis by Xenopus eyecups: inclusion o f  the 
monoamine oxidase inhibitor pargyline or the 5-HT precursor 5-hydroxytryptophan 
each stimulates melatonin production (Cahill and Besharse, 1990). The latter is a 
dose dependent effect and can be induced at all times o f the circadian cycle thus it 
would appear that neither o f the post 5-HT enzymes are normally saturated. Addition 
o f the primary precursor tryptophan does not affect melatonin synthesis indicating that 
retinal TPH may be saturated and thus may be an additional rate-limiting factor. 
Activity o f tryptophan hydroxylase in the chicken in vivo (Thomas and luvone, 1991) 
and TPH mRNA levels in cultured Xenopus eyecups (Green and Besharse, 1994; 
Green et a l, 1995) display true circadian rhythms. Thus there appears to  be a 
coordinated scheme o f  regulation for NAT and TPH which results in an increase in 
the amplitude o f the melatonin rhythm.
The effect o f light on melatonin synthesis is not mediated to any great extent 
through an inhibitory effect on TPH. In chicken retina, one hour o f light exposure 
during the dark phase suppressed TH activity by only 30 % compared with 82 % for 
NAT (Thomas and luvone, 1991). Acute effects o f light on TH mRNA levels are also 
not observed (Thomas and luvone, 1991).
1.5.5 Neurotransmitters
1.5.5.1 Dopamine
The interaction between melatonin and dopamine in the retina are complex 
(review, Besharse et al, 1988). Dopamine has been implicated with the mediation o f 
the suppressive effect o f light on melatonin synthesis (Zawilska and Dubocovich,
1991) and also the phase shifitng effect o f  light on the melatonin rhythm (Cahill and 
Besharse, 1991). In addition, melatonin inhibits dopamine release (Dubocovich, 
1983) (section 1.7.1.1). Figure 1.6 summarises the mutually antagonistic actions o f 
the retinal melatonin and dopamine systems involved in the control o f  rhythmic ocular 
physiology..
1.5.5.2 Others
The retinal neurotransmitter gamma-aminobutyric acid (GABA) and its agonists 
increase NAT activity in light exposed Xenopus eyecups (Boatright and luvone, 
1989a) and also in the chicken eye in vivo (Kazula, 1993). Conversely, the GAB A 
antagonist picrotoxin suppresses the nocturnal surge in NAT activity (Boatright and 
luvone, 1989a). GAB A may have its effect via the dopaminergic system (Boatright 
and luvone, 1989b).
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Beta-adrenergic inhibitory control o f melatonin synthesis has been reported in 
green frog eyecup culture {ibid. Delgado et a l, 1996). Also, melatonin levels are 
decreased in rabbit retina, iris and iris-root ciliary body by the mu opiate agonist 
DAGO (D-ala^-N-methyl-phe^-gly^-ol) (Rohde et a l, 1993). Endogenous opioid 
peptides may therefore contribute to the regulation o f  intraocular melatonin.
1.5.6 Autoregulation o f melatonin
Studies with Xenopus retina have shown that imposition o f  cyclic variation in 
melatonin level via manipulation o f precursor levels does not affect the subsequent 
timing o f  the melatonin rhythm (Cahill et a l, 1991 ). Thus it would appear that
the ocular circadian oscillator controlling the phase o f melatonin synthesis is 
insensitive to melatonin, that is, there is no feedback o f  melatonin to the clock.
There is evidence, however, that the synthesis rate is regulated by melatonin, 
both from the pineal and that within the eye. In the rat, peak night-time retinal 
melatonin levels exhibit a compensatory increase 3-4 weeks following pinealectomy 
implying that normally pineal melatonin exerts some inhibitory effect on retinal 
melatonin, that is, a negative feedback system may be in operation (Yu et a l, 1981; 
Reiter et a l, 1983). The site o f action o f melatonin in this inhibitory capacity may be 
a synthetic enzyme. For example, rat retinal HIOM T activity increases after 
pinealectomy (Nagle et a l, 1973).
In contrast Nowak and colleagues have demonstrated a stimulatory effect o f 
melatonin on retinal melatonin. Both systemic and intraocular exogenous melatonin 
administration increase retinal NAT activity in a dose dependent manner in light- 
exposed chickens (Nowak et al 1992). These authors propose that this action o f 
melatonin is an indirect one, melatonin acting to directly inhibit the dopamine system, 
thus removing the inhibitory influence that the dopaminergic system has on NAT 
activity. There was no effect o f systemically administered melatonin on retinal 
HIOM T activity in this study.
Melatonin may also exert a positive feedback on synthesis o f  its substrates. For 
example, in the chicken, retinal 5-HT is increased following administration o f 
exogenous melatonin (Cassone et a l, 1986).
In addition to the effects melatonin may have on its own synthesis, there is 
evidence that its biosynthetic intermediates may also participate in its regulation. 
Systemic administration o f either NAS and 5-HT stimulates retinal NAT activity in 
light exposed chickens (Nowak et a l, 1992). In contrast, NAS is able to  inhibit 
retinal HIOM T activity in the chicken retina, although it has no effect in rat or rabbit 
retina (Nowak, 1990).
1.5.7 Ontogeny
Studies concerning the ontogeny o f melatonin in the rat retina have shown that 
it first becomes detectable in the twenty day old foetus although significant amounts 
are not apparent until 2 days post partum (Bubenik et a l, 1978). In the chicken, 
NAT activity is measurable as early as embryonic day 6 and maximal levels are 
reached on the day preceding hatching (E20) and maintained post hatching (luvone, 
1990 ). A significant day/night difference in NAT activity is first observed at
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E20. True circadian rhythmicity o f retinal NAT activity also develops at or prior to 
hatching (luvone, 1990). The rat pineal melatonin rhythm only appears at ten days 
post partum (Deguchi, 1978), confirming that the immunoreactive melatonin found in 
the eye before this time is in fact o f extrapineal origin. The ontogeny o f HIOM T 
activity in the rat has also been investigated. Activity is apparent from the 17th day o f  
gestation and subsequently increases to 30 days post partum where it reaches a 
plateau (Cardinali and Rosner, 1971a).
1.5.8 Season
The effect o f  season on ocular melatonin has received little attention to date. 
However, there is some evidence that suggests a relationship between the two. The 
diurnal rhythm o f melatonin is attributable partly to the direct effects o f light. 
Accordingly, as day length decreases towards winter, the duration o f  the night-time 
rise in retinal melatonin has been shown to increase (Delgado and Vivien-Roels, 
1989). Steinlechner and colleagues (1995) have also recently reported that the profile 
o f  day/night melatonin levels in the hamster retina differs greatly with the time o f year. 
In April, for example, a monophasic rhythm peaking at night was present whilst in 
October, melatonin levels were not rhythmic. This effect was specifically related to 
the duration o f the light phase, as temperature (see below) was held constant 
throughout. Hence the atypical melatonin rhythm described by Reiter and co-workers 
(1983) (section 1.5.1.1) may in fact be o f biological significance.
Cardinali et al. (1972) have demonstrated rat retina HIOM T activity to be 
increased after long term exposure to light. In addition, in the hamster retina, mean 
daily HIOM T activity was found to be highest in the summer season (Balemans et al,
1983). On the basis o f these findings Cahill and co-workers (1991) have suggested 
that in contrast to the non-participation o f HIOMT in the short term control o f retinal 
melatonin production, HIOMT may be regulated by long-term lighting conditions to 
effect additional seasonal changes in melatonin levels.
Temperature may also contribute to the seasonal effects on ocular retinal 
melatonin. In the frog eye, for example, a melatonin rhythm is not observed in winter 
unless the environmental temperature is artificially increased and conversely, in 
summer the pronounced melatonin rhythm can be abolished by lowering the 
temperature (Balemans et a l, 1983).
1.5.9 Sex
There is conflicting evidence concerning the effect o f  gender on retinal 
melatonin content. Bubenik and co-workers (1978) were unable to  demonstrate a sex 
difference in the rat retina with the semi-quantitative methodology employed 
(immunocytochemistry). However, quantitative RIA o f retinal tissue from the same 
species indicated an obliteration o f the peak in melatonin content in male rats 
following gonadectomy (Reiter et a l, 1983). This sex difference in retinal melatonin 
levels may be due to a stimulatory effect o f testosterone on HIOM T activity. A 
significant sex difference in HIOMT activity in the rat retina has been reported, with 
activity being less in the female (Cardinali and Rosner, 1971a). Furthermore, Nagle 
and co-workers (1974) have reported a permanent decrease in retinal HIOM T activity
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in male rats 24-72 h after gonadectomy. Activity was able to be restored to  pre­
surgery levels by daily subcutaneous testosterone injections.
1.6 Ocular metabolism of melatonin
Once synthesised or taken up into the eye, melatonin is available to perform its 
function(s) until such time as it is rendered inactive by metabolism or removed in 
some other way from its site o f action. The major metabolic pathway o f  melatonin 
within plasma, that is, that originating primarily from the pineal, is 6-hydroxylation 
(Kopin et a l, 1960). This occurs within the liver and to a lesser extent the kidney. 
Subsequently it is conjugated with sulphate, and to a much lesser extent glucuronide, 
before excretion via the urine (Kopin et a l, 1961 and Kveder and M clsaac, 1961). 
Additionally, in rats (Leone and Silman, 1984; Leone and Silman 1985) and humans 
(Young et a l, 1985) melatonin has been found to be metabolised via déméthylation to 
its synthetic precursor NAS in addition to 6-hydroxymelatonin. In the brain, two 
further minor metabolites o f melatonin, the kynurenamines (= substituted 
kynuramines) M-acetyl-A^-fbrmyl-5-methoxykynurenamine (AFMK) and M -acetyl-5- 
methoxykynurenamine (AMK), are produced (Hirata et a l, 1974). Formation o f  the 
first involves oxidative pyrrole ring cleavage the reaction being catalysed by 
indoleamine 2,3-dioxygenase. AMK is subsequently produced from AMK by the 
action o f  formamidase (Hirata et a l, 1974). Another minor pathway for melatonin 
metabolism (1-2%) in the liver involving deacetylation and deamination produces the 
metabolites 5-methoxytryptamine (5-MT), 5-methoxyindoleacetic acid (5-M lAA) and
5-methoxytryptophol (5-ML) (Rogawski et a l, 1979 and Kveder and Mclsaac, 
1961).
The available evidence suggests that unlike the pineal gland, the eye possesses 
the capacity for rapid, local metabolism o f  melatonin. Metabolism may therefore 
represent an additional regulatory factor controlling melatonin levels. Furthermore, in 
contrast to plasma melatonin, melatonin within the eye does not undergo 
hydroxylation as its major pathway o f catabolism. The major impetus initiating 
studies on ocular melatonin degradation was the fact that, despite high nocturnal 
levels o f both synthetic enzymes and melatonin in eye tissues o f various species, 
relatively little actually enters the circulation (Reppert and Sagar, 1983). Based on 
ocular melatonin levels, they estimated that 50 % o f the night-time plasma melatonin 
should be attributable to that produced in the eyes; whereas the actual value was 9 %. 
A similar situation has been observed in Xenopus eyecup culture in which NAT 
activity is again high (Besharse and luvone, 1983) but melatonin content in the eyecup 
and release into the incubation medium is low (Cahill and Besharse, 1989). In the 
quail, the eyes contribute less than 40 % o f  circulating melatonin, even though they 
contain more melatonin than the pineal (Underwood et a l, 1984). These authors 
have attributed their findings to either some storage mechanism for melatonin or local 
metabolism.
Initial data concerning ocular melatonin metabolism were generated in Xenopus 
eyecup cultures. It was found that both endogenous and exogenous melatonin were 
metabolised to the same three compounds, namely 5-MT, 5-MlAA and 5-ML (Cahill 
and Besharse, 1989), that is, the same indoles produced in the mammalian liver as 
minor melatonin metabolites (Rogawski et a l, 1979; Kveder and M clsaac, 1961).
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The pathway o f  ocular melatonin degradation proposed by Cahill and Besharse (1989) 
is shown in Figure 1.7. Melatonin is first deacetylated to 5-MT by aryl acylamidase. 
This is deaminated by monoamine oxidase (MAO) producing 5- 
methoxyindoleacetaldehyde which is subsequently either reduced to 5-ML or oxidised 
to  5-MlAA. Cahill and Besharse (1989) have employed enzyme inhibitors to confirm 
participation o f  the enzymes in this pathway. The MAO inhibitor pargyline caused 
accumulation o f  5-MT from tritiated melatonin and production o f  5-ML and 5-M lAA 
to be blocked whereas inhibition o f  aryl acylamidase by eserine caused the suppression 
o f  all metabolite formation. In addition, night-time melatonin release from the 
eyecups was increased sevenfold in the presence o f  eserine. Fluctuations in 
deacetylase activity may make some contribution to the generation o f  the melatonin 
rhythm or be responsible for acute modulation o f melatonin concentration at its sites 
o f  action (Cahill et a l, 1991) but at present there are no data regarding this 
hypothesis.
Within the Xenopus eye, NR and choroid-retinal pigment epithelium (C-RPE) 
compartments have been investigated independently and both found to contain 
melatonin deacetylase activity (Grace et al, 1991). In addition, the occurrence o f  this 
degradative pathway for melatonin has been compared in the vertebrate classes 
(Grace et al., 1991). In addition to amphibians {Xenopus), it has been demonstrated 
in teleost fish (goldfish), reptile {Anolis carolinensis) and bird (chicken) eyecup 
preparations. Using similar methodology it appears to  be absent however from 
mammals (rat eyecup and retinal homogenates, and pig retinal homogenates). It may 
be the case that levels in these species are very low and/or the experimental conditions 
employed were inappropriate. Furthermore, other mammalian species may yet be 
shown to possess such a degradative path.
Local metabolism may represent a mechanism for the rapid termination o f 
melatonin’s actions within the eye and its existence might, therefore be indicative o f  a 
short acting role for melatonin, for example, in some neuromodulatory capacity. 
However, although melatonin itself may be metabolised rapidly and thus deactivated, 
the products o f such transformations may in fact themselves possess biological 
activity. 5-MT has been shown to inhibit cAMP accumulation in a similar fashion to  
melatonin in chick NR cell culture (luvone et a l, 1995). Binding sites for certain o f  
the metabolites, for example 5-ML, have also been reported (Skene, 1991). 
Furthermore, 5-MT is reported to be an effective substrate for NAT (Zawilska and 
Nowak, 1991). Thus inactivation o f melatonin within the eye by the proposed 
pathways would generate substrate for further melatonin synthesis. 5-MT also serves 
as a metabolic precursor for 6-methoxy-tetrahydro-P-carboIine which has also been 
implicated in the control o f retinal physiology (review Skene, 1991).
Other metabolic pathways for melatonin may exist within the eye but these have 
been little studied. The cytochrome P-450-catalysed mixed-function oxidation 
reaction catalyses the oxidation o f many endogenous lipophilic molecules with the 
products subsequently being rendered water soluble for excretion by conjugation 
reactions. Several isoenzymes o f the cytochrome P-450 family have been 
demonstrated within the eye (Shichi et a l, 1975; Schwartzman et a l, 1987; Zhao and 
Shichi, 1995). It is feasible therefore that they might make some contribution to  the 
control o f  ocular melatonin levels.
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1.7 A ctions of ocular m elatonin
Ocular melatonin may potentially either act locally within the eye or be released 
and disseminated via the systemic circulation to reach distant targets. Melatonin is 
unusual in that it does in fact mediate its functions in a multiplicity o f ways, that is, as 
an endocrine, paracrine and autocrine factor. Its actions are many and diverse. 
Several are related either directly, or indirectly with some aspect o f  circadian 
physiology.
As described (section 1.6), in several species it is probable that most ocular 
melatonin is rapidly degraded and thus prevented from entering the circulatory 
system. Alternatively, local synthesis may be insufficient for melatonin to  be released 
in significant amounts. There are instances however in which ocular melatonin 
contributes a significant proportion o f  that in the circulatory system. This is 
particularly true o f some avian species and lower vertebrates. Following 
pinealectomy o f the Japanese quail, for example, a significant rhythm in plasma 
melatonin persists (Underwood et a l, 1984). The eyes o f this species contribute 
about one-third o f the dark-time melatonin levels (Underwood et a l, 1984). 
Similarly, in the pigeon, the plasma melatonin rhythm is maintained following 
pinealectomy, with 17% o f the night-time peak o f  blood-borne melatonin deriving 
from the retina (Foa and Menaker, 1988). In the chicken also, despite the presence o f  
an active deacetylation system (Grace et a l, 1991), ocular melatonin makes a small 
but significant contribution (9 %) to plasma melatonin (Reppert and Sagar, 1983). 
The trout retina is also capable o f releasing melatonin into the circulation (Gem  and 
Ralph, 1979).
Thus it is possible that in some species the eye functions as a classical endocrine 
organ releasing melatonin into the circulation where it is assumed to function as does 
that o f pineal origin (Steinlechner, 1991).
In the majority o f species investigated, however, there appears to be little or no 
release o f melatonin into the circulation from the eye. It is likely, therefore, that 
melatonin mediates local physiological events. This hypothesis has been confirmed by 
the demonstration o f several, local actions o f melatonin. However, in some instances, 
the relative contributions that pineal and ocular sources make to the melatonin pool 
which mediates these local actions is not always clear.
1.7.1 Effects o f  melatonin on ocular neurotransmitter systems
1.7.1.1 Dopamine
Melatonin, at picomolar concentrations, inhibits electrically stimulated, calcium 
dependent ^H-dopamine release in the rabbit retina (Dubocovich, 1983). No 
supporting data for this observation were immediately forthcoming but
eventually the finding was confirmed (Nowak, 1988). A similar effect has also been 
observed in an amphibian retina (Boatright and luvone, 1989). Melatonin has also 
been demonstrated to have an inhibitory effect on light-induced dopamine release 
(Nowak, 1988) indicating the possible physiological relevance o f this action o f 
melatonin on dopamine (light stimulates dopamine release within the eye (luvone et 
al, 1978)). This action o f melatonin on dopamine is, as yet, the only one which has 
been found to be specifically mediated by a receptor (section 1.10.1). Systemic
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administration o f exogenous melatonin decreases retinal dopamine in mice (Melamed 
et a l, 1986) providing further evidence for a role o f melatonin in the suppression o f 
retinal dopamine activity.
As previously discussed (section 1.5.2.1.1) melatonin and dopamine participate 
in a double negative feedback loop in which the actions o f  each are mutually 
antagonistic. It has been proposed that some, perhaps all, o f the actions o f melatonin, 
in both lower vertebrates (Besharse et a l, 1988) and mammals (Dubocovich, 1988a), 
are in fact brought about indirectly through an interaction with the dopamine system. 
It is suggested that the interactions between ocular melatonin and dopamine represent 
the neurohumoral correlate o f the dawn and dusk signal (Réme et a l, 1991). The 
multiple points o f (possible) interaction o f the melatonin and dopamine systems within 
the eye are indicated in Figure 1.6.
1.7.1.2 Acetylcholine
In addition to dopamine, melatonin may be involved in similar systems o f 
reciprocal interaction with other neurotransmitters. In rabbit retina, for example, 
melatonin inhibits ACh release induced by a variety o f stimuli including the 
physiologically appropriate stimuli potassium and flashing light (Mitchell and 
Redburn, 1991). These authors postulate that the interaction occurs via melatonin 
receptors located on cholinergic neurons although at present there is no direct 
evidence o f  a receptor.
1.7.2 Photomechanical changes
Many o f  the para-Zautocrine actions o f  melatonin specifically associated with the 
retinal compartment o f the eye are associated with dark-adaptive mechanisms. 
Through the process o f dark-adaptation the vertebrate eye is prepared for optimal 
function in conditions o f darkness.
One aspect o f  dark-adaptation concerns the phenomenon o f photomechanical 
changes (retinomotor movements). Amongst vertebrates, the most extensive 
photomechanical changes occur in the lower classes. At one time they were believed 
to be absent from mammals. Subsequently, however, they were reported to  be 
operational in the guinea pig (Pang et a l, 1978). Photomechanical changes involve 
two components; pigment migration and repositioning o f the photoreceptor elements 
(review, Burnside and Nagle, 1983).
In conditions o f light, pigment containing melanosomes disperse into the long 
apical projections o f the RPE cells. Simultaneously, cone photoreceptors shorten and 
rods elongate. Consequently, cone outer segments are positioned first in line for light 
reception and pigment is able to shield the rod outer segments from damage by bright 
light. Relocation o f  pigment also serves to enhance photopic acuity by absorbing 
scattered light. Conversely, in darkness, pigment aggregates towards the base o f the 
epithelium thus exposing the rod outer segments. Also, cones elongate and rods 
shorten and in doing so the rod outer segments are moved in from the cone segments 
thus the retina is primed for function in scotopic conditions. Both photoreceptor 
(Welsh and Osborn, 1937) and RPE (Douglas, 1982) components o f  these 
photomechanical changes are under the control o f  a circadian oscillator. Melatonin
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has also been implicated in both aspects o f photomechanical changes. Consequently, 
Besharse and colleagues (1988) have hypothesised that ocular melatonin may function 
as a dark-adaptive signal.
1.7.2.1 Pigment aggregation
By analogy to the effect o f  melatonin on pigment in Xenopus laevis dermal 
melanophores (Messenger and Warner, 1977), that is pigment aggregation, melatonin 
might be expected to have similar effects on ocular pigment. This has been verified. 
Intraocular injection o f melatonin in both trout (Chéze and Ali, 1976) and guinea pig 
(Pang and Yew, 1979) causes melanosome aggregation in the RPE. In the latter, 
melatonin causes pigment aggregation in the choroid also.
1.7.2.2 Control o f  cone length
Quay and McLeod (1968) were first to report an effect o f melatonin on cone 
photoreceptors. They showed cone contraction following melatonin treatment in 
Xenopus laevis larvae. These findings, published originally in abstract form, although 
much quoted, were never reproduced. Twenty years later Pierce and Besharse (1985) 
conclusively demonstrated the opposite, that is, in Xenopus eyecups prepared from 
constant light treated animals, melatonin was shown to cause cone elongation. 
Subsequently, it was also shown that, in Xenopus eyecups, melatonin can only 
mediate this effect under a particular set o f experimental conditions as high light 
intensity overrides melatonin’s effects (Pierce and Besharse, 1987) and there is a 
diurnal rhythm o f sensitivity to melatonin: melatonin is unable to  cause cone 
elongation in the subject day (Besharse et a l, 1988).
Melatonin may effect its actions on photomechanical changes directly. 
However given the interaction which occurs between melatonin and dopamine in the 
retina, another mechanism may be one which involves dopamine (Besharse et a l,
1988). There is some evidence for this. For example, the effect o f melatonin on cone 
elongation is inhibited by dopamine (Pierce and Besharse, 1985).
1.7.3 Effects on the electroretinogram and visual information processing
The electroretinogram (ERG) is a record o f changes o f  potential that takes 
place across the retina in a radial direction when light falls upon it. Typically it 
consists o f  a cornea-negative a-wave, then a cornea-positive 6-wave, a slower cornea- 
positive c-wave and in some animals a cZ-wave coincident with cessation o f 
illumination (Berson, 1981). The a-wave arises from the photoreceptors whereas the
6-wave is derived from cells proximal to the photoreceptors (probably Müller cells) 
with some contribution from rod and cone system activity. The c-wave is generated 
by the RPE from a potassium-dependent differential hyperpolarisation o f its apical and 
basal membranes in response to light with some input from the NR. In many 
vertebrate species diurnal changes in the ERG are apparent. In some species, 
including man (Nozaki et a l, 1983), chicken (Lu et a l, 1995) and lizard {Anolis 
carolinensis-. Shaw et a l, 1993; Gecko gecko Fowlkes et a l, 1987), but not all (for 
example, white perch and green sunfish (McMahon and Barlow, 1992), these are true
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circadian rhythms. In general, the 6-wave amplitude exhibits rhythmic fluctuations 
with the maximum being achieved around the early to  middle part o f the light phase 
(Nozaki et a l, 1983). In contrast, the amplitude o f  the a-wave remains fairly constant 
throughout the day although in AnoUs carolinensis (Shaw et a l, 1993) both a- and b- 
waves show circadian rhythms in the time taken for the peak o f  each component to  be 
reached (a-wave longest at midnight and the b-wave at midday).
Effects o f melatonin have been demonstrated on the ERG  and other aspects o f 
ocular electrophysiology in several species. In the rabbit, intraocular irrigation with 
melatonin causes a marked reduction o f the c-wave amplitude and a slight peak in the
6-wave (Textorius and Nilsson, 1987). Amplitude o f the c-wave is similarly 
decreased in chick retina-RPE-choroid preparations treated with melatonin (Nao-I et 
al, 1989). Textorius and Nilsson (1987) also found that melatonin had an effect on 
the standing potential o f  the eye (the potential difference between the basal and apical 
membranes o f  the RPE). A similar effect o f  melatonin on standing potential has been 
observed in chickens both in vivo (Rudolf et a l, 1992) and when melatonin is applied 
to C-RPE preparations (Nao-1 et a l, 1989). Thus melatonin has marked effects on 
the RPE. The route by which melatonin reaches the RPE is important with respect to 
the effect melatonin has: circulating melatonin which arrives via the basal membrane 
causes opposite effects to those produced above when it acts primarily on the apical 
membrane (Textorius and Nilsson, 1987). Furthermore, Nao-1 and co-workers (1989 
) have shown that the effects o f melatonin on RPE electrical activity may be 
mediated indirectly, that is, melatonin may act on retinal neurons to modulate the 
release o f  another agent which then affects the RPE.
Kurusu and co-workers (1993) have shown that melatonin may also have effects 
on the 6-wave, implying therefore an effect on components o f the NR. In the 
Japanese quail, they found that intravitreal injection o f melatonin during the light 
phase significantly decreased the ratio o f  6- to a-wave such that the ERG  more 
closely resembled that obtained during the night. Thus sensitivity to light was 
decreased. In contrast, in the chicken, intraocular injection o f melatonin had no effect 
on the ERG 6-wave (Lu et a l, 1995) although systemic administration o f  melatonin 
significantly decreased 6-wave amplitude. In the human also, oral administration o f 
melatonin causes significant reduction in 6-wave amplitude, that is, a decrease in the 
sensitivity to  light (Emser et a l, 1993).
In view o f  these data a role for melatonin in the generation o f  the circadian 
changes in the ERG is suggested . This may be a direct effect o f  ocular melatonin 
within the eye. However, there is evidence, at least in the chicken, that circulating 
melatonin may be mediating the effect via a central site (Lu et a l, 1995).
There is an apparently conflicting body o f evidence, however, which proposes 
that melatonin may instead be able to increase retinal sensitivity. In salamander retina, 
for example, melatonin has been demonstrated to enhance the sensitivity o f  horizontal 
cells to light (Wiechmann et a l, 1988). Similarly, iontophoretic application o f 
melatonin to  guinea pig retina increases its sensitivity to light (Semm and Vollrath,
1982). Reuss and Kiefer (1989), investigating the effect o f  systemic melatonin 
application on the properties o f cat visual cortex cells, demonstrated an improved 
signal-to-noise ratio in response to visual stimuli in the presence o f  melatonin. Their 
findings led them to suggest that in normal circumstances this action occurs at the 
level o f  the retina and is under the control o f locally produced melatonin.
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The exact nature o f melatonin’s role is uncertain in view o f the opposing nature 
o f  some o f  its actions.
Dopamine is yet again implicated in some o f the effects o f melatonin on the 
ERG. Intraocular depletion o f endogenous dopamine (by inhibitors o f  its synthesis), a 
procedure which increases melatonin, causes standing potential to  be decreased as it is 
in the presence o f  exogenous melatonin (Rudolf et a l, 1992). Furthermore, peak 
sensitivity in terms o f  6-wave amplitude occurs in the morning, that is at the time 
when dopamine synthesis is peaking and when retinal melatonin is declining. In light 
o f  these factors Emser and colleagues (1993) propose a dopaminergic mechanism 
involved with generation o f the ERG 6-wave, with the system subsequently modified 
by the actions o f retinal melatonin.
1.7.4 Other effects on RPE
Two Anther effects o f melatonin on the RPE have been reported. Physiological 
concentrations o f melatonin have an antiproliferative effect on bovine retinal pigment 
cells maintained in vitro (Yu et ah, 1993). Melatonin is also chemotactic for cultured 
chick RPE cells (Shirakawa and Ogino, 1987). The biological significance o f these 
novel actions o f  melatonin is, at present, undetermined.
1.7.5 Control o f intraocular pressure (lOP)
Melatonin may play a part in the regulation o f intraocular pressure (lOP) 
although there is conflicting evidence as to its precise role. Like the photomechanical 
changes described in section 1.7.2, lOP exhibits circadian rhythmicity in several 
species including rabbit (Anjou, 1961) and human (Newell and Krill, 1965). 
Concomitant fluctuations in melatonin level may be responsible: melatonin has been 
demonstrated in both aqueous humor and the ciliary body (sections 1.3.2.2 and 
1.3.2.3) and displays diurnal rhythms in these compartments.
Chiou and McLaughlin (1984) were the first to implicate melatonin in the 
control o f lOP. Systemic administration o f agents which indirectly increase or 
decrease melatonin synthesis (through effects on the melatonin precursor, 5-HT) were 
found to increase and decrease lOP, respectively. In the rabbit lOP is higher at night 
(Anjou, 1961), that is, at the same time that ciliary body melatonin is reported to be 
increased (Rohde et a l, 1985 ). Melatonin applied via the vortex vein
significantly increases lOP in the rabbit (Rohde et a l, 1993). Ocular hypertension 
was also found to be induced by melatonin (Chiou et a l, 1985). Light exposure, 
known to decrease ocular melatonin synthesis, decreases lOP in rabbits during the 
night (Lee e ta l, 1995). Pharmacological treatments, for example with opioids, which 
may alter melatonin levels (Rohde et a l, 1993a) also affect lOP (Rohde et a l, 1993b. 
Taken together these observations provide evidence both direct and indirect for a 
possible role o f  melatonin in the control o f lOP. In contrast, Kiuchi and co-workers
(1993) were unable to demonstrate an increase in rabbit lOP following administration 
o f melatonin by any o f four routes including intravitreal injection and topical 
application.
In humans there is also some evidence confirming an involvement o f  ocular 
melatonin in the control o f lOP. N ot all the data are consistent with this hypothesis, 
however. Human lOP is higher during the daytime than at night and its rhythm is
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therefore out o f phase with that o f  the rabbit (Newell and Krill, 1965). Samples and 
co-workers (1988) have reported lOP to be decreased by oral administration o f 
melatonin consistent with a depressive effect o f  melatonin on lOP. Furthermore, 
bright light suppression o f melatonin production attenuated the night-time fall in lOP. 
In contrast, Koskela and Brubaker (1991) were unable to demonstrate a suppressive 
effect on aqueous flow by bright light. Furthermore, oral melatonin given during the 
day to  mimic possible physiological night-time rises in melatonin does not suppress 
aqueous flow (Viggiano et a l, 1994).
The exact source o f  endogenous melatonin which participates in the control o f 
lO P has not been definitely proven. It is feasible that it might be ocular melatonin. 
Intra-ocular application o f melatonin in the cat, for example, has been reported to 
increase lO P via an effect on aqueous humor outflow (a determinant o f lO P) (Rohde 
et a l, 1985). However, Liu and Dacus (1991a) have shown in the rabbit that 
following unilateral transection o f  the cervical sympathetic trunk dark elevation o f  
lO P o f the decentralised eye is decreased despite melatonin content o f  the aqueous 
humor remaining high. This implies that ocular melatonin itself may not play a major, 
direct role in the elevation o f  lOP.
1.7.6 Activation o f rod disc shedding
Photoreceptors exist in a dynamic state. In 1967, Young showed that the disc 
membranes o f  photoreceptor cell outer segments are continually renewed. 
Subsequently it was found that assembly o f new discs is balanced by a process o f  disc 
shedding from the apex o f  the outer segment (review, Besharse, 1982 and Bok, 1985 
). Cone disc shedding occurs in a similar fashion to that o f  rods. The 
process appears to  be rhythmic but there appears to be no rhythm common to all 
species. Rod disc shedding occurs as a true circadian rhythm (Goldman et a l, 1980; 
LaVail, 1980) with most discs being detached at light onset or soon after. A  dark 
phase at least 30 minutes, “dark priming”, and a light phase, “light induction”, are 
required for shedding to occur. Furthermore, all shedding is totally inhibited after the 
first 30 minutes o f bright light.
A possible relationship between melatonin and photoreceptor disc shedding was 
first suggested by LaVail (1976) on the basis that both are subject to  rhythmic control 
and because reserpine, which blocks pineal melatonin synthesis, also blocked disc 
shedding. Administration o f exogenous melatonin increases disc shedding in rat retina 
further implicating melatonin in the control o f  disc shedding (White and Fisher, 1989). 
The available data indicates that disc shedding is an intrinsic function o f  the eye 
(Teirstein et a l, 1980), as its properties are maintained in enucleated eyes fi’om 
Xenopus laevis as they occur in the eye in situ (Flannery and Fisher, 1979 and 1984). 
Circulating and central factors are therefore not required. Dahl (1992) has suggested 
that the effects o f  light and dark on disc shedding are transduced by photoreceptors 
and then mediated indirectly through various paracrine factors, that is, disc shedding 
is under the control o f intraocular factors. She has proposed a triadic model involving 
melatonin, dopamine and rostrophin as the paracrine agents involved in the control o f  
the disc shedding process. In this model, melatonin, synthesised in darkness, acts as 
the dark priming agent. This role o f  melatonin in activating rod shedding has been 
demonstrated conclusively in Xenopus laevis eyecup preparations (Besharse and 
Dunis, 1983).
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1.7.7 Inhibition o f  phagocytic activity
Once shed, photoreceptor discs are phagocytosed by the RPE cells and 
subsequently degraded (Young and Bok, 1969). Like the disc shedding process, 
processing o f  this phagocytic load is a rhythmic event. In some species, the RPE may 
display a circadian rhythm (for example, Besharse and Hollyfield, 1979). Rod 
photoreceptor disc phagocytosis is maximal in the morning, several hours after light 
onset and that o f cones in early night. Light is essential for expression o f  the rhythm 
o f autophagy (Remé et a l, 1985). This process represents another possible point for 
melatonin involvement. Ogino and co-workers (1983) have shown that melatonin 
specifically inhibits phagocytic activity o f  cultured chick RPE cells (measured by 
phagocytosis o f  latex particles), and suggest that melatonin synthesised in 
photoreceptors carries the stop signal for phagocytosis to the epithelial cells.
1.7.8 Effects on the cytoskeleton
Melatonin is reported to affect cellular processes that involve microtubules and 
microfilaments. In various cell lines, for example, melatonin has been demonstrated to 
modify cytoskeletal organisation (Benitez-King et a l, 1991a). Several o f  the ocular 
physiological processes that melatonin affects, involve the cytoskeleton. These include 
retinomotor movements (review, Burnside and Nagle, 1983) and rod disc shedding 
(review, Besharse, 1982). Hence melatonin may effect its ocular actions by this 
means. Melatonin may need to bind to calmodulin to bring about these effects on the 
cytoskeleton (section 1.10.3.2).
1.7.9 Gross effects o f systemic melatonin on the eye
In addition to the specific actions that melatonin mediates within the eye, 
various effects o f melatonin on gross ocular physiology have been reported. Four 
weeks o f systemic administration o f melatonin by subcutaneous injection caused a 
dose dependent increase in absolute and relative intact eye weight in the hamster 
(Quay, 1984) Part o f this increase was as a result o f increased lens weight (dry and 
wet). Furthermore, there was a net increase in ocular fluid volume. Similar 
gravimetric effects o f  melatonin on eye weights or their component parts were not 
observed in the finch 60 days after melatonin implantation (Quay, 1986) However, 
there were other effects o f  melatonin in this species. In birds maintained under I5h 
light:9 h darkness photoperiod conditions, pupillary diameter measured at both ~ 2 
and ~ 11 hours after light onset was significantly decreased compared with the control 
birds. Interpalpebral diameter (perpendicular distance between edges o f eyelids at 
point o f  maximal separation) was similarly decreased by melatonin. In both these 
studies the melatonin treatment levels were supra-physiological. It is possible 
however that ocular melatonin at physiological levels may contribute similar types o f 
effect.
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1.8 Ocular melatonin - implications for biological rhythmicity
Throughout the preceding discussions o f ocular melatonin a common theme has 
been the obvious relevance o f this melatonin, either directly or indirectly, to  biological 
rhythmicity. N ot only has its synthesis been shown to be under circadian control 
within a number o f  species, but also ocular melatonin, in turn, is known to exert 
influence over certain aspects o f “circadian” ocular physiology. As will become 
apparent, the possible ramifications o f  certain o f  these influences may be profound. 
This section aims to bring together the several routes by which melatonin may “input” 
to  the circadian system. The circadian system can be considered as a hierarchical 
organisation with the main pacemaker, the SCN in the case o f  mammals, being 
located at the top, and with the outward manifestation o f circadian control, that is, the 
rhythms themselves, at the bottom. The routes by which melatonin exerts its 
influences input at several o f  these organisational levels. In this discussion, the effects 
o f  melatonin have been arbitrarily divided into two groups; those involving the eye 
itself and those outside the eye (Figure 1.7). It is apparent however that the tw o may 
overlap to  a certain extent.
1.8.1 Local (ocular) circadian physiology
At the most basic level ocular melatonin synthesis is itself a rhythmic event in 
the vast majority o f species that have been studied. This may be true circadian 
rhythmicity, which in some instances is under the control o f an oscillator which 
resides within the eye itself (section 1.5.2).
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Melatonin in turn may influence other local rhythmic events; an idea first 
propounded by Besharse and luvone (1983). Various physiological processes in the 
eye exhibit diurnal/circadian rhythms. In toads and fishes, levels o f mRNA for the 
photoreceptor protein opsin fluctuate in a circadian manner (Korenbrot and Fernald, 
1989). In the Japanese quail (Sasaki et a l, 1995) and chicken (Oishi, 1984) comeal 
mitotic rate displays a circadian rhythm as does phosopholipid synthesis in rat rod 
photoreceptors (Dudley et a l, 1984). Rod outer segment disc shedding, retinomotor 
movements, and intraocular pressure are also under circadian control (sections 1.7.2 
and 1.7.5).
The circadian production o f  melatonin may be directly responsible for the 
generation o f  these rhythms such that in the absence o f  melatonin they do not exist. 
Alternatively, the ocular rhythms may themselves be products o f a circadian clock(s) 
and ocular melatonin may serve to modulate them in some way via an action on the 
clock. In the quail eye, for example, melatonin is able to phase advance the rhythm in 
corneal mitotic rate (Sasaki, 1995). It may also be responsible for the characteristic 
night-time type ERG, as melatonin has been shown to significantly decrease 6-wave 
amplitude (Kurusu et a l, 1993).
Besharse and co-workers (1988) and Dubocovich (1988a) have proposed that 
by acting in this manner, ocular melatonin, in conjunction with the dopamine system, 
may serve to  signal the dawn and dusk periods and hence may be functioning in the 
capacity o f  a local internal zeitgeber in an analogous situation to that which has been 
proposed for pineal melatonin by Armstrong (1989).
1.8.2 Extra-ocular circadian physiology
The relationships between ocular melatonin and circadian physiology are not 
restricted to  the ocular interface. Ocular melatonin may also have influences on 
aspects o f circadian physiology outside the eye and potentially therefore much further 
up the hierarchy o f circadian control.
The effects to be considered can be divided broadly into two groups. Firstly, 
there are those that result from the endocrine release o f melatonin from the eye. In a 
number o f species ocular melatonin contributes a significant proportion o f  the 
circulating melatonin level (section 1.7). In one o f these, the pigeon, there is evidence 
to  suggest that this release o f melatonin from the eye contributes to maintenance o f 
circadian function. Bilateral enucleation in the pigeon results in diminution o f  the 
clarity o f  locomotor activity and temperature rhythms however these effects can be 
negated by daily administration o f melatonin (Oshima et a l, 1989). In the Japanese 
quail also, a hormonal output from the eye, presumed to be melatonin, is required for 
maintenance o f  the integrity o f the central circadian system (Underwood, 1994). 
Thus it may be that melatonin’s primary action is to input to the central oscillator in 
these species.
The second effect o f melatonin on circadian rhythmicity outside the eye may in 
fact result from some action o f melatonin within the eye. Given that the synthesis o f 
ocular melatonin is very much dependent upon both the ambient lighting conditions 
and the time o f  day, it is possible that it may function to modulate the transmission o f 
information regarding these variables from the eye to the central oscillator. The RHT
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represents a direct anatomical link between the eye and the SCN through which photic 
information integrated by the former reaches the latter (M oore-Ede et al., 1983) and 
is therefore a putative target site for ocular melatonin to exert its influence.
In addition to, or instead of, modulating the light signal once it has been 
received by the retina, melatonin could affect actual reception o f the light signal. 
Melatonin may do this by simply altering the stimulus threshold, or it may even be 
capable o f  influencing the perceived intensity o f  a stimulus in some way. In either 
case the photic information which is eventually relayed to the SCN would not 
necessarily be accurately representative o f  environmental lighting conditions. The 
reduction in pupillary and interpalpebral diameters caused by melatonin (Quay, 1986) 
may be o f  relevance in this context; both may reduce photopic input to the retina and 
thus affect subsequent SCN signalling. In addition, several actions o f  melatonin 
within the eye are involved with some aspect o f visual sensitivity, for example effects 
o f the ERG (section 1.7.3). Several other aspects o f visual sensitivity are also known 
to be under rhythmic control. Humans display a daily fluctuation in visual threshold 
(Bassi and Powers, 1986) and in rats (Terman and Terman, 1985), there is a circadian 
rhythm o f visual sensitivity. At present there is no evidence that ocular melatonin is 
involved with either o f  these but it is possible that it might. The rhythm o f  visual 
sensitivity, for example, is maintained following lesion o f the SCN implying a separate 
pacemaker or other control system (Terman and Terman, 1985). Thus, if  visual 
sensitivity can be modified by melatonin it is likely that light reception required for 
circadian control can also be. Visual information is known to input to  the SCN (via 
the lateral geniculate nucleus) (Rusak, 1977). Therefore, one additional possibility is 
that those changes in visual sensitivity for which melatonin is responsible, 
subsequently also affect the central clock. The specific photoreceptors that mediate 
mammalian circadian responses to light have not been identified. Studies with 
retinally degenerate mice suggest that circadian photoreception might be maintained 
either by a very small number o f photoreceptors or, by an unrecognised class o f 
photoreceptive cell (Foster et al, 1991). The role o f ocular melatonin in circadian 
photoreception is currently poorly defined. The potential repercussions o f  the 
scenario, if  it is physiologically operational, in which melatonin acts locally within the 
eye to effect changes in light reception and consequently in the signal being 
transmitted to the central circadian clock, are considerable. One obvious example 
relates to those circadian timing experiments which require light o f a specified 
intensity to be administered at a particular time (for example phase response curve 
experiments). Depending on the melatonin status within the eye, which itself is 
dependent on light exposure and circadian phase, the actual information subsequently 
relayed to the SCN may or may not be representative o f the experimental lighting 
conditions employed. Thus the response o f the organism may also not be a direct 
translation o f these lighting conditions.
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1.9 Ocular melatonin and disease - cause or cure?
1.9.1 Ocular health and disease
The physiological actions o f melatonin within the eye may, under certain 
circumstances, be deleteriously exaggerated and consequently assume 
pathophysiological relevance. Thus, ocular melatonin may be o f  significance with 
respect to  disease aetiology. Conversely, recent studies have also attributed various 
protective functions to ocular melatonin.
1.9.1.1 Intraocular pressure (lOP)
The hypothesised participation o f melatonin in the control o f  lOP (section 
1.7.5) gives rise to the possibility that melatonin may exacerbate, or indeed contribute 
to  the pathogenesis of, conditions such as glaucoma. Melatonin levels in the iris and 
ciliary body o f chickens with light-induced avian glaucoma are increased compared 
with normal controls, probably as a result o f the increased NAT activity which is also 
observed (Aimoto et al., 1985). Furthermore, the time at which NAT increases is 
coincident with the onset o f the decrease in aqueous outflow Pharmacological 
manipulation o f ocular melatonin levels may therefore be o f some use in the treatment 
o f conditions involving lOP. As previously described, the mu opiate agonist DAGO 
causes a reduction in melatonin content o f iris and ciliary body (Rohde et a l, 1993) 
and several other topically applied opioids also affect melatonin levels in these tissues 
(Rohde et a l, 1993). Consequently, the opioid peptides have been proposed as 
potential drug treatments for glaucoma via an action on the melatonin system.
1.9.1.2 Retinal degeneration
Melatonin has been implicated with retinal pathologies. Chronic administration 
o f  melatonin increases the severity o f retinal damage induced by continuous high 
intensity illumination in rats (Bubenik and Purtill, 1980; Leino et a l, 1984a; 
Wiechmann and O ’Steen, 1992). Wiechmann and O ’Steen (1992) propose that in 
disease states such as retinitis pigmentosa, the presence o f a dark signal (melatonin) 
during light exposure results in disruption o f temporal cell function.
In Royal College o f Surgeons (RCS) rats, photoreceptor disc shedding and 
phagocytosis is compromised leading to retinal and RPE degeneration (LaVail, 1976). 
In view o f the fact that melatonin is inhibitory to the RPE phagocytic process (Ogino 
et a l, 1983), Hawlina and colleagues investigated the melatonin contents o f  RCS 
retina (1992). Melatonin levels in dystrophic rats were found to be significantly 
higher than controls. The possible contribution o f melatonin to the degeneration 
process may be an indirect one through its inhibitory effect on dopamine (Hankins and 
Ikeda, 1994).
1.9.1.3 Other diseases
Yu and co-workers (1993) have proposed that the antiproliferative effect o f 
melatonin on RPE cells that they observed may be exploited in order to  control
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cellular responses accompanying pathological growth activation, for example, in the 
condition o f proliferative vitreoretinopathy.
Myopia can be induced in newly hatched chickens by experimentally inducing 
retinal image degradation (deprivation myopia) (Wallman et a l, 1978). The process 
is under local retinal control and involves dopamine (Weiss and Schaeffel, 1993) and 
D 2 receptors (Rohrer et a l, 1993). In light o f the evidence for the mutual antagonism 
o f the dopaminergic and melatonin systems within the eye (sections 1.7.1.1 and
1.5.5.1), the role o f  melatonin in deprivation myopia has been investigated. It was 
concluded from these studies, however, that melatonin is not involved in the retinal 
signalling pathway translating visual experience to deprivation myopia (Hoffmann and 
Schaeffel, 1996).
1.9.1.4 Melatonin as a functional ocular antioxidant
Ocular melatonin is rarely considered outside the context o f  circadian 
physiology, and indeed on the basis o f its effects described above there is ample 
reason to  warrant such an approach, many o f its effects being able to be interpreted 
with respect to some aspect o f  circadian physiology. However, in addition to  its 
contribution to  both local and whole body circadian physiology, ocular melatonin may 
be o f  significance within the eye in an alternative capacity, namely that o f an 
antioxidative protection mechanism.
The antioxidant action o f melatonin has recently gained support as a potentially 
important role o f pineal melatonin (review, Reiter, 1995) and evidence exists for it 
mediating a similar function within the eye. The retina is characterised by an 
extremely active aerobic metabolism - its oxygen consumption is highest o f  all body 
tissues (Sickel, 1972). The retina is thus susceptible to oxidative damage, particularly 
peroxidation o f  lipids. Furthermore, because o f  the transparency o f  the eye, damaging 
free radicals can also be produced photochemically. The retina possesses several 
proven defences against this damage, for example antioxidative enzymes such as 
superoxide dismutase (Hall and Hall, 1975) and natural antioxidant molecules like 
ascorbate and vitamin E  (Riis et a l, 1981; Organisciak et a l, 1985). Melatonin may 
represent an additional free radical scavenger. The molecule has been demonstrated 
to  be an efficient scavenger o f both peroxyl (Fieri et a l, 1994) and hydroxyl radicals 
(Tan et a l, 1993). In rat retinal homogenates, melatonin was found to  provide 
protection against lipid peroxidation, even in the presence o f  Fe%  a potent stimulator 
o f  lipid peroxidation (Chen et a l, 1995). In addition, daily systemic administration o f 
melatonin inhibits cataract formation induced in newborn rats by glutathione depletion 
(Abe et a l, 1994) (a process known to enhance oxidative stress (Calvin et a l, 1986). 
Thus melatonin may also be able to reduce oxidative damage to protein.
W hether melatonin undertakes similar functions within the eye in vivo at 
physiological concentrations, is as yet undetermined. Positive identification o f  the 
retinal melatonin system as a functional antioxidative system might have profound 
implications for both the aetiology and treatment o f  several ocular disease states 
which have been associated with free radical damage, for example, senile cataract 
(Spector and Gamer, 1981), primary open angle glaucoma (Babizhayev and Bunin,
1989) and possibly autoimmune uveitis (Ishimoto et a l, 1996). The whole concept 
o f  melatonin as a physiologically significant antioxidant is however somewhat
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controversial and much more extensive investigation o f this potential role is 
necessary.
1.9.2 Ocular melatonin - implications for systemic dysfunction
1.9.2.1 Seasonal affective disorder (SAD)
Retinal melatonin, in combination with dopamine, has been proposed by one 
author as the primary causative factor o f SAD. This condition occurs annually in the 
autumn and winter months in certain individuals and is characterised by depression 
plus a collection o f other symptoms such as hypersomnia and dysphoria (Rosenthal et 
al., 1984). Oren (1991) hypothesises that in this condition, there is either excessive 
activity o f  the retinal melatonin system or a deficiency in retinal dopamine, the end 
result being increased retinal melatonin levels. Bright light treatment has been 
demonstrated to be an effective treatment for SAD, particularly its depressive aspects 
(Terman et a l, 1989). According to Oren, this is therefore in agreement with his 
hypothesis that the causal agent o f SAD depression is ocular melatonin: light 
suppresses its synthesis both directly, and indirectly through the stimulation o f 
dopamine synthesis. Another mechanism suggested by Oren for the involvement o f 
ocular melatonin in SAD is via its ability to regulate the putative intraocular clock. 
Lewy and colleagues (1986) have proposed the “phase shift hypothesis” o f SAD in 
which there is a delayed onset o f nocturnal melatonin secretion. Oren postulates that 
inappropriate melatonin activity within the eye affects the local clock such that its 
subsequent input to the central circadian clock is deleteriously altered.
The involvement o f ocular melatonin in SAD is, as yet, only a hypothetical 
concept. Rigorous testing o f these proposals is required before their possible 
physiological relevance can be accepted.
1.9.2.2 Affective disorders
Manic-depressive illness has been associated with abnormal phase relationships 
between normal physiological circadian rhythms (Hallonquist et a l, 1986). It is 
postulated that this in turn may relate, at least in part, to a defect in the retinal 
melatonin system, as described above for SAD (Seggie et a l, 1986; Seggie, 1988, 
and Steiner et a l, 1987). These authors propose that rhythmic ocular melatonin 
synthesis is affected in manic-depressive disorders resulting in increased sensitivity o f 
the retina to  light. Consequently, through changes in light input to the SCN, the 
circadian rhythms become asynchronous. Lithium therapy employed in these 
conditions is believed to act via an effect on retinal melatonin (Seggie et a l, 1986; 
Seggie, 1988).
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1.10 Mechanism of action of melatonin within the eye
1.10.1 Receptors
In order to  mediate the diverse actions o f melatonin within the eye that have 
been described (section 1.7), some mechanism for the translation o f its message into 
cellular activity must exist. Much effort has been devoted to establishing the precise 
mechanism(s) o f action o f  both pineal and ocular melatonin. It has been proposed 
that the biochemical events in target cells are initiated via involvement o f  a specific 
receptor and indeed a large body o f  evidence for the existence o f  the putative 
melatonin receptor has been established. Within the eye, both cell surface and 
intracellular receptors for melatonin have been reported (Table 1.4).
1.10.1.1 Radioligands used in binding studies
Radiolabelled melatonin has long been available in the tritiated form, that is, as 
[2-aminoethyl-2-^H]melatonin or [methoxy-^HJmelatonin (having specific activities o f 
~ 30-40 Ci/mmol and ~ 80 Ci/mmol respectively) and the earliest melatonin binding 
studies used this as the radioligand. Little progress was made however and the initial 
reports o f specific, binding sites have been difficult to replicate. M ore recently 
radioiodinated melatonin (2-[*^^I]iodomelatonin) was developed for use in RIA 
(Vakkuri et a l, 1984a,b ). Subsequently this radioligand was utilised as a
probe for melatonin receptors. It has many advantages over the tritiated ligand as a 
pharmacological tool and consequently has rapidly become the ligand o f  choice for 
the investigation o f melatonin binding sites. It has a much higher specific activity (up 
to 2186 Ci/mmol) thus allowing increased sensitivity o f receptor detection 
(advantageous for the study o f high affinity, low density receptors) and also the 
emission o f both high energy p and y radiation facilitates its detection by 
autoradiography. Despite the significant alteration, following iodination, the 
melatonin molecule retains its biological activity both outside (Weaver et a l, 1988; 
Sugden 1989) and within the eye; 2-iodomelatonin is able to inhibit the calcium- 
dependent release o f [^H]dopamine from chicken N R as effectively as melatonin 
(Dubocovich and Takahashi, 1987).
There is some debate over the appropriateness o f  the two ligands for use in 
melatonin binding studies. It has been suggested by a number o f  authors (Krause and 
Dubocovich, 1991; Kennaway et a l, 1994; Sugden, 1994) that use o f  ^ H-melatonin is 
not a particularly suitable radioligand, in part because o f its low specific activity and 
have attributed the lack o f consistent, reproducible data generated in the early years to  
the radioligand.
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1.10.1.2 High and low affinity sites
Binding studies using tritiated melatonin indicated existence o f  a low affinity 
melatonin binding site with an equilibrium dissociation constant value (Kd) in the 
nanomolar range in a variety o f  tissues including bovine brain membranes (Cardinali 
et a l, 1979) and rodent gonadal cytoplasm (Cohen et a l, 1978). These latter authors 
also reported existence o f a cytoplasmic binding site in the hamster eye. However, as 
discussed above, these investigations were probably hindered by the inherent 
disadvantages o f this radioligand and the findings have not been reproduced. Using 
2-[^^^l]iodomelatonin, high affinity melatonin binding sites were identified for the first 
time in 1987 by both in vitro autoradiography and membrane radioreceptor assay in 
rat brain (Vanecek, 1988). This radioligand was subsequently used extensively in the 
search for melatonin binding sites and has identified putative melatonin receptors in 
many vertebrate species in a variety o f tissues (review, M organ et a l, 1994).
The majority o f  receptors revealed by 2-[^^^l]iodomelatonin, including those 
within the eye, display similar pharmacological characteristics. They are o f  high 
affinity with a Kd within the range 20 - 400 pM. Specific 2-[*^^l]iodomelatonin 
binding is saturable indicating a finite number o f receptors and the interaction 
between melatonin and the receptor is reversible. In addition, the receptor displays 
high selectivity for melatonin or closely related analogues. This high affinity 
melatonin binding site therefore fulfils many pharmacological criteria o f  a receptor.
There is much less evidence, however, that melatonin binding is associated with 
mediation o f a biological function. One o f  the first actions o f  melatonin to be 
described was its ability to cause melanin pigment-containing melanosome 
aggregation in amphibian dermal melanophores, an action mediated through a high- 
affinity melatonin receptor (reviewed by Rollag, 1988). Within the eye only one 
action o f melatonin, namely that o f inhibition o f retinal dopamine release, has been 
specifically attributed to interaction with a binding site. This has been confirmed in 
rabbit (Dubocovich, 1983; Nowak et a l, 1989) and frog (Boatright and luvone, 
1989) retina. In this case it has been postulated that the melatonin receptor is a 
presynaptic heteroreceptor. Within the eye there is also evidence that melatonin 
receptor activation triggers a variety o f intracellular second messenger systems. 
M elatonin’s influence appears predominantly to involve the cAMP system (section 
1. 10.2 .2).
1.10.1.3 Agonists and antagonists
Investigation o f  the relationships between melatonin structure and 
affinity/activity, was first considered in detail in 1975 (Heward and Hadley). Using 
one o f  the few functional bioassays available, namely in vitro condensation o f pigment 
granules in frog skin melanophores, these authors reported that the A-acetyl side 
chain group and a 5-methoxy group on the indole ring were prerequisites for binding 
and receptor activation, respectively. These findings have generally been confirmed 
for retinal melatonin receptors (for example, Dubocovich, 1985; Dubocovich and 
Takahashi, 1987). M ore recent studies however indicate that, at least in the 
melanophore pigment aggregation assay, the 5-methoxy moiety is not essential for
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biological activity (Garratt et a l, 1994) but does in fact make a substantial 
contribution to binding affinity (Sugden and Chong, 1991).
Amongst indoleamines in general, halogenic substitution on C-2 o f  the indole 
ring produces compounds with the highest binding affinity amongst the sites described 
(for example, bromomelatonin (Duranti et a l, 1992). There is evidence that the 
indole nucleus itself is not essential for binding or activation o f  biological responses. 
For example, it can be replaced with a naphthalene group with no adverse effect on 
either o f these properties (Yous et a l, 1992). It has been suggested, therefore, that 
the indole moiety serves to  maintain the appropriate functional groups in the correct 
spatial orientation (Sugden, 1994).
On the basis o f these facts the rank order o f potency o f compounds for the 
inhibition o f  specific 2-[*^^I]iodomelatonin binding at the high affinity melatonin 
binding site is 2-iodomelatonin > melatonin > 6-chloromelatonin > 6-
hydroxymelatonin > N-acetylserotonin »  5-HT. The majority o f  ocular receptor 
characterisation studies have confirmed this order (for example, frog NR: Skene et 
a l, 1993; chicken NR: Dubocovich and Takahashi, 1987; tree shrew NR-RPE: Lu et 
a l, 1991).
Importantly, in support o f the opinion that the melatonin binding site labelled by 
2-[^^^I]iodomelatonin is a functional melatonin receptor, within both the rabbit and 
chicken retina, a highly significant correlation between the potency o f  indoles to 
inhibit the calcium-dependent release o f  ^ H-dopamine and the potency to compete for 
2-[*^^I]iodomelatonin binding in chicken retinal homogenates has been demonstrated 
(Dubocovich 1985; Dubocovich and Takahashi, 1987).
Understanding o f the precise role o f melatonin in physiological processes has 
been hampered by a lack o f potent and selective receptor antagonists. Early 
candidates such as A-(2,4-dinitrophenyl) 5-methoxytryptamine (Zisapel and Laudon, 
1987) have been proven to have poor affinity and weak activity at the high affinity 
melatonin site (for example, Sugden, 1992). Luzindole (2-benzyl-A-acetyltryptamine) 
(Dubocovich, 1988b), another putative antagonist, displays definite antagonistic 
activity in both the eye (inhibition o f calcium-dependent dopamine release in the rabbit 
retina with Kd 20 nM (Dubocovich, 1988a) and inhibition o f cAMP accumulation in 
chick retinal culture (luvone and Gan, 1994) and in other functional bioassays. 
However, there are systems in which luzindole lacks antagonistic action, for example, 
cAMP production in sheep pars tuberalis (Howell and Morgan, 1991). There is no 
commercial source o f  luzindole and this has in part prevented further exploitation o f 
its antagonistic properties.
Dubocovich (1988c) has proposed a classification scheme which incorporates tw o 2- 
[^^^Ijiodomelatonin binding site subtypes. The first, ML-1 corresponds to  a site with 
the pharmacological properties described above. In contrast, the second, ML-2, 
refers to a binding site described in hamster brain membranes which has distinctly 
different properties (Duncan et al, 1986, 1988). It is a low affinity site with a Æa in 
the nM range. Furthermore, the pharmacological specificity o f  the site is not the same 
as that o f the high affinity site: the ML-2 site recognises the melatonin synthetic 
precursor, N-acetylserotonin and melatonin itself with equal affinity. However, this 
schema has not gained wide acceptance for a number o f reasons. Firstly, 
autoradiographic localisation o f the putative ML-2 site has not been accomplished. 
M ore importantly, this site has never been associated with mediation o f  a functional 
biological response. The classification has now in part been superseded as a result o f
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the recent cloning o f a family (encompassing 3 subtypes) o f high affinity melatonin 
receptors (section 1.10.2.4).
1.10.2 Cell surface ocular melatonin receptors
1.10.2.1 Location
Using techniques such as radioreceptor assays and autoradiography, high 
affinity membrane bound melatonin binding sites have been detected in ocular tissue 
o f  species from all animal classes (Table 1.4 (I)). The retina and C-RPE have been 
investigated most extensively. In the retina, specific, saturable, melatonin binding 
sites were first identified by Wiechmann and co-workers (1986). Further studies with 
2-[^^^I]iodomelatonin indicated that within the retina, binding is consistently localised 
to the innerplexiform layer (IPL) (rat and chicken: Laitinen and Saavedra, 1990; frog: 
Wiechmann and Wirsig-Wiechmann, 1991; mouse and rabbit: Blazynski and 
Dubocovich, 1991). In view o f the effects o f  melatonin on retinal dopamine release, 
the existence o f  melatonin binding sites in the IPL is appropriate given that a 
predominant component o f this area is the dopaminergic amacrine cell. Additionally, 
melatonin binding sites have been localised to various areas o f the outer retina 
(Wiechmann et a l, 1986; Blazynski and Dubocovich, 1991; Wiechmann and Wirsig- 
Wiechmann, 1991 ) and the RPE (Chong and Sugden, 1991 ), again regions
at which melatonin has known actions on, for example, photoreceptor disc shedding 
and phagocytosis (sections 1.7.6 and 1.7.7). One other site o f melatonin receptors in 
the rabbit eye has recently been identified as the iris-ciliary body complex (Osborne 
and Chidlow, 1994). This finding may correlate with the reported effects o f  melatonin 
on lOP (section 1.7.5). However there are no other reports o f specific melatonin 
binding in this location.
1.10.2.2 Receptor-mediated signal transduction
There is limited evidence associating occupation o f ocular melatonin receptors 
with activation o f biochemical and cellular responses. That which is available, 
supports the hypothesis that melatonin has an inhibitory effect on cAMP production 
via a guanine nucleotide-binding regulatory protein (G-protein). Such a mechanism is 
in fact common to many extra-ocular melatonin receptors, for example, those in the 
pars tuberalis o f the pituitary (Morgan et a l, 1990). At high micromolar 
concentrations melatonin was shown to elevate intracellular cAMP in rabbit retina 
(Blazynski et a l, 1985), although Dubocovich (1988a) suggested that this effect may 
be mediated by a 5-HT receptor rather than a melatonin receptor. Subsequently 
melatonin has been found to inhibit cAMP accumulation in the retina via a receptor- 
mediated mechanism in both chick retinal cell cultures (luvone and Gan, 1994) and 
retinal membrane preparations (Niles et a l, 1991). Similarly melatonin receptors in 
cultured human and rat RPE cells (Nash and Osborne, 1995) and in the iris-ciliary 
body o f  the rat (Osborne and Chidlow, 1994) appear also to be negatively linked to 
the stimulation o f adenylate cyclase. In chick retinal cell cultures the inhibitory effect 
o f  melatonin on forskolin-stimulated cAMP is blocked with pertussis toxin suggesting 
that coupling o f receptor and adenylate cyclase occurs through a pertussis toxin- 
sensitive G protein such as G| (luvone and Gan, 1994). Laitinen and Saavedra
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(1990a) also demonstrated that binding o f melatonin to the chick retinal receptor is 
modulated by guanine nucleotides. In contrast, Chong and Sugden (1991) reported 
that whilst the chick RPE melatonin receptor is G-protein coupled, that in the N R is 
not. Dubocovich and co-workers (1989) also failed to demonstrate an effect o f  GTP 
on 2-[^^^I]iodomelatonin binding to chicken NR.
M ore recently evidence has been reported which suggest that, in addition to the 
inhibitory effect o f  melatonin on dopamine release, there exists a second receptor- 
related mechanism by which melatonin is able to  modulate dopaminergic 
neurotransmission. In chick NR cell cultures, melatonin receptors have been shown 
to be coupled, via an inhibitory G protein, to dopamine receptor (Di)-regulated 
adenylate cyclase (luvone and Gan, 1995). Melatonin may therefore be able to inhibit 
the cAMP response to dopamine receptor activation with associated consequences.
1.10.2.3 Affinity states
As a result o f its G-protein interaction, the high affinity melatonin binding sites 
can exist in two states (Sugden, 1994). In one, the high affinity state {Kd ~  40 pM), 
the binding site is coupled to the G-protein (for example, chick NR melatonin binding 
site, as assessed by Laitinen and Saavedra, 1990). In the other, the low affinity state 
{Kd ~ 400 pM), the binding site and the G-protein are dissociated (for example, chick 
N R  melatonin binding site as assessed by Chong and Sugden, 1991). GTP is able to 
uncouple the binding site and G-protein in the high affinity state. In contrast the low 
affinity state is insensitive to GTP. Under certain assay conditions the two sites may 
be differentially detected. It is also possible that a given membrane preparation may 
possess a mixture o f the two affinity states. The low affinity state reflecting the G- 
protein uncoupled form o f the high affinity state is distinct from the other low affinity 
sites which have been reported, for example that in the hamster brain (Duncan et a l, 
1986, 1988). No high affinity site o f this latter has been identified.
1.10.2.4 Cloning o f the melatonin receptor - multiple receptor subtypes
In 1994 the Xenopus dermal melanophore melatonin receptor was cloned using 
an expression cloning strategy (Ebisawa et al 1994). Using a polymerase chain 
reaction (PCR) approach based on the sequence o f the frog receptor, the 
corresponding sheep and human melatonin receptors were subsequently cloned 
(Reppert et a l, 1994). These were designated Meha. In 1995, a second receptor in 
this family (Mehb) was cloned from humans (Reppert et a l, 1995a). Subsequently, a 
third subtype (Melic) (the structural homologue o f the Xenopus receptor) was 
identified in the chicken (Reppert et a l, 1995b). The three subtypes are widely 
distributed in the vertebrate classes with two exceptions: Mehc has not yet been 
cloned in mammals and there is no evidence that Mein, occurs in birds.
Despite their structural divergence the expressed receptors o f  each subtype 
exhibit similar binding properties. All are G| coupled and their pharmacological 
characteristics are similar to those o f the endogenous 2-[^^^I]iodomelatonin receptor. 
Rank order o f potencies o f  ligands for inhibiting 2-[*^^I]iodomelatonin are also the 
very similar in the three groups, that is m elatonin>6-chlorom elatonin>NAS»5-HT,
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although there is one difference, namely that 6-chloromelatonin is 10-fold more potent 
in inhibiting specific 2-[^^^I]iodomelatonin binding in Mein, than in Meha.
Cloning o f the melatonin receptor genes is expected to pave the way for rapid 
advances in the study o f the melatonin receptor. In particular, it will be invaluable for 
the localisation o f  receptor expression and investigation o f regulation, areas which 
have already benefited. Application o f site directed mutagenesis will provide further 
means to study receptor structure and function.
1.10.3 Intracellular targets for melatonin
1.10.3.1 Intracellular melatonin binding sites
As previously mentioned, Cohen and co-workers detected low affinity 
cytoplasmic melatonin binding sites in a variety o f tissues including the hamster eye in 
1978 (Cohen et a l, 1978). These data have not been confirmed, however, possibly 
because o f  the difficulties experienced with the use o f tritiated melatonin (section
1.10.1.1.1). M ore recently, interest has arisen in the possibility o f a nuclear signalling 
pathway for melatonin. High affinity {Kd ~ 190 pM) melatonin binding sites have been 
detected in homogenates o f rat liver cell nuclei (Acuna-Costroviejo et a l, 1993 and
1994) and within the eye itself, a significant proportion o f 2-[^^^I]iodomelatonin 
binding to chicken retinal membranes being in fact to the nuclear fraction 
(Dubocovich and Takahashi, 1987).
In addition, melatonin has been identified as a ligand o f the orphan nuclear 
receptor retinoid Z receptor p (RZRp), melatonin both binding and activating it 
(Becker-André et a l, 1994). Thus a nuclear signalling pathway may exist, that is, 
direct melatonin-induced control o f  target gene transcription. RZRp may represent 
one o f  the nuclear binding sites for melatonin that have been described. RZRp has 
been cloned and its mRNA located in various tissues including the eye. Within the rat 
retina highest expression was present in the INL, with lesser amounts in the outer 
nuclear and ganglion layers (Becker-André £?/a/., 1994). The a-subtype o f  RZR was 
also subsequently found to be a nuclear receptor for melatonin (Wiesenberg et a l,
1995). I f  found to be expressed in the eye as is RZRp then this will potentially 
represent an additional route o f action for melatonin.
The possible existence o f these nuclear sites o f melatonin action within the eye 
may be o f  some significance given the reports o f nuclear localisation o f  melatonin in 
several tissues (Menendez-Pelaez et a l, 1993). Menendez-Pelaez and Reiter (1993) 
propose that melatonin preferentially accumulates in the nucleus where it binds to 
specific binding sites in order to initiate various genomic effects. A similar system 
may be in operation within ocular tissues. The existence o f this intracellular melatonin 
binding site is controversial however, as the findings have never been confirmed.
1.10.3.2 Calmodulin
The Ca^^ binding protein calmodulin may also be o f  importance in the mediation o f  
melatonin’s actions. Calmodulin has been shown to bind melatonin in a saturable, 
reversible and specific manner (Benitez-King et a l, 1993) hence calmodulin may 
represent an additional intracellular binding site for melatonin. Alternatively,
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calmodulin may in fact be responsible for the intracellular binding which has 
previously been observed, for example by Cohen and co-workers (1978), (Benitez- 
King e ta l,  1993). Benitez-King and co-workers (1993) propose that several aspects 
o f cell physiology may potentially be affected following melatonin binding to 
calmodulin, for example inhibition o f calmodulin-dependent phosphodiesterase 
activity (Benitez-King et a l, 1991b) and cytoskeletal rearrangements ^enitez-K ing 
et a l, 1991a). This calmodulin-melatonin interaction may be o f  relevance within the 
eye.
1.10.3.3 Non-receptor mediated mechanisms o f  action
The proposed antioxidant properties o f  melatonin (section 1.9.1.4) represent 
functions which do not require a receptor for their mediation. Some authors have 
also suggested that the actions o f melatonin in the RPE, for example, are not 
receptor-mediated and may result from melanin binding melatonin non-specifically 
(Laitinen and Saavedra, 1990a).
1.11 Use of cell cultures for the study of the ocular melatonin system
Several research groups have made use o f in vitro cell culture systems, either 
exclusively or in conjunction with other experimental models, in the study o f  various 
aspects o f ocular melatonin. Some o f  these have been mentioned previously. For 
example, chick retinal cell cultures, generated from embryonic tissue, have been 
utilised to  investigate the control mechanism o f NAT (luvone et a l, 1990), to locate 
the intra-ocular circadian oscillator (Cahill and Besharse, 1993) and to  study 
melatonin receptors (luvone and Gan, 1994). All the cell culture systems described 
so far have represented secondary cell cultures, that is, those prepared directly from 
the healthy tissues. Increasing use, however, is being made o f  the continuous cell line 
Y79. This was established in 1974 from a human retinoblastoma (Reid et a l, 1974). 
The cells are multipotential, that is, they are capable o f  differentiation into all major 
cell types o f the retina depending on culture conditions (Kyritsis et a l, 1987a). Y79 
has been demonstrated to synthesise melatonin from both 5-hydroxytryptophan and 
5-HT by some cAMP-dependent mechanism (Pierce et a l, 1989; Deng et a l, 1991). 
The cells are also capable o f synthesising 5-HT (from tryptophan), the precursor o f 
melatonin (Yorek et a l, 1987). Both NAT (Wiechmann et a l, 1990; Janavs et a l, 
1991) and HIOM T (Kyritsis et a l, 1987b; Wiechmann et a l, 1990; Bernard et a l,
1995) activity is present in Y79 cells with cAMP stimulation o f  melatonin synthesis 
acting through an effect on NAT (Janavs et a l, 1991). The reciprocal inhibition o f 
dopamine and melatonin characteristic o f  the normal retina is retained by Y79 cells; 
melatonin inhibits dopamine release (Godley et a l, 1989) and dopamine inhibits 
melatonin release (Deng et al, 1991). The neoplastic nature o f  these cells, however, 
calls into question their representativeness o f  the retinal situation as it is in vivo. As 
has been described, there are many similarities between the Y79 and normal with 
respect to  the melatonin system, however there are also differences. For example, 
melatonin production in Y79 is not susceptible to  inhibition o f  RNA synthesis (Janavs 
et a l, 1994) in contrast to  the situation in chicken retina (luvone et a l, 1990). I f  its
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limitations are acknowledged and accepted however, the Y79 cell line will represent 
another useful tool for the investigation o f the retinal melatonin system.
1.12 R esearch aims
The field o f research concerned with ocular melatonin is increasing in 
prominence. Melatonin has been demonstrated in various ocular tissues in a large 
proportion o f  the species which have been investigated and evidence for a functional 
synthetic capacity exists. It is likely that melatonin mediates several local actions.
Currently however, there is sparse information regarding melatonin in the 
human eye. As far as the author is aware, only three publications have thus far 
reported attempts to demonstrate and quantify melatonin in human ocular tissue 
(Table 1.1). Further, there is only limited evidence suggesting a capability o f the 
human retina for melatonin synthesis. As is frequently the case, novel research is 
undertaken in a wide range o f other species in preference to humans for obvious 
ethical and practical reasons, obtaining a tissue supply, for example. To a certain 
extent information can be extrapolated from other species to man. H owever, at 
some stage, predictions concerning human biochemistry, made on the basis o f  data 
from other species, need to be confirmed or disproved in human tissue itself. 
Hence one o f  the primary aims o f this thesis was to address the issue o f  the presence 
o f  ocular melatonin in man using a source o f post-mortem eyes. The existence o f  a 
functional melatonin system within the human eye is o f potentially great significance.
Chapter 2 describes the development and appropriate validation o f 
methodology for the quantification o f melatonin in NR and choroid-retinal pigment 
epithelium (C-RPE) tissues from post-mortem human eye specimens. Subsequently 
these methods were employed for the analysis o f 46 specimens in order to  establish 
melatonin levels within the human eye and to identify possible relationships between 
content and various donor parameters such as time o f  donor death, donor age, etc. 
(Chapter 3).
The presence o f human ocular melatonin synthesis coupled with the reported 
effects o f melatonin in other species, raises questions concerning its possible mode(s) 
o f action. The existence o f membrane bound, specific, high affinity melatonin binding 
sites within the eyes o f many species suggests that these actions are receptor 
mediated. Furthermore, there is evidence that melatonin binding sites mediate at least 
one functional response. Therefore, in conjunction with investigations concerning 
melatonin quantification, the existence o f melatonin binding sites within the human 
eye was also investigated (Chapter 6).
Prior to use with human tissues, the methodology for investigation o f  melatonin 
binding sites was established using ocular tissues from the Japanese quail.
The quail, as a species, is o f particular interest to the o f field o f  ocular 
melatonin in its own right. The eyes have been demonstrated to be essential for 
maintenance o f  circadian organisation in this species. M oreover, the quail eye 
displays a robust circadian rhythm o f melatonin production, control o f  which is under 
a biological clock which resides in the eye itself (Underwood et a i, 1990). It was o f 
some relevance, therefore, to ascertain whether binding sites for melatonin exist 
within the quail eye. Furthermore, much evidence already exists for the presence o f 
melatonin and its binding sites within the ocular tissues o f avian species hence it was
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likely that melatonin binding sites would also be found in the quail eye, as indeed was 
subsequently proven to be the case. Having identified specific binding sites in the 
quail eye the effect o f  photoperiod on binding parameters was also investigated. 
Photoperiod related changes in melatonin binding site density in the quail brain have 
previously been demonstrated (Panzica et ah, 1994). The binding site studies 
conducted on quail tissue are reported in Chapter 5. The methods employed for 
melatonin binding site analysis, that is, membrane receptor assay and 
autoradiography, are described in Chapter 4.
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C h a p t e r  2
D e v e l o p m e n t  a n d  v a l id a t io n  o f
METHODOLOGY FOR THE QUANTIFICATION OF 
OCULAR MELATONIN BY RADIOIMMUNOASSAY
2.1 Introduction
Three analytical techniques have previously been employed to  quantify ocular 
melatonin: RIA, HPLC and GC-MS (section 1.3.1). This chapter describes the 
development and validation o f an existing RIA method for the quantitative 
investigation o f  melatonin in human NR and C-RPE. The rationale for use o f RIA as 
the method o f choice was based for the most part on practical considerations. There 
is limited access to the more complex chromatographic techniques, that is, HPLC and 
GC-MS. Furthermore, the melatonin RIA is currently a working assay in the 
laboratory. In addition however, RIA per se confers several advantages as an 
analytical tool. Firstly, the technique is highly sensitive: with the particular protocol 
employed in these studies, 1 to 2 pg/assay tube was consistently detected. Secondly, 
the antibody component conveys high specificity for the ligand being measured. 
Finally, the precision obtained with RIA is comparable in most cases with levels 
obtained for other physico-chemical techniques.
The basis o f  RIA is competition between unlabelled antigen and a finite amount 
o f  the corresponding radiolabelled antigen for a limited number o f antibody binding 
sites in a fixed amount o f  antiserum. The competing reactions that form the basis o f 
RIA are shown in Figure 2.1. Upon attainment o f equilibrium the distribution o f anti­
labelled antigen 
A g*
specific antibody 
Ab
labelled antigen- 
antibody complex
Ag
Ag' A ^
solid phase bound 
second antibody 
directed against Ab
unlabelled antigen in 
Ag known standard solutions 
or unknown samples
A b>  0
free and bound antigen 
separated by 
centrifugation
unlabelled antigen- 
antibody complex
Figure 2.1
The molecular basis of the melatonin RIA employed. Modified from Yalow (1978).
gen between free and bound pools is determined. There are various separation 
methods. In the RIA employed in these studies a solid phase-bound second antibody 
directed against the first was used to pellet the bound fraction. Subsequently, bound 
radiolabelled antigen was quantified and used to estimate the antigen o f interest. As
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the unlabelled antigen content increases less radiolabelled antigen is able to bind the 
antibody.
The RIA employed throughout these studies was that originally reported by 
English and co-workers (1993): a GC-MS validated method for the measurement o f 
melatonin in saliva. There are obvious differences between this sample matrix and 
those under investigation. Thus, in order to  enable accurate quantification o f 
melatonin it was necessary to  develop a method o f  sample processing for use prior to 
RIA which would negate any deleterious effects o f  tissue components on the assay. 
Further, it was necessary to  fully validate processing and assay procedures.
Two sample processing methods were compared. In the first, tissue melatonin 
was extracted directly with dichloromethane prior to  RIA. This procedure has 
previously been used successfully to quantify ocular melatonin in a number o f  species 
(Delgado and Vivien-Roels, 1989; Skene et al., 1991). Other authors have extracted 
with different solvents, for example, chloroform (Reppert and Sagar, 1983); methanol 
(Pang et ah, 1983); and diethylether (Serino et al., 1993). For the second sample 
processing method an additional procedure - acid precipitation o f  proteins - was 
included in the protocol before dichloromethane extraction. This approach was 
adapted fi"om that reported by Pang and co-workers (1980; 1982) for the 
quantification o f  melatonin in the mammalian eye.
Availability o f  human tissue was limited hence validation studies were 
undertaken in both human and chicken ocular tissues. Melatonin has frequently been 
reported in the latter (for example, Hamm and Menaker, 1980; Reppert and Sagar, 
1983). Authenticity o f the endogenous melatonin-like immunoreactivity quantified by 
the RIA was subsequently established by TLC.
2.2 M aterials  and  chemicals
2.2.1 RIA
2-[^^^l]iodomelatonin was obtained from Amersham International, 
Buckinghamshire, U.K. Rabbit anti-melatonin anti serum (Batch 19540 - 16876), 
prepared by Dr. J.P. Ravault (INRA, Tours, France) (Tillet et a l, 1986) and 
cellulose-linked donkey anti-rabbit IgG (SAC-CEL, A A Sacl) (obtained fi"om IDS, 
Boldon) were gifts from Stockgrand Limited, University o f Surrey, Guildford. 
Routine laboratory chemicals (analytical grade) including NaCl, NaOH, KOH, HCLO 4 
(perchloric acid), gelatine, tricine buffer (N-tris(hydroxymethyl)methyl-glycine), Brij 
35, were obtained from Sigma, Poole or Fisons, Loughborough. Analytical reagent 
grade dichloromethane and absolute ethanol were from Fisons. A-Acetyl-5- 
methoxytryptamine (melatonin) standard was from Sigma. Original stock melatonin 
solution (1 mg/ml) was prepared in absolute ethanol and stored at 4 °C for up to  1 
month. Subsequent dilutions (1 pg/ml and 10 ng/ml in water) and the final dilution (in 
RIA buffer (section 2.3.2)) were prepared on the day o f the assay. W ater used 
throughout was double-distilled in glass.
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2.2.2 TLC
Tritiated melatonin ([0-methyl-^H]melatonin) was purchased from Amersham 
International, Buckinghamshire, U.K. Radiolabel was diluted with ethanol to  «  10,000 
dpm/50 pi. TLC plates (20 cm x 20 cm; silica gel adsorbent with fluorescent 
indicator) were from Kodak (No. 13181). Analytical grade solvents (ethyl acetate, 
dichloromethane, methanol, ethanol; propan-2-ol; butan-l-ol; and chloroform), glacial 
acetic acid, toluene (low sulphur content) and PPO (2,5 diphenyloxazole, scintillation 
grade) w ere from Fisons. POPOP (1,4-bis (5-phenyloxazol-2-yl) benzene) was 
obtained from Lancaster synthesis, Morecambe. Ascorbic acid was from Sigma.
Standards: melatonin; 5-methoxytryptamine (5-MT); 5-methoxytryptophol (5- 
ML); 5-hydroxytryptophol; A-acetylserotonin (A-acetyl-5-HT, NAS); 5- 
hydroxytryptamine (serotonin, 5-HT); 6-hydroxymelatonin; 5-methoxyindole-3-acetic 
acid (5M1AA); 5-hydroxyindoleacteic acid (5H1AA); 5-methoxyindole; 5- 
methoxyindole-3-carboxyaldehyde-L-tryptophan; 5-methoxytryptophan; 5- 
hydroxytryptophan; A-acetyltryptophan; and 6-methoxy-1,2,3,4,-tetrahydro-9H- 
pyrido-(3,4P)indole (6MeOTHBC) were from Sigma. A-acetyltryptamine was from 
Aldrich, U.K. 6-sulphatoxy-[^^^l]iodomelatonin was a gift from Stockgrand Limited 
and O-acetyl-5-methoxytryptophol (Smith and Francis, 1980) was a gift from D r 1. 
Smith (Cortauld Institute o f  Biochemistry, The Middlesex Hospital Medical School, 
London, U.K.).
2.2.3 Biological materials
Post-mortem human eyes were obtained from the Moorfields Eye Hospital, 
London. Upon collection, eyes were frozen on dry ice and subsequently stored at -80 
°C until use.
Female chickens (breed Warrens) obtained from EDS, Surrey were used 
throughout. From hatching, birds were maintained under a 8.5:15.5 h light:dark 
photoperiod and water and food (Dalgetty chick crumbs) were available ad libitum. 
Birds were sacrificed in the morning by inhalation o f  an increasing CO2 concentration 
followed by cervical dislocation. At the time o f sacrifice, birds were 6-7 weeks old, 
weight range 500-600 g.
2.3 M ethods
2.3.1 Tissue preparation
2.3.1.1 Human tissue
After thawing the eyes, eye cups (consisting o f sclera, choroid, RPE and NR) 
were prepared. These were produced by cutting around the circumference o f  the eye 
in approximately the region o f the ora serrata thus removing the anterior segment o f  
the eye including any remaining comeal tissue and the iris if  present (Figure 2.2). The 
lens and vitreous body were removed with blunt-ended forceps. Eye cups were 
subsequently cut in half in the vertical plane and N R removed. C-RPE segments were 
teased from the sclera. Tissues were each transferred immediately to sample tubes
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containing chilled RIA buffer (1 ml) (section 2.3.2) then sonicated (Ultrasonic 
Homogenizer - 4710 Series, Cole-Parmer Instruments, Illinois) for tw o separate 10 s 
periods with constant cooling to produce homogeneous suspensions. I f  necessary, 
tissues were sonicated for additional time to achieve this. Aliquots o f  tissue 
suspensions produced by this procedure are termed “ homogenate” throughout. In 
some instances tissue “ homogenate” was centrifuged (15 000 x g, 10 min, 4 °C). 
The resulting tissue supernatants are termed “supernatant” throughout.
Dissection and sonication procedures were carried out in Class II and Class I 
safety cabinets respectively, in accordance with School o f Biological Sciences safety 
rules for working with human tissues. Working areas and instruments were 
disinfected after use with hypochlorite solution (20,000 ppm free chloride) and waste 
materials autoclaved (134 °C for 25 minutes) before disposal.
Tissue wet weights were obtained by weighing the sample tubes containing 
buffer before and after addition o f  the tissue. Measurements were made to  4 decimal 
places.
2.3.1.2 Chicken tissue
Chickens (n = 30) were sacrificed in three batches on separate days. On each 
occasion, the birds were sacrificed singly and the required tissues removed and 
dissected before the next bird was killed in order to minimise any deleterious effects 
o f  death on melatonin content. Collection o f tissues took 2-5 h depending upon the 
number o f birds. Throughout this time period tissue pools were chilled on ice. Eyes 
were dissected in the same way as human eyes (section 2.3.1.1), NR and C-RPE 
tissue compartments removed to chilled RIA buffer and tissue homogenates 
produced.
Six 500 p.1 aliquots o f  each tissue were removed from the homogenates 
produced from the first batch o f  birds. O f these, three were processed fresh according 
to  M ethod 2 (section 2.3.3) and melatonin contents determined by RIA. The 
remaining aliquots were frozen (-80 °C) and assayed later by the same method in 
order to assess the effects o f freezing on melatonin content. The remainder o f  the 
homogenate pools from this batch o f birds were also frozen at -80 °C.
On completion o f  preparation o f the last tissue batch (day 3), all previous N R 
and C-RPE tissue pools were thawed at low temperature. The three batches were 
then pooled and an aliquot o f both tissues removed for use in RIA validation studies 
(parallelism). The remaining tissue was diluted with RIA buffer on the basis o f  data 
fi'om the first RIA to yield tissue melatonin concentrations which upon assay would 
produce melatonin contents (pg/tube) within the centre range o f  the standard curve 
(approximate final concentrations o f  eye tissues were 1.5 NR/ml and 3.5 C-RPE/ml). 
Tissues were sonicated again to ensure thorough mixing and split into 500 pi aliquots 
which w ere stored at -80 °C until assay. All RIA and TEC validation work using 
chicken tissue was carried out on these tissue pools.
The chicken tissue used to compare homogenate and supernatant melatonin 
contents was obtained from a separate batch o f  birds the body tissues o f  which were 
used in other experiments. Birds were o f the same breed, sex, etc., and were 
maintained, as described previously (section 2.2.3). Upon thawing, eyes were 
removed immediately after sacrifice and frozen whole in isopentane chilled to  -40 °C
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with dry ice before storage at -80 °C. Eyes were dissected and N R  and C-RPE 
homogenates and supernatants prepared as described for human tissues.
2.3.2 Melatonin RIA
Melatonin-like immunoreactivity o f  processed samples was quantified according 
to  the method o f  English and co-workers (1993) for the measurement o f  salivary 
melatonin. Assay buffer used throughout, including as a diluent for antibody and 
radioligand, was 0.1 M tricine, containing 0.9 % NaCl and 0.2 % gelatine, prepared in 
w ater and adjusted to  pH 8.0 with 1 M NaOH. Buffer was stored at 4 °C and used 
within 10 days o f  preparation. Duplicate standards (range: 1-100 pg melatonin/tube 
and a zero standard), unknowns and quality control samples (QCs) (500 pi) were 
incubated with 100 pi rabbit anti-melatonin antiserum (1:20,000) for 30 min at 
ambient temperature. Radioligand (100 pi 2-[^^^I]-iodomelatonin - approximately 
8,000 - 10,000 cpm) was then added to all tubes including duplicate non-specific 
binding tubes (600 pi buffer) and the assay incubated for a further 15 - 18 h at 4 °C. 
Tubes were vortex mixed after each addition. At the end o f  this second incubation 
period a solid phase second antibody system was used to  separate first antibody- 
bound ligand and free ligand. Cellulose-linked donkey anti-rabbit IgG  (100 pi) was 
added and the tubes incubated for 1 h at ambient temperature with intermittent 
mixing. Subsequently, 1 ml saline wash solution containing Brij (0.2 % (v/v) Brij 35, 
0.9 % (w/v) NaCl in H 2O) was added and the incubation mixtures centrifuged (1,500 
X g  for 10 min at 20 °C). Immediately after centrifugation, supernatants were 
decanted and discarded. Radioactivity o f  the remaining pellets was determined by a 
1260 MultiGamma, gamma counter (LKB, Wallac). Unknowns and QC 
concentrations were determined from the standard curve data using a RIACalc in 
which the curve fitting algorithm was a smoothed spline. Non-specific binding was 
expressed as the proportion o f radioligand bound directly to  second antibody.
The assay limit o f  sensitivity was defined as the lowest standard for which 
specific binding was at least two standard deviations away from mean specific binding 
o f  the zero standard. Coefficient o f  variation data (% CV values) were calculated as: 
standard deviation/mean x 100.
Tissue volumes routinely processed for quantification o f melatonin by RIA were 
500 pi, thus approximately half the tissue from each eye was assayed per experiment. 
The remaining aliquot was used either individually or was combined to  produce pools 
o f N R  or C-RPE tissue containing low or high amounts o f melatonin-like 
immunoreactivity for use in subsequent RIA validation (section 2.4.1) or TLC 
identification studies (section 2.4.2).
Melatonin contents o f  individual human eyes as determined by RIA  were 
expressed as pg/g wet weight tissue. Human specimens were occasionally incomplete 
or damaged thus precluding calculation o f  absolute tissue melatonin contents per eye. 
Melatonin contents o f  tissues which read less than the assay limit o f sensitivity on the 
standard curve were quoted as “ < least detectable melatonin level/tissue weight (g)” . 
For example, if  assay limit o f  sensitivity = 1 pg/tube and melatonin in the tube 
represents content o f  50 mg tissue, then least detectable melatonin concentration = 1 
pg melatonin/50 mg tissue = 20 pg/g tissue.
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2.3.3 Sample preparation
Prior to RIA, unknown samples, standards and QCs were processed in a variety 
o f  ways.
M ethod 1 : no treatment
Referred to  as “ unextracted” throughout, that is, unknowns, standards and QCs were 
assayed directly.
M ethod 2: dichloromethane extraction
Referred to  as “ extracted” throughout, that is, unknowns, standards and QCs were 
solvent extracted as described below (section 2.3.4).
M ethod 3 : acid protein precipitation followed by dichloromethane extraction 
Referred to  as “ acid extracted” throughout. Unknowns, standards and QCs were 
treated with an equal volume o f  0.4 M perchloric acid and vortex mixed. The 
mixtures were then brought to  pH 8 with 4 M KOH. (The exact volume used was 
that which was shown at the time o f the experiment to bring a comparable volume o f 
the same batches o f  perchloric acid and assay buffer (1:1) to pH 8.) Samples were 
centrifuged at 13,000 rpm for 3 min in an Eppendorf centrifuge. An aliquot o f  the 
resultant supernatant was then removed and extracted with dichloromethane as 
described below (section 2.3.4).
Within an RIA, unknowns, standards and QCs were always processed in exactly 
the same way. Unknown, standard and QC volumes were equalised with RIA buffer 
as necessary, before processing. The starting amounts o f  melatonin standard were 
increased proportionately to account for the different losses associated with each 
method such that the standard curve for each method covered the same final range o f 
melatonin concentrations, that is 1-100 pg/assay tube. For all methods, standards 
were always prepared in RIA buffer.
2.3.4 Dichloromethane extraction
Unknowns, standards and QCs were extracted with 5 ml dichloromethane. I f  
necessary, aqueous volumes were equalised with RIA buffer prior to  extraction. 
Following addition o f the solvent, samples were vortex mixed for 10 seconds then the 
tw o phases allowed to separate by standing. Subsequently, the majority o f  the 
aqueous phase was removed by glass pipette. Sample bottles were then submerged in 
dry ice-chilled acetone in order to freeze the remaining aqueous phase thus preventing 
contamination o f  the organic phase. The latter (4 ml) was removed to large glass test 
tubes and the solvent evaporated to dryness in a water bath maintained at 40 °C under 
a stream o f nitrogen gas. Samples were routinely reconstituted in 1.2 ml assay buffer 
with 10 seconds vortex mixing. Duplicate 500 \x\ aliquots were then removed for RIA 
as described (section 2.3.2).
2.3.5 Quality control samples
Low, medium and high QC samples were prepared from assay buffer spiked 
with melatonin standard. QCs were made in bulk and aliquots stored at -20 °C. 
Buffer was spiked to yield nominal melatonin concentrations o f 22.5, 90 and 360 
pg/ml (QCs) such that following extraction QCs covered the range o f  the standard 
curve (3.75, 15 and 60 pg/tube). Preparation o f  QCs fi'om human eye tissue
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homogenates (either containing endogenous melatonin or by addition o f  exogenous 
melatonin) although desirable was not feasible due to limitations in terms o f tissue 
availability
2.3.6 Identification o f melatonin-like immunoreactivity by GC-MS
Initial attempts to quantify melatonin by GC-MS with the methodology o f 
Skene and co-workers (1983) failed to achieve sufficient sensitivity with the in-house 
system utilising the existing column conditions, etc. (tig rather than picograms as 
required). Consequently the technique was not pursued.
2.3.7 Identification o f  melatonin-like immunoreactivity by TLC
TLC was subsequently chosen as the method o f  choice for melatonin 
identification. Although not sensitive alone, in conjunction with RIA (TLC/RIA) 
sufficient sensitivity could be achieved.
2.3.7.1 General TLC conditions
Prior to  use TLC plates were divided into 10 tracks by narrow silica-free 
channels to prevent inter-sample contamination. They were then “washed” by running 
once in the appropriate mobile phase and sprayed with ascorbic acid solution (0.1 % 
w/v in methanol) to  minimise indole oxidation. Samples were applied to  the origin 
which was 1.5 cm from the plate edge. The tank (internal dimensions 21 x 6 x 22 
cm) was filled with mobile phase (« 90 ml) at least 30 minutes before use and lined 
with filter paper to ensure saturation o f the atmosphere with solvent throughout the 
run. Immediately before separation, the TLC tank was flooded with nitrogen gas to 
further prevent compound oxidation.
The mobile phase was either ethyl acetate (100 %) or
chloroform/methanol/acetic acid (9/1/0.1 by volume) as specified in section 2.4.2 and 
figure legends. Plates were run either 3 times in ethyl acetate or once in the other 
solvent.
values were calculated thus:
R {-  distance moved bv solute (measured to top o f spot! 
total distance moved by solvent from origin
Although absolute R f values varied slightly with ambient conditions the order o f  
compound separation for each mobile phase remained the same between runs.
2.3.7.2 TLC o f standards
The resolution o f several potential antibody cross-reactants was investigated in 
the solvent systems. Standards (1 mg/ml) were prepared in ethanol and 10 pi aliquots 
applied to prepared plates for TLC. Compounds were visualised under ultraviolet 
light.
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2.3.7.3 Sample preparation prior to TLC
Samples were treated by either o f  the following methods: M ethod 2: 
dichloromethane extraction (“ extracted” ), or M ethod 3 : acid precipitation followed 
by dichloromethane extraction (“ acid extracted” ) (section 2.3.3). The evaporated 
extracts produced were then reconstituted in 100 pi chloroform with 10 s vortex 
mixing. These were applied to the TLC plate in 5 x 20 pi aliquots and 
chromatographed in the conditions described above. Authentic melatonin was always 
run simultaneously (either applied directly to the plate or extracted from buffer spiked 
with ethanolic melatonin) to determine its R f  value and as an indicator o f  plate elution 
efficiency.
2.3.7.4 Quantification o f melatonin-like immunoreactivity following TLC
After chromatography, individual tracks were cut into fractions. Fractions 1 
(the origin fraction) and 19 were 1.5 cm in length, and the remaining fractions were 
each 1 cm. Fractions were transferred to glass vials for elution.
Two elution procedures were utilised. “ M ethod a” was used for chicken tissue 
experiments. For the experiments with human tissue, which contained much less 
melatonin-like immunoreactivity than the chicken tissue, an alternative elution system 
with improved elution efficiency was sought. Various solvents were investigated for 
their ability to elute tritiated melatonin (Table 2.1). The solvent system selected and 
used subsequently in all human tissue experiments is described as “M ethod b” .
M ethod a: referred to as “ dichloromethane elution” throughout. Plate 
fractions w ere vortex mixed in dichloromethane (1 ml) for 10 s. Fractions were 
removed and the solvent evaporated to dryness in a water bath maintained at 40 °C 
under a stream o f nitrogen gas. Samples were then reconstituted in 1.1 ml RIA buffer 
and duplicate 500 pi aliquots assayed by RIA (section 2.3.2).
M ethod b: referred to as “ dichloromethane:butan-l-ol elution” throughout. 
Plate fractions were vortex mixed in dichloromethane:butan-1 -ol (1:1) (3 ml) for 10 s 
and sample bottles allowed to stand at ambient temperature for 2.5 h. Plate fractions 
were then removed and the solvent evaporated as above. Samples were reconstituted 
in 1.3 ml RIA buffer, vortex mixed for 10 s then centrifuged (3,000 x g, 20 min at 4 
°C). Duplicate 500 pi aliquots o f the resultant supernatant were removed for RIA.
In the RIA, all plate eluent samples were read against unextracted standards, 
that is, standards were processed by M ethod 1 (section 2.3.3).
2.3.7.5 Quantification o f  tritiated melatonin standard following TLC
Standard tracks were fractionated and eluted by M ethod a for chicken tissues 
experiments or Method b for human tissues experiments (section 2.3.7.4). For 
determination o f  ^H-melatonin, evaporated eluents were re-dissolved in 4 ml 
scintillant (toluene containing 5g/l PPO and 0.3 g/1 POPOP) and counted (Wallac 
1410 Liquid scintillation counter).
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2.4 Results
2.4.1 RIA Validation
2.4.1.1 Identity o f  extracted and unextracted melatonin
The solvent extraction procedure employed in sample preparation M ethods 2 
and 3 (section 2.3.3) might potentially have introduced two types o f  non-identity; 
either the melatonin might have been physico-chemically altered, so that it no longer 
reacts in the same way with the antibody (for example, a proportion o f  the different 
binding sites on the ligand may be damaged), or, the extract may contain materials 
which interfere with the antibody-antigen interaction, that is, a non-specific chemical 
effect on the reaction. The most obvious result o f  non-identity is non-parallelism 
between unextracted and extracted melatonin standards.
Figure 2.3 shows unextracted (sample preparation M ethod 1) and extracted 
standard curves (sample preparation M ethod 2) to be parallel indicating no significant 
alteration o f  melatonin during dichloromethane extraction. Extracted buffer blank 
samples consistently read less than the lowest standard (1 pg/tube) against both 
unextracted and extracted standard curves. Standards in all subsequent assays (except 
those quantifying melatonin in TLC eluents) were extracted.
2.4.1.2 Tissue homogenate versus supernatant
In order to investigate whether sonication disrupted cellular material sufficiently 
to  release melatonin from the tissue, melatonin contents o f chicken tissue 
homogenates and supernatants derived from the same tissue were compared. NR 
supernatant and homogenate melatonin contents were similar (Table 2.2). However, 
in the C-RPE, 95 % more melatonin was measured in the homogenate than in the 
supernatant. Melatonin contents o f the human tissues examined w ere generally too 
low to observe any supernatant-homogenate difference although in C-RPE from pool 
B, in contrast to  the supernatant, there was sufficient melatonin in the homogenate to 
be quantified accurately. All subsequent measurements were thus made on tissue 
homogenates.
Tissue supernatant homogenate
Chicken NR 269.7 264.9
C-RPE 449.3 874.3
Human tissue pool A NR <4.1 <4.1
C-RPE nd <14.1
Human tissue pool B NR <7.5 <7.5
C-RPE <16.2 32.3
Table 2.2
Comparison o f  tissue supernatant and homogenate melatonin contents. 
Values are pg/g wet weight tissue. Samples were dichloromethane 
extracted prior to assay, {nd not detectable)
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100-1
8 0 -
20 -
1 10 100
Melatonin (pg/tube)
Figure 2.3
Parallelism o f  unextracted (A) and extracted (■ ) standard curves prepared in buffer. 
Binding is expressed as a percentage o f  that observed at zero displacement (Bo). 
D ata are means ± s.e.m. (n=6). Error bars are masked by symbols.
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2.4.1.3 Effect o f freezing
Chicken tissue melatonin contents before and after freezing w ere 165.9 ± 4.1 
and 168.3 ±  6.5 (NR) and 85.0 ± 3.2 and 80.2 ± 2.9 (C-RPE) pg/500 pi tissue aliquot 
(mean ± s.e.m. o f  3 aliquots), respectively, implying no effect o f  freezing on chicken 
N R  or C-RPE melatonin contents.
2.4.1.4 Comparison o f sample preparation M ethods 2 and 3 for the determination o f 
melatonin-like immunoreactivity by RIA
2.4.1.4.1 Assay characteristics
Resultant standard curves were very similar for both extracted methods o f 
sample processing (Figure 2.4). Non-specific binding (expressed as a percentage o f 
total radioligand activity) was routinely less than 4 % for both assays. Intra- and 
inter-assay coefficients o f  variation (CV) for buffer QC samples are presented in Table 
2.3.
Method QC C V (% )
Melatonin amount Intra-assay Inter-assay
(pg/tube)
Extracted 60 7.1 10.5 (11,8)
15 11.1 12.2 (14.2)
4 12.6 14.0(14.8)
(n=8) (n=12 (20))
Acid extracted 70 3.7 11.4
18 6.1 12.8
5 10.1 14.1
(n=10) (n=12)
T able 2.3
Intra- and inter-assay CVs (%) for quality control samples prepared in buffer, n 
values refer to number o f assays. For the extracted method two QC batches 
were used.
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Melatonin (pg/tube)
Figure 2.4
Parallelism o f  RIA buffer standard curves following treatment o f standards by the 
tw o extraction methods. Method 2 (A): standards were extracted with 
dichloromethane, M ethod 3 (■): standards were acid precipitated prior to 
dichloromethane extraction. Specific binding is expressed as a percentage o f  that 
observed at zero displacement (Bo). Data are means ± s.e.m. (n=4). W here error 
bars are not visible they are masked by symbols.
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2.4.1.4.2 Assay consistency
Intra-assay CVs for the quantification o f  endogenous melatonin in chicken 
tissues are given in Table 2.4. The most widely ranging values were obtained for C- 
RPE processed by the acid extracted method.
Method Tissue
N R C-RPE
extracted 6.3 4.7
acid extracted 8.0 18.3
Table 2.4
Intra-assay CVs (%) for the measurement o f  endogenous 
melatonin-like immunoreactivity in chicken tissue pools. 
Mean melatonin contents (pg/ tube) as determined by the 
extracted method were 69.2 ± 2.0 and 38.0 ± 0.8 for N R 
and C-RPE, respectively (mean ± s.e.m., n=5).
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Inter-assay CVs for the quantification o f melatonin in chicken tissues are given 
in Table 2,5. Melatonin contents (pg/500 p.1 tissue aliquot) are also shown. Mean N R 
melatonin contents as determined by extracted and acid extracted methods were very 
similar. In contrast, for C-RPE melatonin content, there was a statistically significant 
difference between the methods; the acid extracted method value was much lower 
than the extracted method (unpaired Student’s /-test, p < 0.01).
Method Tis
N R
sue
C-RPE
extracted
% C V
207.6
198.5
184.4
186.5 
194.3 +  5.5
5.6
114.1
125.0
107.3
115.5 +  5.1
7.7
acid extracted 
% CV
162.5 
200.0
202.5 
243.8 
168.3
195.4 ±  14.5
16.6
38.8
70.0
73.0 
42.5
56.1 ± 9 .0
31.9
Table 2.5
Comparison o f  extracted and acid extracted methods for the 
determination o f melatonin contents o f chicken N R and C-RPE 
pools. D ata units are pg/500 pi tissue aliquot. Each value 
represents the mean o f 2-5 aliquots measured in an individual 
assay. Figures in bold type represent the mean ± s.e.m. o f  the 
data from individual assays.
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2.4.1.4.3 Recoveries
Melatonin added to NR homogenates prepared from either individual specimens 
or pooled specimens was quantitatively recovered by both methods (Table 2.6). 
However, although melatonin was quantitatively recovered from C-RPE using the 
extracted method, the proportion o f melatonin recovered from C-RPE was 
significantly less with the acid extracted method (Mann-Whitney U  test, p < 0.05).
M ethod Tissue N R C-RPE
extracted A 102.1 102.5
B 85.3 125.5
C 119.2 84.5
D 112.0 103.1
E 100.8 92.5
F 96.7 92.5
G 84.7 98.9
H 99.7 107.2
I 99.4 104.7
100.0 ± 3 .7 101.3 ± 3 .9
(mean ±  s.e.m.) (mean ±  s.e.m.)
acid extracted A 94.0 97.1
B 113.0 86.0
C 94.8 79.8
D 109.4 85.0
J 86.6 70.8
K 107.0 98.3
L 81.6 68.8
98.1 ± 4 .5 83.7 ± 4 .4
(mean ± s.e.m.) (mean ±  s.e.m.)
Table 2.6
Recovery o f  melatonin (140-150 pg) from human N R and C-RPE 
tissue with two assay methods. Data are expressed as percentages 
o f values obtained from spiking buffer in the same assay with the 
same amount in order to  account for small inter-assay differences in 
spiking level. Tissues A-D were tissue pools, and E-L were 
individual specimens. Figures in bold type represent the mean ± 
s.e.m. o f the data in each group.
Further studies with the extracted method investigated recovery o f  a range o f 
melatonin amounts (1 - 100 pg/assay tube post-extraction) from human N R  and C- 
RPE pools. Quantitative recovery o f melatonin, from both tissues, was obtained over 
the entire range o f  concentrations studied (Figure 2.5). The correlation coefficient o f 
the relationship between recovered and added amounts o f  melatonin for N R  and C-
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(B) C-RPE
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Figure 2.5
Recovery o f  exogenous melatonin from pooled human NR (A) and C-RPE (B) 
homogenates. Tissue aliquots were spiked with a range o f melatonin amounts (3- 
300 pg pre-extraction). Tissue samples and standards were extracted prior to  RIA.
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RPE homogenates was 0.998 in each case. The equations o f the corresponding least 
squares regression lines o f  the data were y = 1.26x + 1.54 and y = 1.17x - 1.04 for 
N R  and C-RPE, respectively, where x = melatonin added, and y = melatonin 
recovered implying endogenous tissue melatonin contents o f  4.6 and 0 pg/500 p,l 
aliquot, respectively, for NR and C-RPE. The former value compares with 3.5 
pg/500 pi aliquot as determined by assay o f  an unspiked aliquot o f  the same tissue 
pool. C-RPE homogenate assayed similarly, yielded a value below the assay detection 
limit.
2.4.1.4.4 Parallelism
Serial dilution o f  chicken N R  and C-RPE homogenates containing endogenous 
melatonin-like immunoreactivity and processed by extraction produced binding 
inhibition curves parallel with the extracted melatonin standard curve (Figure 2.6). 
Similar results were obtained in extracted human tissues from a single specimen or 
pooled from several eye specimens (Figure 2.7) and acid extracted human tissue from 
a single specimen (Figure 2.8).
2.19
(A) NR 100 n 145 290 Kil
8 0 -
6 0 -
4 0 -
20 -
1 10 100
(B) C-RPE 100-1 215108
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Melatonin (pg/tube)
Figure 2.6
Parallelism o f serial dilutions o f chicken NR (A) and C-RPE (B) homogenates 
containing endogenous melatonin-like immunoreactivity (A ,B) with buffer 
standard curves ( • ) .  Tissue samples and standards were extracted prior to  RIA. 
Tissue volumes were made up to  500 pi with buffer prior to extraction. Specific 
binding is expressed as a percentage o f that observed at zero displacement (Bo).
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(B) C -R PE
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Melatonin (pg/tube)
F igure  2.7
Parallelism o f  serial dilations o f human N R (A) and C-RPE (B) homogenates 
containing endogenous melatonin-like immunoreactivity (A, ■ ) with buffer 
extracted standard curve ( • ) .  Tissue was either derived from a single eye 
specimen (■ ) or pooled from several eyes (A). Tissue samples and standards were 
extracted prior to  RIA. Tissue volumes were made up to 500 pi with buffer prior 
to  extraction. Specific binding is expressed as a percentage o f  that observed at 
zero displacement (Bo).
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F igure 2.7
Parallelism o f serial dilations o f human NR (A) and C-RPE (B) homogenates 
containing endogenous melatonin-like immunoreactivity (À, ■ ) with buffer 
extracted standard curve ( • ) .  Tissue was either derived from a single eye 
specimen (■ ) or pooled from several eyes (A). Tissue samples and standards were 
extracted prior to  RIA. Tissue volumes were made up to 500 pi with buffer prior 
to extraction. Specific binding is expressed as a percentage o f  that observed at 
zero displacement (Bo).
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Figure 2.8
Parallelism o f serial dilutions o f  human NR (■ ) and C-RPE (À ) homogenates 
containing endogenous melatonin-like immunoreactivity with buffer acid extracted 
standard curve ( • ) .  Tissue samples were acid extracted prior to RIA. Tissue 
volumes were made up to 500 pi with buffer prior to extraction. Specific binding is 
expressed as a percentage o f  that observed at zero displacement (Bo).
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2.4.2 Identification o f melatonin-like immunoreactivity by TLC
2.4.2.1 TLC o f standards
Adequate separation o f  those compounds investigated (potential antibody cross­
reactants) was obtained with ethyl acetate as the mobile phase (Figure 2.9). 
Resolution o f  melatonin and NAS was improved in the second mobile phase 
(chloroform/methanol/acetic acid, 9/1/0.1 by volume). In this system, the Rf values o f 
melatonin and NAS were 0.65 and 0.87, respectively and on the TLC plates the 
compounds were always separated by at least 2 x 1 cm fractions.
2.4.2.2 Chicken N R
TLC data are plotted throughout in terms o f  melatonin-like immunoreactivity o f 
each plate fraction rather than at Rf values in order to indicate actual distances 
between compounds on the plate. All the data on each individual figure were derived 
from samples run simultaneously on the same TLC plate.
In order to  determine whether the TLC experimental protocol itself generated 
compounds which cross-reacted with the anti serum, and which may therefore have 
falsely elevated the levels o f  melatonin-like immunoreactivity observed in tissue 
samples, various reagent blanks were prepared and subjected to the TLC/RIA 
procedure used with chicken NR. None were found to  produce melatonin-like 
immunoreactivity (Figure 2.10A).
Following TLC, both extracted and acid extracted N R yielded single bands 
which were coincident with authentic melatonin standard (Figure 2.1GB). Table 2.7 
shows that for both methods o f  sample processing calculated tissue melatonin 
contents were similar when assessed by either RIA directly, or by RIA o f the 
melatonin-like immunoreactivity peak coinciding with melatonin standard in TLC, 
implying that the melatonin-like immunoreactivity content o f the tissue was 
contributed solely by melatonin.
Sample preparation RIA TLC/RIA
extracted 194.3 ± 5.5 
(n = 5)
185.8 ± 5 7 .2  
(n = 2)
acid extracted 195.4 ±  14.5 
(n = 5)
201.8 + 28.2 
(n = 2)
Table 2.7
Comparison o f  chicken NR homogenate melatonin contents as 
determined by direct RIA o f the tissue or RIA o f  the melatonin 
peak coinciding with authentic melatonin standard in TLC 
(TLC/RIA). D ata are means ±  s.e.m. Units are pg/500 pi tissue 
aliquot.
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Figure 2.10
(A) The plate elution system employed with chicken tissue did not create melatonin­
like immunoreactivity in various reagent blanks following TLC: extracted buffer (■ ); 
acid extracted buffer ( • ) ;  and chloroform (À).
(B) Dichloromethane extracted ( • )  and acid extracted (À ) chicken N R  containing 
endogenous melatonin-like immunoreactivity gave single peaks which were coincident 
with authentic melatonin standard (tritiated melatonin, bars; and cold melatonin 
visualised by UV
TLC mobile phase was ethyl acetate. Melatonin was eluted from the TLC plate with 
dichloromethane. Arrows indicate RIA limit o f sensitivity.
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2.4.2.3 Human tissues
The alternative, increased efficiency, elution system used with human tissues 
(section 2.3.7.4 M ethod b) was also established not to generate melatonin-like 
immunoreactivity in various reagent blanks (Figure 2.11 A). Dichloromethane 
extracted and unextracted melatonin standards were shown to run together indicating 
no effect o f  the extraction procedure on the chromatographic properties o f  melatonin 
(Figure 2.1 IB). Subsequently all melatonin standards were extracted prior to  
chromatography.
The low endogenous melatonin-like immunoreactivity contents o f  human N R 
and C-RPE homogenates as determined by direct RIA were confirmed by TLC/RIA 
(Figure 2.12A and 2.13 A). These same tissues spiked with melatonin showed peaks 
o f  immunoreactivity which co-eluted with authentic standard. Calculated melatonin 
contents o f  standard and spiked tissue were equivalent (NR spiked with melatonin 
42.8 pg, melatonin standard 47.3 pg; C-RPE spiked with melatonin 40.4 pg, 
melatonin standard 40.4 pg),. There was, therefore, no loss o f  melatonin as a result o f 
tissue metabolism, etc.
TLC o f N R and C-RPE containing high levels o f endogenous melatonin-like 
immunoreactivity produced single melatonin peaks coincident with authentic 
melatonin (Figures 2.12B and 2.13B). Melatonin contents were similar when 
determined by direct RIA or by TLC/RIA methods (Figure 2.14).
These same tissue pools containing high levels o f endogenous melatonin were 
subsequently extracted and chromatographed in a second mobile phase which was 
better able to resolve melatonin from NAS (section 2.4.2.1). In both N R  and C-RPE 
tissues, single peaks o f melatonin-like immunoreactivity which chromatographed with 
authentic melatonin standard were obtained (Figure 2.15). Tissue melatonin contents 
(melatonin-like immunoreactivity co-eluting with authentic melatonin) as determined 
by this TLC method (NR = 17.9 pg, C-RPE = 32.4 pg) were comparable with those 
obtained with the previous TLC method (NR = 14.8 pg, C-RPE = 33.3 pg) indicating 
that the melatonin-like immunoreactivity content o f  the tissues was not contributed by 
NAS.
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F igure  2.11
(A) The plate elution system used with human tissues did not create melatonin-like 
immunoreactivity in various reagent blanks following TLC: extracted buffer (■ ); 
extracted buffer spiked with ethanol ( • ) ;  and chloroform (A).
(B) Dichloromethane extracted (■ ) and unextracted ( • )  melatonin standards were 
coincident.
TLC mobile phase was ethyl acetate. Melatonin was eluted from the TLC plate with 
butan-1 -ol : dichloromethane (1:1). Arrows indicate RIA limit o f sensitivity.
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Figure 2.12
(A) The low melatonin-like immunoreactivity content o f a pool o f  human NR 
homogenate as determined by direct RIA was confirmed by TLC/RIA ( • ) .  Spiking 
this same tissue with melatonin (A) produced a single peak o f  melatonin-like 
immunoreactivity which was coincident with melatonin standard (bars).
(B) Endogenous melatonin-like immunoreactivity o f  human N R homogenate ( ♦ )  was 
coincident with authentic melatonin standard (bars).
All samples were extracted prior to TLC. TLC mobile phase was ethyl acetate. 
Melatonin was eluted from the TLC plate with butan-1 -o l:dichloromethane (1:1). 
Arrows indicate RIA limit o f  sensitivity.
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Figure 2.13
(A) The low melatonin-like immunoreactivity content o f  a pool o f  human C-RPE 
homogenate indicated by direct RIA was confirmed by TLC/RIA ( • ) .  Spiking 
this same tissue with melatonin (A) produced a single peak o f  melatonin-like 
immunoreactivity which was coincident with melatonin standard (bars).
(B) Endogenous melatonin-like immunoreactivity o f human C-RPE homogenate 
( ♦ )  was coincident with authentic melatonin standard (bars).
All samples were extracted prior to TLC. TLC mobile phase was ethyl acetate. 
Melatonin was eluted from the TLC plate with butan-l-ol:dichlorom ethane (1:1). 
Arrows indicate RIA limit o f sensitivity.
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RIA 
TLC/RIA
N R low NR high C-RPE low C-RPE high
Figure 2.14
Melatonin contents o f  human NR and C-RPE tissues as determined by two 
methods. Low  and high refer to the endogenous melatonin-like immunoreactivity 
level. For RIA ( H )  tissues were extracted then assayed for melatonin. For 
TLC/RIA ( I  ) tissues were extracted then subjected to  TLC and only the 
melatonin peak co-eluting with authentic standard quantified by RIA. TLC mobile 
phase was ethyl acetate and the elution system was butan-l-ol:dichloromethane.
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Figure 2.15
Endogenous melatonin-like immunoreactivity contents o f  human N R  ( • )  and C-RPE 
(À ) homogenates were coincident with authentic melatonin standard (bars). The 
expected position o f NAS is indicated by the area o f shading (\ \ .^ NAS was
chromatographed simultaneously under identical TLC conditions in a separate tank to 
avoid contamination o f the tissue samples - its relative position with respect to  that o f 
melatonin standard and the tissue samples was calculated on the basis o f its Revalue.
All samples (except NAS standard) were extracted prior to  TLC. TLC mobile phase 
was chloroform/methanol/acetic acid (9/1/0.1 by volume). Melatonin was eluted from 
the TLC plate with butan-l-ol:dichloromethane (1:1). The arrow  indicates RIA  limit 
o f  sensitivity.
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2.5 Discussion
A series o f validation studies has been undertaken in order to ascertain which o f  
two possible sample extraction methodologies was most suitable for the quantification 
o f  melatonin in human N R and C-RPE homogenates by an existing RIA. Samples 
w ere either protein precipitated with acid then dichloromethane extracted (acid 
extracted method) or extracted directly with dichloromethane (extracted method). 
Both extraction methods were able to measure melatonin quality control samples 
prepared in buffer consistently. However, for the measurement o f  endogenous 
melatonin in tissue, although there was no difference between the methods when 
investigating NR, the acid extracted method was found not to be suitable for use with 
C-RPE as there were both intra- and inter-assay inconsistencies. Additionally, this 
acid extracted method measured significantly less melatonin in C-RPE than did the 
extracted method. Recovery o f exogenous melatonin from C-RPE using the acid 
extracted method was also incomplete. None o f these problems were encountered 
with the extracted method. Furthermore, serial dilution o f  N R and C-RPE tissues 
processed by the extraction method produced curves parallel to the melatonin 
standard curve. On the basis o f  these findings the extracted method (direct extraction 
o f  samples with dichloromethane) was selected for use in all subsequent melatonin 
quantification studies.
Throughout these investigations, standard curves should ideally have been 
constructed in the biological fluids under investigation, that is, N R  and C-RPE 
homogenates. However the availability o f human ocular tissue was limited. In 
addition, this would require that the tissue homogenates contained no melatonin 
which in turn would require artificial preparation o f  such a melatonin-ffee sample, for 
example, by adsorption o f  the hormone or by use o f  affinity chromatography. Neither 
approach is ideal. With the former method there may be secondary effects on other 
components o f  the fluid that would eliminate a non-specific blank at the same time, 
whereas the latter is time consuming. Preparation o f the standard curve in low 
melatonin content pools is another option but this too has inherent disadvantages. For 
example, tissue composition would not be identical between different assays.
In previous studies, melatonin has been extracted and measured successfully in 
both tissue supernatants (Skene et a l, 1991) and homogenates (for example, Reppert 
and Sagar, 1983; Delgado and Vivien-Roels, 1989). However, in the present studies, 
comparisons o f extracted tissue homogenate and supernatant indicated greater 
melatonin contents in the former. The effect was more apparent in C-RPE tissue. 
This may be because melatonin, which is lipophilic, is able to  become more intricately 
bound within the more structured tissue matrix o f  the choroid and pigment layers 
compared with the N R which consists solely o f  “ soft” neuronal tissue. Brief 
sonication would then not be able to effectively release the melatonin from the tissue 
into the supernatant. There may also be a receptor bound source o f  melatonin which 
again is not released into the supernatant by sonication. Finally, melatonin may be 
tightly bound to melanin and thus unavailable for assay: melanin is known to bind 
various drugs and other molecules non-specifically (for example, Lindquist, 1973). 
This latter theory might explain the finding that the difference between melatonin 
contents o f  supernatant and homogenates was greater for C-RPE, that is, the tissue 
containing more melanin. Extraction o f  the whole homogenate (as performed in the 
present studies) would be expected to transfer these bound pools o f  melatonin into the
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organic phase for assaying and thus allow for more accurate measurement o f 
melatonin concentrations.
The endogenous tissue melatonin-like immunoreactivity was subjected to TLC in 
order to verify its authenticity and was found to co-chromatograph with melatonin 
standard. However, there existed the possibility that the immunoreactivity was being 
contributed, either partially or totally, by an antibody cross reactant. O f the possible 
cross reactants investigated (melatonin metabolites and various generic indoles), NAS 
and A-acetyltryptamine were shown to run closest to melatonin in the TLC conditions 
employed. The latter has neither been reported in the eye nor recognised as a 
component o f  the melatonin synthetic or degradative pathways, hence it is unlikely 
that its cross reactivity with the antibody (0.08 %) (product data sheet, Stockgrand 
Ltd.) is o f  great importance. In contrast, NAS presented a particular problem for a 
number o f  reasons. Although it too has a relatively low cross reactivity with the 
antibody (0.084 %), (product data sheet, Stockgrand Ltd), NAS is the synthetic 
precursor o f  melatonin within the eye and in some species, its levels have been 
demonstrated to match, if not exceed, those o f melatonin (Yu et al., 1982; Allen et 
a/., 1991). A proportion o f  serum NAS does not derive from the pineal (its primary 
site o f  synthesis) providing additional evidence for some other active site o f  synthesis, 
for example, the eye (Yu et a l, 1981a; Brown et a l, 1984). Furthermore, NAS may 
also be a metabolite o f  circulating melatonin (Leone and Silman, 1984; Leone and 
Silman 1985; Young et a l, 1985). Ocular melatonin may possibly have a similar 
metabolic fate which would further contribute to local NAS levels. On the basis o f  its 
physico-chemical properties it is unlikely that a large proportion o f  NAS would be 
extracted into the dichloromethane and thus made available for RIA. However, no 
NAS RIA was available to  confirm this. Hence, the mobile phase o f  the TLC system 
was changed in order to  improve the resolution o f  melatonin and NAS. It was 
subsequently demonstrated that the melatonin-like immunoreactivity measured was 
not being contributed by NAS. It is likely therefore that the melatonin-like 
immunoreactivity is melatonin and the validated extraction method RIA  described, 
accurately measures melatonin concentrations in N R and C-RPE tissues. Unequivocal 
identification would, however, require mass spectrometric evidence. There is a small 
chance that the immunoreactivity could relate to some unknown antibody cross 
reactant which co-eluted with melatonin under the TLC conditions employed. Such a 
compound would need to  be o f a similar structure to melatonin. It would also have to 
be physiologically relevant, that is, a possible precursor or metabolite in the eye. All 
the known precursors and metabolites were checked in TLC and did not co-elute with 
melatonin. Hence the most likely conclusion is that the RIA measures melatonin.
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C h a p t e r  3
Q u a n t if ic a t io n  o f  m e l a t o n in  in  p o s t ­
m o r t e m  HUMAN EYES
3.1 Introduction
The existence o f ocular melatonin has been reported in a number o f mammalian 
species with interest being centred predominantly upon the retinal compartment 
(Table 1.1). Immunohistological studies have indicated that within the mammalian 
retina o f those species investigated, as is the case for other vertebrate classes, 
melatonin is localised predominantly to the outer nuclear layer (for example, Vivien- 
Roels et a l, 1981; Mennenga, 1991). It is likely on the basis o f  a number o f  findings 
that this ocular melatonin is synthesised de novo locally rather than being taken up 
from the circulation. Firstly, several precursors and intermediate molecules have been 
identified within the tissues o f the eye, for example 5-HT (Ehinger et a l, 1981) and 
NAS (Pang et a l, 1983). Secondly, the presence o f a variety o f synthetic enzymes 
including NAT and HIOMT, the final two enzymes in the metabolic pathway o f 
melatonin, has been demonstrated within various components o f the eye (Tables 1.2 
and 1.3).
In contrast, information concerning melatonin and its biochemistry specifically 
within the human eye is fragmentary. Currently, to the author’s knowledge, there are 
only three reports which document attempts to quantify melatonin in human eye 
tissues. These studies all involved limited sample sizes. The procedures employed 
and the findings o f these studies are summarised in Table 3.1. Two o f  the three 
groups measured melatonin in the NR. O f these, the investigation o f  Leino (1984) 
was methodologically more thorough employing GC-MS. In contrast, Osol and 
Schwartz (1984) utilised a RIA for the measurement o f  melatonin in chloroform- 
extracted tissue. A significant omission from their study concerned assay validation 
data. Although the method had been validated and utilised previously by another 
research group for the measurement o f melatonin in retinal tissue, this was in fact for 
a different species (Pang et a l, 1977): no validation data were provided for use o f  the 
RIA specifically with human tissues. The third study o f human ocular melatonin 
utilised HPLC with electrochemical detection (EC) to investigate the aqueous humor 
compartment. The presence o f melatonin was reported in all three studies.
In addition to quantitative melatonin data there is an increasing body o f  
circumstantial evidence that points towards the likelihood o f melatonin being 
synthesised within the human eye. Evidence concerning the existence o f  melatonin 
synthetic enzymes is o f  particular significance. HIOM T activity has been reported in 
N R  (Wiechmann and Hollyfield, 1987) and ciliary body (Martin et a l, 1992). 
HIOM T gene transcripts have also been detected in the retina (Rodriguez et a l, 
1994; Bernard et a l, 1995). In addition, the recent cloning o f the human NAT gene 
has enabled identification o f human retinal NAT mRNA (Coon et a l, 1996). The 
human ciliary body is also reported to possess NAT activity (Martin et a l, 1992).
Ocular melatonin has been reported to mediate several actions on local 
physiological processes (section 1.7) including effects for example on retinomotor 
movements (Pierce and Besharse, 1985). None o f these postulated actions for 
melatonin have yet been established in the human eye, but it is probable that at least 
some will be common to man. Ocular melatonin has been implicated as a causative 
factor in some disease states (section 1.9.1). Conversely it has also been attributed 
protective properties. It may function, for example, as a local antioxidant (Chen et
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3.2
a l, 1995). Manipulation o f  the human ocular melatonin system may represent a 
future strategy for disease management.
In this study, the melatonin contents o f post-mortem human N R  and C-RPE 
w ere quantified. N R and C-RPE were obvious tissue choices for study based on 
findings from other species. In addition, various practical considerations indicated to 
a certain extent which tissues and tissue groupings were investigated. 
Embryologically the RPE belongs to the retina, however, whereas it is firmly attached 
to  the basal lamina o f  the choroid, it is only loosely attached to  the rods and cones, 
this latter plane corresponding to  the embryonic optic vesicle. Consequently, when 
dissecting the eye, the natural cleavage plane is between the N R and the RPE, hence 
the RPE was always investigated in conjunction with the choroid rather than the NR. 
Anterior uveal tissues such as the iris and ciliary body were not investigated as they 
were frequently absent or badly damaged, particularly as a result o f comeal removal 
for keratoplasty.
3.2 Specim en inform ation
The source o f  experimental tissue was as previously described (section 2.2.3). 
In most instances comeal tissue had been removed for keratoplasty. At the time o f 
specimen collection, various parameters regarding the donor were recorded. 
Information regarding each o f the following was generally available:
1. donor age
2. donor sex
3. time o f donor death (TOD)
4. date o f  donor death (DOD)
5. cause o f  donor death (COD)
6. time o f  removal o f  the specimen from the donor
From these, two additional parameters were calculated, namely post-mortem 
interval ( = time between donor death and enucleation, PMI) and “specimen age” ( = 
time between donor death and eventual storage o f  the tissue at -80 °C).
3.3 M ethods
3.3.1 RIA
Melatonin contents o f  the N R and C-RPE tissues o f 46 human post-mortem 
eyes w ere assessed by the validated method previously described, that is, RIA  o f 
dichloromethane tissue extracts (Chapter 2). Specimens were investigated 
individually in order that any relationships that existed between melatonin content and 
the donor parameters could be identified.
3.3
3.3.2 Statistical analysis
Basic statistical testing was carried out by the author. Other analyses (Mann- 
Whitney tests; Chi-squared tests; analysis o f  variance; /-tests; some Spearman’s 
correlation tests; stepwise logistic regression; and stepwise multiple regression) were 
carried out by The Statistical Advisory Service, University o f  Surrey (SPSS program 
V  4.0).
For correlation analysis specimens were necessarily omitted if  the parameter 
being investigated was not available for that specimen. For analysis purposes, times 
o f  deaths were converted to values representing minutes away from a theoretical 
melatonin maximum (03:00 h). Date o f death was analysed as month o f  death (MOD): 
dates were converted to values representing the number o f  months away from June
The level o f  significance was taken as p < 0.05 unless otherwise stated.
3.4 Results
The melatonin contents o f eyes from 46 individuals were investigated (Figure 
3.1): 17 contained quantifiable melatonin in both N R and C-RPE; 2 in N R only and 7 
in C-RPE only. The donor parameters o f these specimens are shown in Figures 3.2 to 
3.4. Both tissues o f a further 20 specimens contained melatonin levels below the 
assay limit o f detection. In those eyes containing melatonin, levels were variable, 
ranging from 10.0 to 425.5 pg/g w et tissue weight (mean 106.5, n = 19) for NR, and
34.4 to  486.8 pg/g wet tissue weight (mean 179.3, n = 24) pg/g w et for C-RPE. The 
Pearson’s correlation coefficient between specimen N R  and C-RPE melatonin 
contents was 0.70 (n=46). Excluding the pairs o f  N R and C-RPE data which 
contained undetectable melatonin levels in both tissues a correlation coefficient o f  
0.60 (n=26) was found. In those specimens that contained melatonin in both tissues, 
C-RPE melatonin contents were significantly higher than N R contents (paired 
Student’s /-test, n=17). Similarly, in the eight eyes which contained high melatonin 
levels (> 200 pg/g) in at least one tissue, C-RPE melatonin contents were also 
significantly higher than in NR.
3.4
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The associated donor parameters o f  the specimens are provided in Table 3.2. The 
presence o f melatonin in either NR or C-RPE was not obviously related to any o f the 
donor parameters, specimen age, or PMI (Figures 3.2 to 3.4). The eight eyes with 
high melatonin levels (> 200 pg/g) in at least one tissue also did not share a common 
parameter (Table 3.3).
A summary o f  the statistical analyses undertaken and their results is given in 
Table 3.4. There were no significant correlations between any o f  the variables and 
melatonin contents (all data) o f  either N R or C-RPE when assessed both 
parametrically (donor-age, -TOD, -MOD, specimen age, PMI: Pearson’s correlation) 
and non-parametrically (donor-age, -TOD, -MOD, specimen age, PMI: Spearman’s 
correlation; donor sex: Mann Whitney test). Stepwise logistic regression analysis, in 
which the melatonin data were treated as a binary variable (that is, melatonin either 
present or absent), failed to identify any relationships between the presence o f 
melatonin in N R or C-RPE and the parameters donor-age, -sex, -TOD, -MOD, 
specimen age and PMI. Similarly there were no significant differences for either NR 
or C-RPE between those specimens containing melatonin and those without, in terms 
o f  donor-age, -TOD, -MOD, specimen age, PM I (Mann Whitney test) or donor sex 
(Chi-squared test).
Tissue weights obtained from individuals eyes varied depending on the specimen 
size and its condition. The ranges o f weights were 19.5 mg to 1.2614 g, and 9.57 mg 
to 592.6 mg for N R and C-RPE, respectively. For each specimen, all the tissue 
retrieved was homogenised, hence, for low weight tissues, their melatonin 
concentration would have to be greater than for high weight tissues in order for the 
final melatonin content measured to be above the assay limit o f  sensitivity. There was 
no correlation between assay limit o f detection and those melatonin levels above zero 
and nor was assay limit o f detection correlated with PM I or specimen age.
Subsequently, those specimens containing no melatonin were excluded fi*om 
further analysis in order to test whether for the positive melatonin data there w ere any 
relationships specifically between the level o f  melatonin in the specimens and any o f 
the parameters. Scatter plots o f  these data are shown in Figure 3.5. For C-RPE, 
none o f  the variables were correlated with melatonin level (Pearson’s correlation or 
Spearman’s correlation). Similar analyses on N R identified one significant 
relationship, between melatonin level and PM I (Spearman’s correlation, r = -0.66, p < 
0 .01). Stepwise multiple regression failed to reveal regression relationships between 
melatonin content and any o f the variables. Analysis o f  melatonin contents in terms o f 
season (analysis o f  variance) and time o f death (night versus day [08:00 to  20:00 h]) 
(unpaired Student’s /-test and Mann Whitney test) also indicated no significant 
differences for either N R or C-RPE.
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Statistical test Data 
analysed/format of 
analysis
NR C-RPE
stepwise logistic regression 
using variables of age; 
MOD; TOD; sex; specimen 
age; PMI
analysis of 
melatonin data as a 
binary dependent 
variable; melatonin 
content = 0 or > 0
no relationships no relationships
Mann-Whitney test 
(U values)
melatonin content 
= 0 or > 0
donor age 241 
TOD 185 
MOD 196 
specimen age 192 
PMI 120 
none significant
donor age 232 
TOD 201 
MOD 245 
specimen age 210 
PMI 180 
none significant
Chi-squared test 
(chi-squared statistic)
melatonin content = 
0 or > 0
sex 0.05 sex 0.04
Pearson product moment 
correlation coefficient 
(r values)
all melatonin data 
including zeros
donor age 0.04 
TOD-0.14 
MOD 0.07 
specimen age 0.00 
PMI -0.07 
none significant
donor age 0.14 
TOD -0.14 
MOD 0.12 
specimen age -0.07 
PMI-0.12 
none significant
Spearman’s correlation 
coefficient 
(rs values)
all melatonin data 
including zeros
donor age 0.01 
TOD 0.06 
MOD 0.17 
specimen age 0.03 
PMI 0.12 
none significant
donor age 0.08 
TOD 0.01 
MOD 0.06 
specimen age -0.12 
PMI-0.12 
none significant
Mann-Whitney test 
(U values)
all melatonin data 
including zeros
donor sex 219 
not significant
donor sex 224 
not significant
stepwise multiple regression 
using variables of age; 
MOD; TOD; sex; specimen 
age; PMI
melatonin values 
greater than 0
not possible to enter or 
remove any variables - 
no relationships
not possible to enter or 
remove any variables - 
no relationships
Pearson product moment 
correlation coefficient 
(r values)
melatonin values 
greater than 0
donor age 0.09 
TOD -0.24 
MOD -0.18 
specimen age -0.18 
PMI -0.34 
none significant
donor age 0.22 
TOD -0.20 
MOD 0.34 
specimen age -0.12 
PMI -0.26 
none significant
Spearman’s correlation 
coefficient 
(revalues)
melatonin values 
greater than 0
donor age -0.06 
TOD -0.05 
MOD-0.14 
specimen age -0.43 
PMI -0.66" 
none significant, 
except " (p < 0.01)
donor age 0.05 
TOD-0.14 
MOD 0.38 
specimen age -0.14 
PMI -0.20 
none significant
continued.
Table 3.4
Summary o f statistical analyses undertaken on N R and C-RPE melatonin contents o f 
46 post-mortem human eyes.
Abbreviations
TOD, time o f death; MOD, month o f death; PMI, post-mortem interval
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Table 3.4 ...continued
Statistical test Data 
analysed/format of 
analysis
NR C-RPE
Mann-Whitney test 
(U values)
melatonin values 
greater than 0
donor sex 59 
not significant
donor sex 90 
not significant
Analysis of variance: data 
grouped into 4 seasons 
(March-May; June-August; 
September-November; 
December-February)
(F values)
melatonin values 
greater than 0
0.59
not significant
0.58
not significant
Unpaired Student’s /-test 
night V  day (where night = 
20:00 to 08:00)
(/ values)
melatonin values 
greater than 0
0.28
not significant
0.46
not significant
Mann Whitney test for 
night V  day 
(U values)
melatonin values 
greater than 0
82
not significant
74
not significant
Pearson product moment 
correlation coefficient (r) 
between assay limit of 
detection and:
a) melatonin level
b) specimen age
c)PMI
all data including 
zeros
a) -0.16
b) 0.0
c)-0.10
not significant
a )-0.11
b)-0.11
c)-0.12
not significant
Correlation coefficient (r) 
between assay limit of 
detection and: 
melatonin level
a) Pearson’s
b) Spearman’s
melatonin values 
greater than 0
a) -0.03
b) 0.38
not significant
a) 0.22
b) 0.20
not significant
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3.5 Discussion
Over half o f the specimens investigated in this study were found to contain 
melatonin in either or both N R and C-RPE compartments. The RIA methodology 
employed was validated for use with both tissues and TLC indicated that the tissue 
melatonin-like immunoreactivity was coincident with authentic melatonin standard in 
tw o mobile phase systems (section 2.4.2.3). These facts, together with the previous 
mass spectrometric identification o f melatonin within the human eye (Leino, 1984) 
indicate that the immunoreactivity measured in these studies was almost certainly true 
melatonin. These findings thus confirm previous reports o f melatonin within the 
human eye (Osol and Schwartz, 1984; Leino, 1984; Martin et a l, 1992).
It is likely that this melatonin is synthesised locally rather than being taken up 
fi"om the circulation. In the bovine retina, for example, the movement o f melatonin 
across the RPE component o f  the blood:retinal barrier has been shown to  be passive 
(Pautler and Hall, 1987), that is, there is no mechanism for concentration, and in 
several species, retinal melatonin persists following pinealectomy (for example, Yu et 
ah, 1981a, b; Reiter et al., 1983; Underwood et al., 1984). In addition there is 
increasing evidence for the local presence o f the requisite biosynthetic enzymes. 
HIOM T activity has been demonstrated in human retina (Wiechmann and Hollyfield, 
1987) as have HIOM T (Rodriguez et al., 1994; Bernard et a l, 1995) and NAT gene 
transcripts (Coon et al., 1996). In the human, isolated choroid and RPE tissues have 
not been investigated either for the presence o f  melatonin or the synthetic enzymes. 
In other species however melatonin has specifically been demonstrated to exist in 
both RPE (Binkley et a l, 1979; Hamm and Menaker, 1980) and choroid (Rohde et 
al, 1993). NAT and HIOMT have also been identified in RPE (Quay et a l, 1969; 
Binkley et a l, 1979; Hamm and Menaker, 1980) but not by all authors (Cardinali and 
Rosner, 1971a). C-RPE melatonin contents were significantly higher than those o f 
NR. In contrast, Hamm and M enaker (1980) reported that in the chick eye, N R  
contained more melatonin RPE.
In both previous studies with human retina, all specimens investigated were 
found to  contain melatonin. In contrast in this study, a sizeable proportion (20/46 
eyes) contained no detectable melatonin in either tissue. There are a number o f 
reasons why melatonin may not have been detected. Firstly, these particular donors 
may simply never have possessed ocular melatonin as a result o f  a lack o f  synthetic 
capacity: there are species in which ocular melatonin is reportedly at very low levels 
or undetectable, for example, the lizard, Anolis carolinensis (Underwood, 1985). 
Furthermore, although, as discussed above, there is some evidence for the presence o f 
synthetic enzymes within the human eye, this is not conclusive. Wiechmann and 
Hollyfield’s demonstration o f retinal HIOMT activity (1987) has not been confirmed. 
Recently, Bernard and co-workers (1995) were unable to detect either HIOM T 
activity or immunoreactive protein in human retina. In addition, whilst these authors 
did report the presence o f retinal HIOMT mRNA transcripts, actual levels were 
extremely low (Bernard et a l, 1995). Together these findings led Bernard and 
colleagues (1995) to question the capacity o f the human retina for melatonin 
synthesis. However, the fact that melatonin was present in some human specimens in 
this study indicates that it is unlikely that the human eye lacks the requisite synthetic 
machinery. Instead, some form o f differential expression o f  the synthetic enzymes 
may exist between individuals. Certain individuals display atypical pineal melatonin
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production, that is, circulating melatonin levels are much lower than usual or even 
undetectable (Arendt, 1985). This may be the result o f  a genetic abnormality 
involving, for example, HIOMT. I f  such an abnormality exists then it is feasible that 
such a defect might also affect ocular melatonin synthesis. Incidence o f  this condition 
in the population is, however, rare, hence it seems unlikely that this alone is 
responsible for such a large proportion o f  specimens as found here not to  contain 
melatonin.
In addition to donor parameters, information regarding two related factors was 
available in most instances for the specimens; PM I and specimen age, the former 
relating to  the time between death and enucleation and the latter relating to  the total 
time period between death and freezing o f  the sample. In NR, melatonin content was 
significantly negatively correlated with PMI, indicating that the two are associated. A 
similar effect was not apparent in C-RPE however, nor were there any relationships 
between specimen age and NR or C-RPE melatonin content. Reppert and Sagar
(1983) observed that melatonin content o f the chick eye remained constant at 0 °C for 
up to  three hours prior to  dissection, implying that changes did in fact occur 
subsequently. Furthermore, retinal melatonin levels measured in freshly enucleated 
eyes from live donors (Leino, 1984) were reported to be considerably higher (up to  
10 ng/g) than those measured in post-mortem tissues, both by Osol and Schwartz
(1984) (350 to  2000 pg/g) and in this study (not detectable up to ~  500 pg/g wet 
weight). Thus certain aspects o f  specimen storage prior to freezing may have been 
responsible for a reduction (partial or complete) in tissue melatonin content in this 
investigation. For example, some form o f degradation o f the melatonin molecule may 
have occurred during this period. The presence o f  a functional deacetylase (aryl 
acylamidase) has been demonstrated in retinal tissue from a number o f  species, for 
example chicken and Xenopus laevis (Grace et al., 1991). This enzyme degrades 
melatonin to 5-MT which is subsequently deaminated by monoamine oxidase 
producing 5-MIAA and 5-ML (Cahill and Besharse, 1989). In those mammals which 
have been investigated however, that is, rat and pig, existence o f  this pathway o f 
deacetylation has not been demonstrated (Grace et a l, 1991). The primary 
degradative route o f  circulating melatonin involves hydroxylation and sulphation 
forming 6-sulphatoxymelatonin for urinary excretion (Kopin et a l, 1961 and Kveder 
and M clsaac, 1961). This metabolic route has not been investigated in the eye. It is 
possible, however, that it is operative: members o f  the mixed function oxidase 
cytochrome P-450 family, for example, are present within the eye (Shichi et a l, 1975; 
Schwartzman et a l, 1987; Zhao and Shichi, 1995). Furthermore, quantifiable levels 
o f  6-hydroxymelatonin have been demonstrated in human aqueous humor (Martin et 
ah, 1992). In addition to  this specific metabolic degradation, the melatonin molecule 
may be altered in the process o f carrying out certain o f  its actions. M elatonin is 
reported to possess antioxidant capacity and this feature may be exploited functionally 
in the eye (Chen et a l, 1995; Abe et a l, 1994). Melatonin can react, both 
enzymatically and non-enzymatically with the superoxide anion via pyrrole ring 
cleavage to  produce M-acetyl-/V^-fbrmyl-5-methoxykynurenamine (AFMK). The 
former involves catalysis by the haem-containing enzyme indoleamine 2,3- 
dioxygenase (Hirata et a l, 1977). This enzyme has been shown to be present in the 
eye: bovine iris/ciliary body, aqueous humor and retina all possess enzyme activity 
(Malina and Martin, 1993). Furthermore, in the ciliary body o f  this species, the 
enzyme has been shown to  produce kynurenamines from melatonin (Malina and
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Martin, 1992). Indoleamine 2,3-dioxygenase is distributed widely in human tissues 
(Yamazaki et al., 1985) and it is possible that it is present in the human eye. 
Melatonin is able directly to trap superoxide anions and hydroxyl radicals (particularly 
in the presence o f  the chemical hemin (Hardeland et al., 1993a)), that is, with no 
enzyme involvement (Hardeland et al., 1993b). Such oxidative degradation o f 
melatonin may also, therefore have contributed some decrease in ocular melatonin 
contents o f  the human specimens between donor death and eventual frozen storage o f 
the tissue in the studies undertaken here.
The human retina melatonin contents reported by Osol and Schwartz (1984) 
were higher than observed in the present investigation despite both studies having 
being undertaken on post-mortem human tissues. This may be because the specimen 
ages were less in the former study, however, no information regarding this parameter 
was provided so this cannot be confirmed. Furthermore, the method employed by 
these authors was not fully validated and the antibody used may have been measuring 
a cross reactant.
The occurrence o f melatonin was not associated with any donor parameter (age; 
sex; time, month or cause o f  death), therefore additional analyses were performed on 
only those specimens which contained quantifiable melatonin in order to identify any 
relationships between the level o f  melatonin and the donor parameters. Again, none 
indicated concurrence. In contrast, in other species, melatonin levels within the eye 
do appear to be related to various biological factors. The most prominent is the 
relationship between melatonin level and time o f day. In the majority o f  species which 
have been demonstrated to possess retinal melatonin, levels are in most cases 
substantially raised during the dark phase (Table 1.1). Such day/night variations are 
generated in part by the direct inhibitory effect o f light on the melatonin synthetic 
process (for example, Hamm and Menaker, 1980; Hamm et al., 1983; Reppert and 
Sagar, 1983) with the remainder o f  the rhythmic component possibly being under the 
control o f  an endogenous oscillator (for example, Hamm and Menaker, 1980 ; 
Underwood et al., 1988; Cahill and Besharse, 1990; 1991). NAT is the key 
regulatory enzyme mediating the changes in melatonin resulting from both the effect 
o f light (Binkley et al., 1979; Hamm et a l, 1983) and the internal oscillator (Besharse 
and luvone, 1983). The controlling clock may be situated either centrally or locally. 
There is increasing evidence for the latter and recently, Tosini and M enaker (1996) 
have demonstrated that circadian melatonin production in the mammalian retina is 
under control o f an intra-ocular clock. In this investigation, however, although time 
points throughout the 24 hour period were examined, time o f  death was not 
correlated with melatonin level in either NR or C-RPE tissues, nor was there an 
overall significant difference between night and day levels. A small number o f  studies 
have previously reported similar findings. In squirrel retina (Reiter et al., 1981); 
rabbit retina-choroid (Aimoto et a l, 1985); and chicken RPE (Hamm and Menaker, 
1980), the characteristic day night variation in melatonin level when determined by 
these authors was lacking. In the latter case (chicken RPE), there was a 
corresponding absence o f rhythmic NAT activity (Hamm and Menaker, 1980). As 
previously mentioned however these cases represent the minority; commonly, ocular 
melatonin is higher at night.
Other parameters have also been reported to affect ocular melatonin levels. In 
the rat eye there appears to be a difference in melatonin content between the sexes: 
testosterone may have a stimulatory effect on retinal HIOMT activity (Cardinali and
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Rosner, 1971a; Nagle et al., 1974) and retinal melatonin is decreased following 
castration (Reiter et al., 1983). Seasonal differences in ocular melatonin may also 
exist. Delgado and Vivien-Roels (1989) have shown in the frog eye that the night 
time melatonin rise is higher and o f  longer than duration when the animals are 
maintained under short period conditions. Steinlechner and colleagues (1995a) have 
also recently reported the profile o f  day/night melatonin levels in the hamster retina to 
differ greatly with the time o f year. Cahill and co-workers (1991) have suggested that 
HIOM T may be regulated by long-term lighting conditions to  effect seasonal changes 
in melatonin levels. In addition to light, season may also have effects via the 
associated temperature changes. In the frog eye, for example, the melatonin rhythm is 
only maintained in higher environmental temperatures (Balemans et al., 1983). In this 
study, however, for neither sex nor month/season o f  death was there any statistically 
significant relationship with melatonin content.
Similarly there were no obvious changes in specimen melatonin content 
associated with donor age. In other species, retinal melatonin and its synthetic 
enzymes become detectable during the foetal stage with the most dramatic changes in 
levels occurring in the period prior to adulthood (Cardinali and Rosner, 1971a; 
Bubenik et al., 1978; luvone, 1990). NAT activity in the chicken retina appears to 
reach a maximum one day prior to hatching (luvone, 1990) and in the rat retinal 
HIOM T activity plateaus at 30 days post partum (Cardinali and Rosner, 1971a). The 
changes which occur in ocular melatonin throughout later life once the adult 
maximum has been reached have been little reported in any species.
Although a comprehensive data set concerning the donor parameters, etc. o f  the 
specimens used in this study were available, there exist many more variables about 
which no information was available. In particular, almost certainly all o f the donors 
had received some form o f medication in the period immediately prior to  death and 
this may have had effects on melatonin synthesis or metabolism - certain medication 
strategies, for example, beta-blockers are known to suppress pineal melatonin 
production (Arendt et al., 1985; Cowen et al., 1985). Also, no information was 
available regarding treatment o f the specimens prior to enucleation. For example, 
cooling period and conditions o f the cadaver would have varied greatly between 
specimens. Thus, two specimens having the same PMI, may be greatly different in 
terms o f a range o f  other parameters, yet these samples would still be grouped 
together for analysis o f  relationships between melatonin content and PM I length. 
These “unknown factors” may also have influenced those variables about which 
information was available. For example, although the times o f death w ere known, the 
lighting conditions immediately preceding death were not. Therefore, even if  death 
occurred during the dark phase, for example, when melatonin would be expected to 
be high, if  this was in the presence o f  bright light, then melatonin synthesis may have 
been inhibited. In addition, although melatonin levels may have the potential to be 
affected by season, modem man’s lifestyle in terms o f  heating and lighting is such that 
the appropriate seasonal cues might be overridden. These examples represent just a 
few o f  many ways in which relationships, which almost certainly exist biologically in 
vivo, may in fact be masked in the data from a study such as this.
Other ocular tissues were not considered in this investigation. Previously, 
however, melatonin has been quantified in human aqueous humor obtained from live 
donors (undergoing cataract surgery (Martin et al., 1992). This melatonin may have 
been synthesised locally in ciliary body/iris compartments, but as it was only present in
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five out o f ten samples it is possible that it did in fact diffiise to the aqueous 
compartment from another active synthetic site such as the NR. Aqueous humor is 
essentially a plasma filtrate so it is also possible that the melatonin measured may have 
derived from the plasma. In favour o f their hypothesis that melatonin is synthesised 
within the ciliary body, these same authors were also able to demonstrate NAT and 
HIOM T activity in human ciliary body although the findings have never been 
confirmed. In some other species there does appear to be NAT activity in these 
tissues, for example chicken iris and ciliary body (Aimoto et al., 1985), and rabbit iris- 
ciliary body (Rohde and Chiou, 1987). Importantly, however, HIOM T activity has 
never been reported in these ocular tissues by other authors in any species. 
Furthermore, Cardinali and Rosner (1971a) have specifically demonstrated HIOM T 
activity to  be lacking from rat iris.
The present study provides definite evidence for the existence o f  melatonin 
within human N R  and C-RPE. No role for this chemical in the human eye has yet 
been identified. Given, however, the many actions which it is reported to undertake in 
other species and its postulated role in certain eye diseases, extensive future 
investigation o f the human ocular melatonin system is warranted.
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C h a p t e r  4
M e t h o d o l o g y  e m p l o y e d  f o r  t h e  a n a l y s is
OF OCULAR 2- lODOMELATONIN BINDING
SITES
4 .1  Introduction
This chapter describes the methodology employed for analysis o f 2- 
[^^^IJiodomelatonin binding sites in ocular tissues from human and quail species. 
Findings o f these studies are reported in subsequent chapters. Binding was 
investigated both in membrane preparations and by autoradiography. Also discussed 
are various methodological problems which were encountered.
4.2 Materials
4.2.1 Chemicals
Na^^^I was obtained from ICN Biochemicals Ltd., Thame, U.K. or Amersham 
International, Little Chalfont, U.K. lodogen (l,3 ,4 ,6-tetrachloro-3a,6a- 
diphenylglycouril), GTP (guanosine 5'-triphosphate, sodium salt) and ATP (adenosine 
5'-triphosphate, calcium salt) were obtained from Sigma, Poole, U.K. Indoles used in 
displacement studies were also from Sigma with the exceptions o f  6-chloromelatonin 
which was obtained from Eli Lilly Laboratories (Indianapolis, Indiana, U.S.A.); 2- 
iodomelatonin from RBI (Natick, Massachusetts, U.S.A); and 2-bromomelatonin and 
2-phenylmelatonin (Spadoni et a\., 1993) which were gifts from D r B. Stankov 
(University o f Milan, Department o f  Pharmacology, University o f  Milan, Italy). Other 
chemicals and general laboratoiy reagents (all analytical grade), including solvents, 
Folin and Ciocalteu's phenol reagent, eosin yellowish, Ehrlich’s haematoxylin, chrome 
alum (chromium (III) potassium sulphate dodecahydrate) and bovine serum albumin 
were obtained from Sigma. Analytical grade hydrochloric acid and glacial acetic acid 
were purchased from Fisons, Loughborough, U.K.
4.2.2 Biological materials
Quail eyes were provided by D r B. Stankov. For binding site characterisation 
and autoradiography studies, adult male quails (Coturnix japonica) w ere maintained 
in natural photoperiod conditions prior to sacrifice. For rearing purposes the birds 
were exposed to artificial light (50-60 lux) during the period o f  natural darkness. 
Birds were sacrificed between 11:00 and 12:00 h. For the studies investigating the 
effect o f  photoperiod on receptor density and affinity (section 5.2.2), adult male quails 
were maintained under either long day (16 h light : 8 h darkness, lights on at 06:00 h) 
or short day (8 h light : 16 h darkness, lights on at 09:00 h) photoperiods and 
sacrificed at intervals across the 24 hour period. Following enucleation, quail eyes 
were frozen at -80 °C and subsequently transported to the University o f  Surrey on dry 
ice.
Human eyes were obtained as described previously (section 2.2.3). Ovine eyes 
were obtained from a local abattoir on the day o f slaughter (no longer than 5 h post­
slaughter). N o information regarding the sheep (sex, age, etc.) was available.
The source o f chickens was as previously described (section 2.2.3). Birds were 
sacrificed by cervical dislocation. For routine membrane binding experiments, tissues 
were removed immediately and used for the production o f  membrane preparations.
4.1
To investigate whether the time period between sacrifice and membrane preparation 
had an effect on the quality o f  2-[^^^I]iodomelatonin binding, the following protocol 
was employed. Six chickens were sacrificed, one eye from each bird was removed 
and membranes prepared as detailed below (section 4.3.2.1) and frozen. The 
carcasses, each with one remaining eye in situ, were left at room temperature for 48 
h. Subsequently, enucleations were performed and the eyes transferred to  refrigerated 
storage (4 °C) for a further 48 h. After this period eyes were frozen on dry ice, left 
for 2 hr and finally stored at -80 °C. Membranes were prepared six days later and 
frozen.
4.3 M ethods
4.3.1 Preparation o f  2-[^^^I]iodomelatonin radiolabel
The radiolabel used throughout was prepared according to the method o f 
Vakkuri and co-workers (1984 a,b), that is, direct iodination involving the oxidation 
o f  I to I2 (I T) followed by electrophilic substitution o f  T  into the indole nucleus o f 
the melatonin molecule at carbon-2, the initial oxidation being effected by “lodogen” .
Aliquots (10 |t1) o f lodogen solution (0.1 mg/ml in chloroform) were transferred 
to  Eppendorf tubes and the chloroform evaporated thus leaving 1 jrg lodogen per 
tube. Tubes were stored at 4 °C until use. The iodination procedure was carried out 
in one o f  these tubes; 10 jj.1 o f  a 1 mg/ml melatonin in 0.05 M sodium phosphate buffer, 
pH 6.0 was combined with 2 pi Na^^^I solution (« 0.2 mCi) and vortex mixed. The 
reaction was quenched after 2 minutes by the addition o f  100 pi chloroform. The 
mixture was then vortex mixed and incubated for ~ 24 hr at 4 °C.
lodinated melatonin was subsequently purified by TLC. The TLC plates were 
those previously described (section 2.2.2). Plates were prepared for use by dividing 
them into tracks and washing with ethyl acetate (section 2.3.7.1). Melatonin 
standards (5 pi and 10 pi 1 mg/ml melatonin in 0.05 M sodium phosphate buffer, pH 
6.0, and 5 pi 1 mg/ml melatonin in chloroform) were spotted on the end and centre 
tracks. The organic phase o f the iodination mixture was applied to the remaining 
tracks and the plate run three times in an ethyl acetate (100 %) mobile phase as 
described in section 2.3.7.1.
Following separation, a single sample track was cut into 1 cm segments and 
each counted (1260 MultiGamma counter; LKB, Wallac, 79 % counting efficiency) to  
determine the position o f iodinated melatonin. The position o f  cold melatonin was 
also determined (under UV light) to ensure adequate separation o f  labelled and cold 
melatonin. lodinated melatonin was always separated from cold melatonin by a least 
2 cm. Subsequently, those fractions o f the TLC plate containing iodinated melatonin 
were cut into fine strips, transferred to a glass storage container and a known volume 
o f propan-2-ol (~ 4 ml depending on label activity) added to  elute the radiolabel. 
Following vortex mixing the product was stored at 4 °C. After 24 h a 10 pi aliquot 
was counted in order to determine actual label concentration.
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4.3.2 Membrane radioreceptor binding studies
4.3.2.1 Dissection o f  tissues
4.3.2.1.1 N R  and C-RPE
N R  and C-RPE tissue components were dissected as described previously 
(section 2.3.1.1, Figure 2.2). With the sheep and human eyes, these two tissues were 
easily dissected with no obvious contamination in either fresh or frozen eyes. In 
contrast, in the chicken and quail eyes there was occasional contamination o f  N R with 
melanin pigment. With the fresh chicken eyes, the extent o f  the contamination was 
found to be very much affected by the time period between sacrifice and dissection; 
the longer this period the more practical difficulty in separating the N R  from the C- 
RPE and therefore the greater the risk o f  contamination. For this reason chickens 
were always sacrificed sequentially and the required tissues from an individual bird 
dissected before sacrifice o f the next. With the frozen chicken and quail eyes 
contamination worsened as the length o f the thawing period increased therefore 
specimens were thawed for the minimum period necessary.
4.3.2.1.2 Iris muscles and ciliary body
Ovine and human iris sphincter pupillae, dilator pupillae and ciliary body tissue 
were dissected as illustrated in Figure 4.1. Sheep iris muscles and ciliary tissue were 
used for membrane preparation on the day o f dissection. Human iris muscles were 
removed from specimens dissected for use in other studies, and refrozen at -80 °C 
until there were sufficient to pool for use.
4.3.2.2 Preparation o f membrane homogenates
Dissected tissues were transferred to chilled buffer. Buffer used throughout 
including for binding experimemts was 50 mM Tris-HCl, with 4 mM CaClz, pH 7.4. 
Tissues were sonicated (Ultrasonic Homogenizer - 4710 Series, Cole-Parmer 
Instruments, Illinois, U.S.A.) for two separate 30 s periods (1 x 30 s only for NR) 
with constant cooling. Membranes were subsequently ultracentrifijged at 50,000 x g  
for 20 min at 4 °C. The rotor and chamber were pre-chilled. Supernatant was 
discarded and the surface o f  the membrane pellet washed once with buffer. 
Membranes were then resuspended in buffer and washed by sonication and 
ultracentrifugation as previously. Pellets were again washed and the membranes 
finally resuspended in buffer by sonication. Throughout the procedure both 
membrane preparations and buffer were maintained at 4 °C. Final membrane pellets 
were resuspended in buffer to achieve desired working protein concentrations.
For quail N R  and C-RPE membranes, 1 ml buffer usually contained tissue from 
1 to 1.5 quail eyes. Chicken NR and C-RPE membrane suspensions were prepared at 
a concentration o f  0.75 to  1 eye/ml. These concentrations routinely yielded 20 to  70 
|ig  protein per assay tube. Sheep NR and C-RPE were pooled at 0.25 eyes/ml and
0.5 eyes/ml, respectively to give ~ 80 to 100 pg protein per assay tube. Human eyes 
were generally processed individually and each N R or C-RPE was prepared in ~ 5 ml 
buffer, hence incubation protein contents were variable (20 to 150 pg ).
4.3
aI
Or d
m
C/5*’î3
•è-OXI
I
o
T3
§
c/3
(4-,
O
G
O
€
<L)
c/3
C/3
c2
2^
3T3
<U
ü
2
PU
Tf
2
&
j î t
ilt
c/3 4-» ce
-a T3 u. 
«1
ii n
îilill
ëî î
ï î ïa  I  g> I I -e ^"S • -(u 4-»
5 g g 
■S o . t !
cd
^  ü  
c/3lîl
4.4
Human and sheep iris muscle studies were undertaken on tissue pooled from 
several specimens (~ 2 eyes/ml). These concentrations yielded 15 to 30 pg  protein 
per assay tube.
Sheep ciliary body tissue was prepared at a concentration o f approximately 1 
eye/1 ml (~ 50 |ng per assay tube).
Eye membrane preparations were usually used immediately after production, 
however those from quail, chicken and sheep N R and C-RPE were occasionally 
stored at -80 °C prior to use. In these instances membranes were resuspended in 
lesser buffer volumes and diluted for use upon thawing. Prepared eye tissues were 
stored for no longer than three weeks before assay.
Chicken brain membranes were resuspended at a final concentration o f  1 
brain/50 ml. Aliquots (1 ml) were frozen (-80 °C) and diluted for use (1/10, v/v). 
This produced an incubation protein content o f -  90 pg per tube.
4.3.2.3 Removal o f  melanin
In some instances, initial tissue homogenates were subjected to  an additional 
pre-centrifugation step (2,000 x g  for 10 min at 4 °C) to remove melanin pigment. 
The resulting supernatants were then ultracentrifuged for the production o f 
membranes as described (section 4.3.2.2).
4.3.2.4 Binding studies
4.3.2.4.1 General
The binding method employed was based on that previously reported by
Vanecek (1988). Binding reactions were carried out in disposable glass tubes.
Incubations for all binding studies contained 100 pi radioligand solution, 100 pi 
membrane suspension and 50 pi buffer, drug or drug vehicle (for displacement studies 
and receptor-effector coupling studies), that is 250 pi total volume. Non-specific 
binding was determined throughout in the presence o f 1 pM cold melatonin. Specific 
binding was defined by subtraction o f non-specific binding from total radioligand 
binding. Binding reactions were always initiated by addition o f  tissue. All incubations 
were carried out in a water bath maintained at 28 ± 0.5 °C, over a 40 min period (with 
the exception o f  kinetic studies in which the incubation time varied). Separation o f 
bound and free radioligand was achieved by rapid filtration o f the incubate through 
Whatman GF/B filter paper using a 24-channel Brandel cell harvester followed by 
three x 3 ml ice cold buffer washes. Filter bound radioactivity was subsequently 
determined using a 1260 MultiGamma counter (LKB, Wallac, 79 % counting 
efficiency). Generally, binding was investigated for each condition within an
experiment in triplicate and at the least in duplicate.
4.3.2.4.2 Kinetic studies
Total and non-specific binding were determined at timed intervals over a 40 min 
period (association data). Addition o f 1 pM cold melatonin (end concentration) was 
employed to study dissociation over the following 250 min period. Filter bound
4.5
radioactivity was subsequently determined and analysed by pseudo-first order and first 
order rate equations using the EBDA/LIGAND computer program v 4.0 (Munson 
and Rodbard, 1980; McPherson, 1985) to determine observed association and 
dissociation rate constants, respectively. The actual association rate constant was 
derived from the observed association rate constant by the following relationship; k+i 
=  kobs - k.i/[L] where [L] = radioligand concentration and k_i = dissociation rate 
constant.
4.3.2.4.S Saturation studies
For saturation studies, binding was routinely measured over a range o f 
radioligand concentrations, nominally 9 to  600 pM. Data, as disintegrations per 
minute, were analysed using the EBD A/LIGAND non-linear curve-fitting computer 
program using one-site model fits for the determination o f receptor equilibrium 
dissociation constants (Kd) and number o f receptors (B^ax). Throughout the course o f 
experiments saturation binding studies were undertaken at regular intervals with 
chicken brain membrane preparations as a quality control in order to confirm that the 
binding methodology was functional; Æd = 31.2 ±  1.8 pM, jS^ax = 7.94 ±  0.42 finol/mg 
protein (mean ± s.e.m., n=12). New batches o f 2-[^^^I]iodomelatonin were also tested 
in this same system prior to use in eye tissue studies.
4.3.2.4.4 Displacement studies
Incubations were carried out at a fixed concentration o f  radioligand in the 
presence o f 50 pi displacing drug (to produce a range o f final concentrations) or drug 
vehicle. Initial stock drug solutions (5 x 10'^ M) were prepared with the following 
proportions o f ethanol: melatonin, 5-ML, 5-MT (10 %); 2-phenylmelatonin (40 %); 
6-chloromelatonin, 2-iodomelatonin, NAS (50 %); 6-hydroxymelatonin (100 %); 2- 
bromomelatonin (45 %). 5-HT was prepared in 30 % 0.01 N  HCl. Subsequent 
dilutions were with buffer or water (5-HT). Precautions were taken as necessary to 
minimise drug breakdown due to instability and light sensitivity. Radioligand 
concentration was between 100 and 108 pM. Competition curves were analysed with 
the EBDA computer program for the determination o f Ki values (equilibrium 
dissociation constant o f  the unlabelled competing ligand). Best fit curves including a 
blank were plotted using the GRAPH?AD INPLOT computer program. In a few 
instances the lowest drug concentration was used as a blank.
4.3.2.4.5 Effect o f nucleotides on 2-[^^^I]iodomelatonin binding
Incubations were carried out as described for displacement studies (section 
4.3.2.4.4) but with varying concentrations o f  GTP or ATP instead o f  displacing drug. 
The drug vehicle was buffer. I C 5 0  values (concentration o f unlabelled ligand that 
inhibits 50 % o f the specific binding o f  the radioligand) were obtained using the 
EBDA computer program.
4.6
4.3.2.5 Protein determinations
Protein contents o f the membrane suspensions were determined according to 
the method o f  Lowry (Lowry et al. 1951). Standard curve tubes each contained 0 to 
150 or 200 pig protein in 400 pi water (prepared from a 1 mg/ml bovine serum 
albumin stock solution) and 100 pi binding buffer. Tissue aliquots (100 pi) were 
made up to 500 pi with water. To all tubes were added 2.5 ml alkaline copper 
reagent (2 % (v/v) copper tartrate solution (0.5 g CUSO4.5 H 2O + 1 g Nascitrate in 
100 ml H 2O) in aqueous Na2C0 3  (20 % w /v )^ a O H  (4 % w/v) solution). Tubes were 
vortex mixed and allowed to stand at room temperature for 10 minutes. Folin- 
Ciocalteu's phenol reagent (250 pi) was then added to  each tube and following 
mixing, colour was allowed to develop by standing at ambient temperature for a 
further 2 hours before reading absorbances at 720 nm (Kontron Uvikon 860 
spectrophotometer). Protein contents o f tissue samples (assayed at least in duplicate) 
were calculated from standard curve data (duplicate determinations per concentration) 
using the "Lowry" option o f  the EBDA/LIGAND program.
In some instances protein assay sample tubes were centrifuged (2000 x g, 10 
min, 20 °C) after the 2 hr incubation period to remove melanin, and the resulting 
supernatant measured. Standards were unaffected by this procedure: standard curves 
constructed from absorbances measured on the same standards before and after this 
centrifugation step were superimposable.
4.3.2.6 M ethod development
4.3.2.6.1 Effect o f  melanin pigment on 2-[^^^I]iodomelatonin binding
Initial saturation binding studies with quail tissues, particularly C-RPE showed 
non-specific binding levels to  be consistently high. Studies by other workers have 
previously shown non-specific radiolabelled melatonin binding in choroid and/or RPE 
membranes to  be higher than that in neural retina (Wiechmann et al.  ^ 1986; Chong 
and Sugden, 1991). Furthermore, the autoradiography studies o f  Wiechmann and 
Wirsig-Wiechmann (1991) and Laitinen and Saavedra (1990a) have indicated that 
within the eye, 2-[^^^I]iodomelatonin may associate non-specifically with 
melanosomes. To investigate whether the presence o f melanin was contributing to  the 
non-specific 2-[^^^I]iodomelatonin binding observed in the quail tissues the following 
protocol was employed. Tissues were sonicated and the resulting N R and C-RPE 
homogenates each divided into two portions. One portion was used to prepare 
membranes directly (section 4.3.2.2). The other was subjected to an additional low 
speed pre-centrifugation procedure to remove melanin (section 4.3.2.3) prior to 
preparation o f  membranes in exactly the same way. Cell nuclei would also have been 
removed by this pre-centrifugation process. The resultant membranes from both 
procedures were used in saturation binding studies. Figure 4.2 shows that removal o f 
melanin decreased total 2-[^^^I]iodomelatonin binding in both C-RPE and NR.. This 
decrease could be largely attributed to loss o f  non-specific binding as specific binding 
remained at a similar level. Even though not naturally pigmented, pre-centrifugation 
also reduced the non-specific binding o f  NR. As described previously, quail N R  was 
susceptible to  contamination with melanin from other pigmented tissues during the
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dissection procedure. It is likely therefore that the decreases in non-specific binding 
observed in NR resulted from loss o f  contaminating melanin.
On the basis o f these observations the majority o f subsequent quail studies were 
conducted using pre-centrifuged membrane preparations. Further details regarding 
this melanin issue in experiments using both quail and other species are provided 
where appropriate in subsequent chapters.
4.3.2.6.2 Effect o f  melanin on protein determinations
The method employed for determination o f  membrane protein content utilised 
the Folin phenol method as adapted by Lowry (1951), that is, a colorimetric reaction 
with absorbance being measured in the 700-750 nm wavelength range (section 
4.3.2.5). It was considered important therefore to determine whether the presence o f 
melanin pigment within the tissue samples, if  not removed by pre-centrifugation 
during the membrane preparation procedure, interfered with the accurate 
determination o f tissue protein contents. I f  there was an effect this would have 
implications for subsequent .Smax calculations; an overestimated protein content would 
lead to low jB^ ax values.
Low  speed centrifugation o f  protein assay sample tubes prior to  measurement o f 
absorbances (section 4.3.2.5) caused an apparent decrease in protein content in quail 
and chicken N R and C-RPE tissues. This decrease was assumed to  be as a result o f 
removal o f  melanin, either endogenous (C-RPE) or contaminating (NR), rather than 
removal o f other cellular components, as there was no effect on quail N R or C-RPE 
which had been centrifuged during membrane preparation, or on human N R tissue 
which was not initially contaminated with melanin and which had not been pre- 
centrifuged (Figure 4.3). Quality control samples (aqueous albumin standard) were 
similarly unaffected by centrifugation. Subsequently therefore, unless stated 
otherwise, for all those tissues not pre-spun to remove melanin during membrane 
preparation, tissue sample protein assay tubes were subjected to  the additional low 
speed centrifugation procedure prior to measurement o f  absorbances.
4.3.3 In vitro autoradiography
4.3.3.1 Preparation o f slides
Slides (glass) were sonicated in Decon detergent (-1 0  %) for 75 min then 
allowed to soak in the same solution overnight. Subsequently the slides were rinsed 
in running water until it formed an even film over the slide surface (at least 3 hr), 
washed in double distilled water (30 min) and allowed to  air dry. Slides were subbed 
with gelatin solution (1 % gelatin (w/v) in double distilled water, containing 0.1 % 
chrome alum) and dried at ambient temperature in a dust free environment. Human 
sections were mounted on large slides (76 x 39 mm. Chance Propper Ltd., Waverley, 
U.K.). Sections from other species were mounted on standard slides (75 x 25 mm).
4.3.3.2 Specimen preparation and sectioning
Various problems are encountered when cryostat sectioning the eye. The 
existence o f  several tissues types each with different consistencies poses particular
4.9
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Figure 4.3
Effect o f  low speed centrifugation o f membrane protein assay samples on protein 
content. Samples were assayed for protein according to the method o f  Lowry (1951). 
Abs (720nm) was measured before ( B O )  and after ( H  H  ) a low speed 
centrifugation step. (A) quail membranes; (B) chicken membranes; (C) quail 
membranes (pre-centrifuged during membrane preparation); (D) human membranes; 
(E) albumin standard quality controls. Data are means ±  s.e.m. (n = 3 samples). 
Where error bars are not visible they are masked.
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problems. For example, the frozen lens is susceptible to cracking and whereas the 
neural retina can very easily be cut, the sclera is tough. In addition, if cutting whole 
cross sections o f large eyes, as the vitreous body is cut the friction o f  the blade causes 
it to melt. Loss o f this support results in the section structure breaking down. The 
following methods were eventually found to be most suitable for use with the species 
investigated.
Frozen whole eyes were cut using a saw into hemispheres along the plane o f the 
visual axis, that is through the pupil and lens to the posterior o f  the eye in 
approximately the region o f  the fovea (Figure 4.4 ). The majority o f  vitreous and lens 
material was then scraped out. A small amount o f  vitreous material in contact with 
N R  was not removed to prevent damage to the N R structure. All manipulations were 
carried out on dry ice to  prevent thawing. The half eye cups so produced were then 
fully embedded in Tissue-Tek OCT compound (Miles Inc., Elkhart, Indiana, U.S.A.). 
Sections were produced from the cut face, therefore each tissue slice continued NR, 
C-RPE and iris tissue. In two instances unfrozen human eyes were obtained. For 
these, the anterior section o f  the eye was cut away to produce eye cups as detailed in 
section 2.3.1.1 and the vitreous body removed. Specimens were frozen in dry ice 
chilled isopentane at -30 °C. The whole eye cup was then embedded in OCT for 
sectioning.
Frozen, whole sheep eyes were prepared in a similar way to frozen human eyes 
except that the eyes were cut in half to produce anterior and posterior sections. The 
latter were then cut in half and N R and C-RPE studied in sections cut from this face 
(Figure 4.4).
Quail eyes were sufficiently small to be embedded whole in OCT and cut 
without further preparation (Figure 4.4).
Human sections were cut in a Bright cryostat. All other sections were cut in a 
Microm cryostat (HM505E). All sections were cut in some combination o f  the 
transverse and sagittal planes. The exact orientation was unknown as only enucleated 
eyes were ever obtained. Sections (20 pm thickness) were cut at -20 °C, thaw- 
mounted onto prepared slides and air-dried at ambient temperature. Dried sections 
were stored at -20 °C in airtight containers with silica gel desiccant. Human sections, 
cut at the Institute o f Ophthalmology, London, were transported back to  the 
University o f  Surrey in containers o f desiccant, packed on dry ice and were then 
transferred to -20 °C storage. Sections were stored for no longer than tw o weeks 
before use.
Sections were cut in pairs, the first onto slide 1 for determination o f total 
binding and the second onto slide 2 for non-specific binding. Depending on the 
section size each slide contained two to four slices cut in this manner. Further 
sections were cut onto additional slides in a similar fashion. Between each pair o f 
sections, two slices were discarded.
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4 .3 .33  Binding studies
The protocol employed was based on that previously reported by Laitinen and 
Saavedra (1990a). Sections were equilibrated to  room temperature before incubation 
in buffer (50 mM Tris-HCl, with 4 mM CaCb, pH 7.4) for 15 min. Slides were shaken 
to  remove excess moisture and then laid flat. For determination o f  total binding an 
aliquot o f  2-[^^^I]iodomelatonin solution in buffer was applied to each section. N on­
specific binding was determined in the presence o f  the same radiolabel solution 
containing 1 pM  melatonin. Radioligand aliquot volume was dependent on section 
size (100 to 750 pi) but within an experiment for an individual species all sections 
w ere treated with the same volume. In all instances binding was investigated by single 
point analysis using a subsaturating concentration o f  radiolabel selected for each 
species on the basis o f  previous membrane saturation experiments (nominal 
concentrations: quail 100 pM, human and sheep 120 pM). After a 1 h incubation, 
slides were washed three times in ice cold buffer (5 min each), rinsed in chilled double 
distilled water (30 s) then allowed to air dry. Unless otherwise stated all solutions 
were maintained, and incubations carried out, at ambient temperature (18 to  22 °C).
Dried sections were apposed to  X-ray film (Hyperfilm-^H, Amersham 
International, Buckinghamshire) in cassettes (Hypercassettes, Amersham 
International) for variable time periods at ambient temperature. All the sections from 
an individual eye were always placed in the same cassette and apposed to  a single 
piece o f  film. Total and non-specific slide pairs were always placed next to  each 
other. Films were processed manually at ambient temperature with the “Photosol” 
system (Fuji Medical): films were developed (CD 18) for 3 min, fixed (CF 40) for 5 
min and washed (water) for 10 min. All manipulations with film w ere performed 
under dim red light (15 W, Kodak Safelight Filter GBX-2).
After production o f  autoradiographs, all tissue sections were stained to  reveal 
the histological organisation. Prior to staining, sections were fixed for 2 min in 
Clark’s solution (75 % absolute ethanol, 25 % glacial acetic acid (v/v)) then allowed 
to  air dry. The following protocol for haematoxylin and eosin staining was employed. 
Incubation times are shown in brackets. Slides were agitated gently once during each 
step to  ensure thorough mixing o f  the reagents with sections.
1. Stain in haematoxylin (15 min).
2. Rinse in running water (1 min)
3. Differentiate in acidified alcohol (70 % ethanol (v/v) containing 1 % conc. HCl
(v/v)) (5 s).
4. Rinse in running tap water (10 min)
5. Stain in eosin (1 % in tap water (w/v)) (2 min).
6. Remove excess stain in water.
7. Dehydrate in an ethanol series; 85 % , 2 x 100 % (30 s each).
8. Clear in xylene series ( 2 x 3 0  s).
Coverslips were applied to sections with DPX (BDH, Poole, U.K.) as the mountant.
4.3.3.4 Analysis
Autoradiographs and stained sections were digitised and analysed with the 
M CID M4 (Microcomputer imaging device) image analysis system (Imaging Research
Inc.) after acquisition o f images through a CCD video camera (Model XC-77CE,
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Sony). Autoradiographs were illuminated on a Northern Light lightbox (Model B 
95). To correct for non-uniform illumination in the field o f view, a shading error 
correction was acquired and automatically applied to subsequent images. A new 
shading error correction was always established following any modification o f  factors 
such as magnification which would affect the illumination pattern.
Once optimal lighting, magnification and focusing conditions were established 
all autoradiographs (and histology sections) from an individual experiment were 
digitised under the exact same conditions to enable valid comparison between them. 
Individual tissue areas were frequently visually indistinct on digitised images o f  the 
autoradiographs, for example, N R and RPE. Also, irregularity o f  the sections 
precluded subtraction o f non-specific binding image from total binding image to 
ascertain extent o f  specific binding. To overcome these problems the following 
protocol for analysis was adopted. Each histology section was digitised and then the 
corresponding autoradiograph was aligned with this image and digitised. Histology 
and autoradiograph images were thus captured in different channels. During 
subsequent analysis the channels were linked. It was then possible to  select 
appropriate tissues for analysis on the histology image whilst sampling from the 
corresponding area on the autoradiograph.
For quail N R and C-RPE analysis, the specimen magnification employed was 
such as to obtain an image o f approximately half o f the posterior portion o f  each 
section, that is, from the centre to the region o f  the ora serrata. For human and sheep 
N R  and C-RPE analysis, about one-third o f  the whole posterior portion, from the 
centre outwards, was imaged. All N R or C-RPE in each image was sampled. For 
analysis o f  human iris/ciliary body tissues images o f  the anterior portion o f  the eye 
from posterior to the ciliary body were captured. All iris and ciliary tissue within the 
image was sampled. In addition, in some specimens, sections were o f  sufficient 
quality to  allow sampling o f  ciliary muscle.
In all instances, data were automatically acquired as relative optical density 
(ROD) values:
where, ROD = login maximum possible number o f  grev levels 1256)
observed grey levels
ROD values for each segment o f a particular tissue within an image were then 
used to  generate a weighted mean ROD value for the tissue within that image. The 
contributions o f  individual ROD values to the mean were weighted on the basis o f 
target area from which they were taken. One mean ROD value per tissue was thus 
derived from each tissue section. For each film analysed under a particular set o f 
conditions, a ROD value for background was established by averaging ROD values 
obtained from a number o f section-free film areas distributed across the film. This 
background value was subtracted from all mean tissue ROD values.
For each eye, for each tissue mean ROD values for total and non-specific binding 
were usually each obtained from at least five sections. Comparisons between the total 
and non-specific binding mean ROD values were made by the Student’sunpairedMest. 
Pairing was such that consecutive sections were compared. This method also had the 
advantage o f  accounting for any effect o f  variation o f  optical density across the film 
caused by storage cassettes, etc. as pairs o f slides were always exposed in the same
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region o f  film. A significant difference (p < 0.05) between total and non-specific 
binding was taken as evidence o f  specific 2-[^^^I]iodomelatonin binding. Calibration 
standards (^^^I) were not used therefore no inter-eye comparisons were made.
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C h a p t e r  5
A n a l y s is  o f  q u a il  e y e  2-[^^^I]io d o m e l a t o n in
BINDING SITES
5.1 Introduction
The eyes o f the Japanese quail {Coturnix japonica) are increasingly being 
recognised as major contributors to the organisation o f circadian physiology in this 
species. Their influence is multifaceted. It is likely that some o f these effects are 
mediated through ocular melatonin.
Locom otor activity in the intact quail displays rhythmicity which persists in 
constant darkness, and is therefore circadian rhythmicity (Underwood and Siopes,
1984). Bilateral enucleation o f  quails results in disruption o f  the activity rhythm of 
birds maintained in both 24 hour light:dark cycles and continuous darkness implying 
an important role o f  the eyes in the circadian organisation o f  this species (Underwood 
and Siopes, 1984; Konishi et al., 1985). The rhythm o f body temperature in the quail 
is also dependent on the eyes; there is complete loss o f  its circadian control following 
enucleation (Underwood, 1994).
The eyes are, however, but one component o f the quail’s circadian system. 
Circadian organisation in this species is the product o f a complex interaction o f 
multiple oscillators, namely the eyes, the pineal and the SON (Underwood and 
Edmonds, 1995). The involvement o f the eyes in the circadian control o f  the quail is 
believed to be via their participation in an eye-SCN axis: output from the eyes appears 
to  be a requirement for maintenance o f  normal SCN rhythmicity (Underwood, 1994).
Within the quail eye itself, as in many species, there is a diurnal rhythm in 
melatonin concentration (Underwood et al., 1984). This is a true circadian rhythm 
(Underwood and Siopes, 1985). Furthermore, the clock controlling this rhythm has 
been demonstrated to reside within the eye itself (Underwood et al., 1988; 1990b). 
Some melatonin is released from the eyes and enters the circulation. According to 
Underwood and co-workers (1984), about 33 % o f the night-time blood levels o f 
melatonin are in fact contributed by the eyes. Initially, this release o f  melatonin was 
believed not to  be the means o f  communication between the eyes and the other 
components o f  the circadian system. Rather, some form o f  neural message was 
assumed, as optic nerve sectioning was found to  produce the same effects as blinding 
by enucleation on the circadian activity rhythm (Underwood et al., 1990a). Later, the 
effect o f  optic nerve section on the quail’s body temperature rhythm was investigated 
and it was discovered that unlike enucleation this procedure does not abolish its 
circadian rhythmicity (Underwood, 1994). Current opinion therefore attributes at 
least some part o f  the eyes’ influence on whole body circadian organisation to occur 
via an hormonal output, with melatonin as the obvious candidate (Underwood and 
Edmonds, 1995).
The significance o f any possible local actions o f ocular melatonin in the quail, 
either in relation to extra- or intraocular circadian physiology, has hardly been 
considered. Similarly, to date, no mechanism by which such an effect o f  melatonin 
could be mediated within the eye has been investigated. As has been discussed 
previously (section 1.7), several important local functions o f ocular melatonin in other 
species, many o f which have circadian implications, have been reported. It has been 
proposed that it serves as an internal zeitgeber to control the timing o f local rhythmic 
events (Besharse and luvone, 1983). In the quail eye itself a circadian rhythm in 
comeal mitotic rate has been described (Sasaki et al., 1995). It is feasible therefore 
that this or other local rhythms might be under the control o f  ocular melatonin.
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Given (1) the importance o f  the role the eyes play in the circadian system o f the 
quail; 2) the presence o f  a robust ocular melatonin rhythm under the control o f  an 
intraocular clock; and (3) the existence o f  melatonin binding sites within the eyes o f 
several species, some o f which have been linked to a functional response, it was o f 
interest to  ascertain the presence or absence o f melatonin binding sites within the quail 
eye.
The quail is a photoperiodic species, that is, its reproductive potential fluctuates 
seasonally according to the length o f  the prevailing daily light period (Follett et al., 
1992). In the quail, as in other species, a role for melatonin as the link between 
environmental conditions and this aspect o f  physiology has been strongly implicated. 
The circulating level o f melatonin is synchronised with day length: a direct 
relationship exists between the duration o f  night length and its secretion (Underwood 
and Siopes, 1985; Kumar and Follett, 1993) and immunological manipulation o f 
plasma melatonin levels has been shown to induce gonadal growth (Ohta et al., 1989). 
In addition to  its effects on reproduction, photoperiod has also been shown to 
influence the density o f high affinity melatonin binding sites within certain areas o f  the 
quail brain (Panzica et al., 1994). These authors have suggested that this additional 
effect o f  photoperiod may also be a result o f  changes in the circulating melatonin 
profile. In the investigations described, ocular melatonin binding site characteristics 
(affinity and density) were investigated in order to determine whether an analogous 
system is in operation in the quail eye. That is, are changes in ocular melatonin 
binding sites concomitant with alteration o f the photoperiod, an action known to 
influence ocular melatonin profiles (Underwood et a l, 1984; Underwood and Siopes,
1985).
5.2 Methods
The occurrence and characteristics o f high affinity 2-[^^^I]iodomelatonin binding 
sites were investigated in NR and C-RPE tissue membranes by radioreceptor assay 
(sections 4.3.2). N R and C-RPE membrane binding site affinities and densities were 
also investigated at intervals across a 24 h period in birds which had previously been 
maintained under either long or short day photoperiods. Details o f the quails used are 
described in section 4.2.2.
The presence o f a binding site in both N R and C-RPE tissues was confirmed by 
autoradiography as described in section 4.3.3.
5.3 Results
5.3.1 Characterisation o f  2-[^^^I]iodomelatonin binding sites
Tissues used in all the studies except NR displacement studies were subjected to 
the additional centrifugation step during membrane preparation to remove melanin 
(section 4.3.2.3). This difference for the NR displacement studies was unlikely to 
affect the results as there was little visible contamination o f the N R and subsequent 
repeats o f  this study using NR from which melanin was removed yielded identical
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results for those compounds tested (limited tissues supplies prevented testing o f the 
complete series o f compounds).
5.3.1.1 Kinetic studies
Figure 5.1 shows rapid association o f  2-[^^^I]iodomelatonin with the binding site 
in both N R  and C-RPE preparations at 28 °C over the first 40 minutes o f  the 
incubation period, equilibration being reached by the end o f  this time period. Binding 
was stable over the subsequent 250 min period in NR. In C-RPE, binding was stable 
for 150 min but at 250 min there was a significant decrease in binding. Binding o f  2- 
[^^^IJiodomelatonin was reversible upon the addition o f  1 pM cold melatonin, specific 
binding being reduced by 85 % and 95 % after 250 minutes in N R and C-RPE, 
respectively. Rate constants are shown in Table 5.1. Kinetic dissociation constants 
(Kd) derived from these parameters (k.i/k+i) were 11.9 and 15.0 pM for NR and C- 
RPE, respectively.
5.3.1.2 Saturation studies
Saturation binding data reported here were always obtained from freshly 
prepared tissue. In both NR and C-RPE membrane preparations, specific 2- 
[^^^I]iodomelatonin binding increased with radioligand concentration over the range 7 
- 150 pM. Above approximately 150 pM specific binding failed to  increase 
significantly indicating attainment o f  saturation. Scatchard transformation o f  specific 
binding data from both preparations yielded linear plots. Hill coefficients (mean ± 
s.e.m., n=4) were 0.96 ± 0.06 and 0.94 ± 0.03 for NR and C-RPE, respectively. 
Calculated equilibrium dissociation constants (Kd) (mean ± s.e.m., n=4) were N R 50.8 
±  19.5 pM and C-RPE 98.2 ± 35.4 pM. Corresponding values (maximum 
numbers o f binding sites, mean ± s.e.m.) were 12.4 ± 2.7 fmol/mg protein and 21.5 ±
3.2 fmol/mg protein for N R and C-RPE, respectively. Representative examples o f 
saturation studies are shown in Figure 5.2.
In one instance choroid and RPE tissues were separated. Saturation studies on 
these individual tissues provided evidence for the presence o f specific, saturable 2- 
[^^^IJiodomelatonin binding sites in each (Figure 5.3). As these were preliminary 
studies, melanin was neither removed during membrane preparation nor for protein 
determination, hence the Bnux values quoted may not be wholly representative.
Specific binding as a proportion o f total 2-[^^^I]iodomelatonin binding for NR 
and C-RPE tissues was typically between 70 to  95 % in preparations from which 
contaminating melanin had been removed. I f  melanin was present, however, as 
previously discussed (section 4.3.2.6.1) the proportion o f  specific binding was much 
lower; over the radioligand concentration employed specific binding was only between 
30 to 90 % (NR) or 5 to 30 % (C-RPE) o f  total. Full saturation studies performed on 
tissue containing melanin (Figure 5.4) gave similar Kd values (51.6 ± 2.5 pM, and
102.4 ± 1 1 .4  pM for NR and C-RPE, respectively (values ±  associated error using 
LIGAND) implying that the change in methodology to remove the melanin, had little 
effect on specific binding thus confirming the results o f  preliminary experiments 
(section 4.3.2.6.1, Figure 4.2).
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Association Dissociation Kinetic dissociation constant
(M‘'min') (min') Ki (pM)
N R 7.18 X 10' 8.55 X 10'^ 11.9
C-RPE 7.99 X 10' 1.20 X 10'^ 15.0
Table 5.1
Association and dissociation rate constants o f  2-[^^^I]iodomeIatonin binding in the 
quail eye.
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Figure 5.1
Kinetic analysis o f specific 2-[‘^ ^I]iodomelatonin binding to (A) NR and (B) C-RPE 
membranes at 28 °C. Binding was reversible upon the addition o f  1 [Im cold 
melatonin. Radioligand concentration was 104 pM in (A) and 112 pM (B).
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Throughout, unless stated otherwise, Ki and .Bmax values are quoted ± approximate 
standard error values attributed by the LIGAND program. Values are estimates from 
single experiments only. This procedure has been employed in Figures 5.2-5.4, 5.6, 
6.1-6.3 and 6.5 and Tables 6.2 and 6.3.
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Figure 5.4
Saturation o f  specific 2-[*^^I]iodomelatonin binding (O) in NR (A) and C-RPE (B) 
membranes from which melanin pigment had not been removed. Non-specific binding 
( • )  was determined in the presence o f 1 p,M melatonin; total binding (■ ). In this 
example, Kd values for NR and C-RPE were 51.6 ± 2.5 pM and 102.4 ± 1 1 .4  pM, 
respectively (data are values ± associated error using LIGAND).
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5.3.1.3 Displacement studies
Several unlabelled indoles, including the melatonin analogues 2 -bromomelatonin 
and 2 -iodomelatonin, were assessed for their ability to displace specific 2 - 
[^^^I]iodomelatonin binding. Monophasic displacement curves for all inhibitors were 
obtained in both tissues (Figure 5.5A, B). However for 6 -chloromelatonin in C-RPE 
a two-site model produced a significantly better fit {K\ values for the tw o sites were 
0.028 and 32 nM). Apart from this discrepancy, pharmacological profiles o f the 
binding site in both N R  and C-RPE preparations were very similar. Linear regression 
o f  logarithmically transformed K{ data (except 6 -chloromelatonin) yielded a highly 
significant correlation between the binding sites o f the two tissues (r=0.98; slope = 
0.91; p<0.00001, n=9) (Figure 5.5C). In general, substituted A-acetyl-5- 
methoxytryptamine compounds were most effective in displacing 2 - 
[^^^I]iodomelatonin. The 5-hydroxyindole, 5-HT and the 5-methoxyindoles, 5-ML 
and 5-MT, had little effect. 2-Phenylmelatonin was a very effective inhibitor o f 2- 
[^^^I]iodomelatonin binding in both tissues.
5.3.1.4 Effect o f nucleotides on 2-[^^^I]iodomelatonin binding
In both N R  and C-RPE membranes, GTP inhibited 2-[^^^I]iodomelatonin 
binding in a dose dependent manner. The inhibitory effect o f ATP was much less than 
that o f  GTP. Representative GTP and ATP IC50 values were 140 and 2050 pM, 
respectively, for NR, and 16 and 1220 |iM , respectively, for C-RPE.
5.3.2 Effect o f photoperiod on NR and C-RPE 2-[^^^I]iodomelatonin binding
Figure 5. 6  shows the changes in binding site affinity and density across a 24 h 
period when quails were maintained in either long or short day photoperiods (see 
section 4.2.2 for photoperiod details). Eyes were dissected and membranes prepared 
fresh on the day o f  each saturation study. All tissue homogenates were pre­
centrifuged to remove melanin. The same batch o f radioligand was used throughout. 
Tissues from randomly selected time points were assayed on each occasion.
Hill coefficients for all saturation experiments approached unity implying the 
presence o f a single class o f high affinity binding sites at each time point o f  the 24 h 
cycle. There was insufficient material to perform more_thanjone_Scatchard per time 
point therefore for statistical analysis, for each photoperiod, light phase data were 
combined and compared with combined dark phase data (Figure 5.7). Two factor 
analysis o f  variance was performed on the parameters o f each tissue with photoperiod 
(short or long) and light phase (day or night) as the independent variables. There 
w ere no significant differences (p < 0.05) associated with the Bmax or Kd values for 
NR, or the C-RPE values. For C-RPE Kd values, however, there was a 
significant interaction between light phase and photoperiod. Subsequent one way 
analysis o f  variance indicated that in the day time, Kd was significantly higher in the 
long day photoperiod compared with the short day photoperiod (p <0 .0 0 1 ), and in the 
long day photoperiod Kd was higher during the day than in the night (p <0 .0 0 1 ).
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F igure  5.6
Effect o f  photoperiod duration on quail NR and C-RPE melatonin binding site affinity 
and density over a 24 hour period. Quails were maintained under short (8L:16D) (■  
full line) or long (16L:8D) (O dashed line) photoperiods prior to sacrifice. Periods o f 
darkness are indicated by shaded areas: short day dark period E  , long day dark 
period • Individual data points were derived from a single saturation binding
experiment using membranes prepared from 4 eyes. In each graph the end point is 
double plotted. Saturation data for the 1 h C-RPE point could not be Scatchard 
transformed. Data are values ± associated standard error using LIGAND.
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Effect o f  photoperiod (SP 8L:16D; LP 16L:8D) on mean day ( ) and mean
night ( m  ) 2-[^^^I]iodomelatonin binding site affinity and density in quail N R and 
C-RPE membranes. Data are means ± s.e.m. (n values for NR and C-RPE: SP day
(3), night (5); LP day (5), night (3); except C-RPE LP night (2)). * p < 0.001
compared with LP day
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5.3.3 Localisation o f specific 2-[^^^I]iodomelatonin by autoradiography
Duplicate total and non-specific binding sections were exposed for a range o f 
times (fi*om 1 day to 6 weeks). Binding o f 2-[^^^I]iodomelatonin (nominal 
concentration 100 pM) in N R and C-RPE areas was apparent after 7 days o f 
exposure. Preliminary visual inspection o f  the autoradiographs indicated that fi'om 
this time onwards there was a difference in density between total and non-specific 
sections across the entire region o f  the NR, that is, throughout the circumference o f 
the eye. O f the exposure times investigated, the difference appeared to  be greatest at 
3 weeks. Subsequently therefore, sections were routinely exposed for 3 weeks. 
Semi-quantitative densitometric analysis (section 4.3.3.4) o f single eyes from 6 
individual birds indicated that displaceable 2-[^^^I]iodomelatonin binding was present 
in both the N R and C-RPE regions (Figure 5.8). For both N R  and C-RPE there was a 
significant difference between total and non-specific binding (unpairedStudent’s ^-test). 
In agreement with previous membrane binding study findings (section 5.3.1.2), the 
proportion o f  specific binding was greater in N R than C-RPE. Representative 
autoradiographs are shown in Figure 5.9.
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5.4 Discussion
The present data provide definite evidence for the presence o f melatonin binding 
sites within the quail eye. 2-[^^^I]Iodomelatonin bound specifically to both N R and C- 
RPE membranes. In both tissue preparations there was a saturable population o f 
binding sites. Transformation o f specific binding data to yield linear Scatchard plots 
and Hill coefficients approaching unity suggest a single class o f  binding sites which 
interact with their ligand non-cooperatively. Specific binding o f  2-[^^^I]iodomelatonin 
was rapid initially and subsequently stable with time. Further, the binding was 
reversible. values indicate the binding to be o f high affinity and Bmzx values provide 
evidence for a binding site o f low capacity. Equilibrium and kinetic dissociation 
constants were comparable. Thus several criteria required for definition o f  a binding 
site as a receptor have been satisfied.
Within the quail it seems that there are in fact populations o f 2- 
[^^^I]iodomelatonin binding sites in both NR and C-RPE tissue compartments 
although pharmacologically, they are very similar. This is consistent with results from 
studies performed on another avian species. Using a similar radioreceptor assay, 
Chong and Sugden (1991) demonstrated the presence o f melatonin binding sites in 
both N R  and RPE o f the chicken eye. Prior to this melatonin receptors had been 
reported in chicken N R by Dubocovich and Takahashi (1987). Autoradiographic 
studies in the same species however showed melatonin receptors to  be located 
exclusively within the inner plexiform layer o f  the N R with no saturable specific 
binding in the RPE (Laitinen and Saavedra, 1990a). In other species also the 
melatonin binding site appears to be localised predominantly to the NR (for example: 
mouse and rabbit, Blazynski and Dubocovich, 1991; and frog, Skene et al., 1993). 
Wiechmann and co-workers (1986) have demonstrated that the melanosomes within 
frog C-RPE bind melatonin specifically. However, in the present studies the C-RPE 
membrane preparation contained no melanosomes so this cannot explain the presence 
o f binding sites in the C-RPE tissue investigated. In addition to the chicken (Chong 
and Sugden, 1991), specific, albeit low affinity, melatonin binding has only been 
identified in C-RPE tissues (cytosol fraction) from one other species; the trout (Gern 
e ta l,  1981).
With the dissection procedure employed, it was recognised that the potential for 
cross contamination between NR and C-RPE tissues existed and that the binding 
observed in both tissues may in fact be contributed by a single tissue only. 
Autoradiographical studies were therefore undertaken to ascertain the precise 
localisation o f 2-[^^^l]iodomelatonin binding. These studies confirmed the presence o f 
specific binding in both N R and C-RPE tissues. In addition, preliminary radioreceptor 
binding assays indicated the possibility o f a saturable, specific binding site in both 
choroid and RPE. Unfortunately, however, the autoradiography methodology 
employed did not provide sufficient resolution to enable discrimination o f  binding 
between RPE and choroid components. Melatonin binding specifically within RPE 
has been investigated by few groups. As previously mentioned, it is present in the 
chicken (Chong and Sugden, 1991) but is reported to be absent from Xenopus and 
Rana frog species (Skene et a l, 1993). Recently, two distinct melatonin receptor 
cDNAs (CKA and CKB) have been cloned from chicken brain (Reppert et al., 
1995b). CKA is the structural homologue o f  the mammalian Mefia receptor and CKB
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represents the third receptor subtype Mehc (Reppert et al., 1995b). Both CKA and 
CKB are expressed in the chick retina, however, although the proteins are structurally 
distinct, they cannot be distinguished with existing ligands (Reppert et al., 1995b).
The affinity o f  the melatonin binding site observed in the quail N R is higher than 
that o f  the chicken N R as determined by Dubocovich and Takahashi (1987) {Ka 434 
pM), (the binding site is also o f lower capacity) and is in better agreement with the Ka 
estimate o f  Laitinen and Saavedra (1990a) (^d 19.8 pM). Affinity data from tree 
shrew retina (Lu et al., 1991) were comparable to that o f the quail although binding 
capacity o f  the tree shrew was much lower (1.97 fmol/mg protein). Differences 
between species, binding assay methodologies (temperature o f  incubation and method 
o f  tissue preparation, for example) and animal housing conditions, could explain these 
differences in values.
In both N R and C-RPE tissues binding was highly specific, presence o f a 
methoxy group at position C5 and an A-acetyl group on the indole nucleus o f the 
inhibiting compound conferring highest potency for competition for 2- 
[^^^IJiodomelatonin binding. Both the chicken pharmacological profile (NR and RPE) 
derived by Chong and Sugden (1991) and that o f the frog NR, derived by Skene and 
colleagues (1993), are identical with that obtained in the quail NR with the exception 
o f  6-chloromelatonin. Pharmacological profiles obtained in the quail were also 
broadly similar to the N R melatonin binding sites previously characterised in the 
chicken (Dubocovich and Takahashi, 1987), rabbit (Dubocovich, 1985) and tree 
shrew (Lu et al., 1991) although there were slight differences notably within the 
melatonin, 2-iodomelatonin, 6-chloromelatonin group o f compounds.
With regards to the signal transduction mechanism o f the melatonin binding site 
in the quail eye, involvement o f a G protein seems likely on the basis o f  present data. 
A large proportion o f the melatonin binding sites investigated to date for G  protein 
coupling have yielded positive results, for example ovine pars tuberalis (M organ et 
al, 1989), rat SCN (Laitinen and Saavedra, 1990b) and European hamster pars 
tuberalis (Skene et a l, 1992b). In addition, data concerning G protein linkage o f 
melatonin retinal receptors in another avian species, the chicken, is consistent with 
this hypothesis. Laitinen and Saavedra (1990a) demonstrated the regulation o f  2- 
[^^^IJiodomelatonin binding by guanine nucleotides in the N R o f  this species. Chong 
and Sugden (1991) report similar findings in RPE although coupling o f  the binding 
site to a G protein was not observed in NR. In contrast however, some workers have 
failed to  show an effect o f  GTP on 2-[*^^I]iodomelatonin binding in chick N R 
(Dubocovich et a l, 1989). G-protein coupled melatonin binding sites have also been 
demonstrated in frog NR (Skene et a l, 1993).
Melatonin binding sites have previously been investigated in the quail brain 
(Yuan and Pang, 1990; Cozzi et a l, 1993). The binding site described by Cozzi et al 
(1993) displays marked similarities with those investigated in the present study. 
These include comparable affinities, sensitivity to GTP and almost identical 
pharmacological profiles. Such similarities between retina and brain melatonin 
receptors are also apparent in the chicken (Dubocovich et al, 1989). The recent 
demonstration o f  the expression o f the CKA and CKB melatonin receptor subtypes in 
both chicken brain and retina may explain the reported similarities between the brain 
and retina binding sites in avian species.
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In chick brain (Brooks and Cassone, 1992) and rat SCN and pars tuberalis 
(Gauer et al., 1993) there exists a diurnal variation in melatonin binding site density. 
Other tissues also display diurnal variations in 2-[^^^I]iodomelatonin melatonin 
binding, for example, rat thymus (Martin-Cacao et al., 1995). Frequently the highest 
density is observed during the light phase, however Laitinen and co-workers (1988) 
have reported the reverse in rat SCN. Importantly, with respect to the studies 
reported here, within the quail brain, the number o f binding sites is reported to be 
over 40 % higher at mid-light in birds maintained under a 12L;12D photoperiod 
(Yuan and Pang, 1990). Furthermore, in the quail, melatonin receptor density during 
the light phase is dependent upon the prevailing photoperiod (Panzica et al., 1994). 
The variation in melatonin binding site density is proposed to  be melatonin-related, 
that is homologous regulation, resulting either from fluctuations in the level o f 
circulating melatonin (Yuan and Pang, 1990; Gauer et al., 1993; Martin-Cacao et al., 
1995), or in the case o f the photoperiod effects, changes in the melatonin profile 
(Panzica et al., 1994). In contrast, in this study, melatonin binding site density in the 
quail eye in both NR and C-RPE tissues remained constant between light and dark 
phases irrespective o f  photoperiod despite the fact that the ocular melatonin level is 
reportedly influenced in a similar fashion to that o f  the plasma level (Underwood et 
a l, 1984; Underwood and Slopes, 1985). There are other tissues within the quail 
however that do not display variations in melatonin binding, for example, the testes 
(Wang g/ a/., 1992 1906).
The reported day/night fluctuations in melatonin receptor number occur without 
changes in affinity (for example. Yuan and Pang, 1992; Gauer et al., 1993) and in the 
quail NR, in addition to the lack o f effect on 5max, there was also no effect o f  the 
light/dark phase or photoperiod on Ka values. In contrast, in C-RPE there were 
statistically significant differences in affinity. Given the magnitude o f these differences 
however, that is, less than twofold, their physiological significance is questionable. 
The differences cannot be a result o f G-protein coupling as a shift from the G-protein 
coupled to  uncoupled form o f the binding site results in a low affinity state with Ka 
-4 0 0  pM (Sugden, 1994).
N o attempt was made in these studies to elucidate the functional role o f  the 
melatonin binding site described. Within the quail eye these binding sites might 
potentially contribute to any o f the following:
1) Mediation o f local physiological functions.
Within chicken and rabbit NR, for example, there is clear evidence for melatonin 
binding sites mediating inhibition o f dopamine release (Dubocovich, 1983,1985; 
Dubocovich and Takahashi, 1987). Many other actions o f  ocular melatonin on N R  or 
C-RPE tissue components have also been reported, but few have yet been associated 
with receptor binding (section 1.7). These may also be o f significance in the quail.
2) Manipulation o f an intraocular clock, for example in the role o f  entraining 
agent.
The ocular melatonin-generating system itself is controlled by an intraocular clock 
(Underwood et al., 1990b). This clock may serve to regulate other local circadian 
events. Melatonin binding sites represent a possible route by which melatonin could 
exert an influence on the ocular clock.
3) M odulatory input to the whole body clock mechanism.
This might be either indirectly through effects on the intraocular clock and the 
contribution it subsequently makes to whole body circadian organisation, or directly
5.17
via modification o f information being sent from the eye to the centres o f circadian 
control. The eyes are o f great importance with respect to  maintenance o f  circadian 
integrity within the quail. Endocrine release o f  retinal melatonin contributes part o f  
the signal through which the eyes influence the rest o f  the circadian system 
(Underwood and Edmonds, 1995). In addition there is evidence for involvement o f  a 
neural pathway (Underwood et a l, 1990a). One possibility therefore is that 
melatonin, at the receptor level, may exert some modulatory influence over the 
message being relayed via this neural pathway.
5.18
C h a p t e r  6
In v e s t ig a t io n  o f  2-[^^^I]io d o m e l a t o n in
BINDING SITES IN POST-MORTEM HUMAN EYES
6.1 Introduction
There is substantial evidence for the existence o f high affinity melatonin binding 
sites within the vertebrate eye including that o f several mammals (Table 1.4). The NR 
component o f the eye has been most often studied and in accordance with the findings 
in other animal classes, there are several reports documenting the existence o f high 
affinity binding sites in this tissue in mammals. Within the mammalian retina the 
highest density o f  binding sites appears to be located within the inner areas o f the 
retina, particularly the inner plexiform layer where the integrating neurons and the 
retinal ganglion cells synapse (Laitinen and Saavedra, 1990a; Blazynski and 
Dubocovich, 1991 ).
Studies have concentrated mainly upon various laboratory species. Until 
relatively recently there were no reports concerning the investigation o f  melatonin 
binding sites within the human eye, although specific melatonin binding had been 
demonstrated in a lower primate, the tree shrew (Lu et al., 1991). The restricted 
availability o f  appropriate human tissue sources, that is, non-pathological specimens 
from live donors, has undoubtedly been one o f the major factors responsible for this 
paucity o f  data. In 1994, Capsoni and co-workers (1994) reported, in abstract form, 
for the first time, results o f a study investigating melatonin binding sites in human 
tissue. Little information regarding the methodology employed and the specimens 
investigated, for example, donor details, was provided, thus making evaluation o f 
their findings difficult. High affinity, reversible binding was observed. Scatchard 
analysis and indole displacement studies revealed the existence o f two, picomolar 
affinity sites. The autoradiographic methodology employed (high resolution liquid 
emulsion type) allowed localisation o f the binding site to the C-RPE complex. To 
date however, these findings have not been reported in an extended form and their 
validity may therefore, be questioned.
O f much greater significance is a subsequent paper detailing the cloning o f  a 
human gene encoding a melatonin receptor (Meftb) which is expressed predominantly 
in retina (Reppert et al., 1995a). The Mefta receptor (Reppert et al., 1994) has also 
been found to be expressed in human retina, albeit at much lower levels (Reppert et 
al., 1995a). Both o f these recombinant receptors are functionally coupled to the 
inhibition o f adenylyl cyclase: melatonin prevents forskolin induced cAMP 
accumulation.
O f all species the human melatonin binding site is, at least in terms o f  its 
potential for future therapeutic exploitation, perhaps the most worthy o f  study. 
Ocular melatonin is increasingly viewed as being o f local physiological relevance. 
The reported actions o f melatonin within the mammalian eye are now many. In rabbit 
retina, melatonin inhibits the calcium-dependent ^H-dopamine release, elicited by 
depolarisation with either electrical field stimulation or high potassium, from 
prelabelled tissue (Dubocovich, 1983). This action o f melatonin has been 
unequivocally established to be receptor-mediated (Dubocovich, 1985) and it is likely 
that at least some o f its other actions will eventually be attributed to  receptor 
activation. Interest is growing in melatonin as a contributory factor in retinal disease. 
In the Royal College o f Surgeons rat, for example, the endogenous defect leading to 
photoreceptor degeneration is believed to be related to abnormalities associated with 
the retinal dopamine-melatonin system (Hankins and Ikeda, 1994). O ther authors 
have linked melatonin, in conjunction with the damaging effects o f bright light, with
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ocular disease states such as macular degeneration (Wiechmann and O ’Steen, 1992) 
and retinitis pigmentosa (Bubenik and Purtill, 1980). Thus identification and 
thorough characterisation o f a human ocular melatonin receptor would facilitate 
design o f  specific agonists and antagonists and enable pharmacological intervention 
for the possible treatment o f melatonin-related ocular disease. Melatonin receptor 
defects may also be o f  aetiological significance and represent additional therapeutic 
targets.
In these studies, high affinity melatonin binding sites were investigated in post­
mortem human eyes. Given the known sites o f action o f  melatonin within the eye and 
the reported distribution o f ocular melatonin binding sites within other species, 
primary consideration was given to NR and C-RPE tissues. The methodology 
previously developed (section 4.3.2) and used successfully for the identification and 
characterisation o f  melatonin binding sites in the quail eye (Chapter 5) was employed, 
that is, membrane radioreceptor assay and autoradiography with 2-[^^^I]iodomelatonin 
as the ligand. Specimens were investigated individually in order that any relationships 
existing between the resulting binding data and the donor parameters could be 
identified.
6.2 M ethods
Membrane radioreceptor assays and autoradiography were carried out as 
described in sections 4.3.2 and 4.3.3, respectively. The human tissue source was the 
same as reported in section 2.2.3. Sheep and chicken tissue sources were as described 
in section 4.2.2.
6.3 Results
6.3.1. Human membrane radioreceptor assays
6.3.1.1 N R and C-RPE
6.3.1.1.1 Saturation studies
Saturation studies were undertaken on NR and C-RPE membranes from 18 
human eyes investigated individually. The donor parameters o f  the specimens are 
provided in Table 6.1. In one eye (eye 4) saturable, specific 2-[^^^I]iodomelatonin 
binding was present in both N R and C-RPE components (Figure 6.1). In tw o 
additional eyes binding was present in either NR or C-RPE, only (Figure 6.2). In all 
cases a single site was suggested on the basis that Scatchard transformation o f  the 
data yielded linear plots, with Hill coefficients approaching unity. The maximum level 
o f  specific binding observed in these instances was low (14-20 % total binding) but 
consistent. Binding parameters are shown in Table 6.2. These three specimens 
shared a common donor parameter with respect to time o f  death; all deaths had 
occurred in the daytime. However, five other specimens from day time donor deaths 
lacked a melatonin binding site.
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In all other instances (NR and C-RPE o f  15/18 eyes) specific binding was either 
not observed, or, was present (at most, although not all radioligand concentrations) 
but could not be Scatchard transformed.
Eye ID Tissue Protein
(pg)
K,
(pM)
-^ max
(fmol/mg protein)
Hill
coefficient
4 NR 30.0 236.2 + 58.1 2.1 + 0 .4 1.00
C-RPE 69.9 208.4 + 53.6 5 .0 + 1 .0 0.97
104 NR 23.7 nd nd
C-RPE 29.0 377.7 + 47.3 10.2 + 1.3 1.10
122 NR 110.8 202.4 ± 3 6 .0 1.2+0.1 1.04
C-RPE 32.2 nd nd
Mean ± s.e.m. NR 219.3 + 16.9 1 .6+  0.5 1.02 + 0.02
(n=2) C-RPE 293.1 + 84 .7 7 .6 +  2.6 1.04 + 0.07
Table 6.2
Binding parameters obtained in 2-[^^^I]iodomelatonin saturation studies in individual 
human eyes. Data are values ± associated standard error using LIGAND, nd, specific 
binding not detectable, or present but not able to be Scatchard transformed.
6.3.1.1.2 Effect o f  melanin
On the basis o f studies undertaken in the quail which showed that melanin 
increased the level o f non-specific binding (section 4.3.2.4.1), in some instances (as 
indicated in Table 6.1) N R and C-RPE tissue homogenates were pre-centrifuged 
before membrane preparation to remove melanin (section 4.3.2.3) This was to 
determine if  the absence o f  binding in the initial human studies was because specific 
binding was masked by high levels o f non-specific binding. As expected, in NR, 
which was never visibly contaminated with melanin, this pre-centrifugation did not 
change the results. A similar lack o f effect was observed with C-RPE despite removal 
o f  large amounts o f melanin.
6.3.1.1.3 Effect o f  protein
Saturation studies were performed on tissues from individual specimens 
therefore there were limits on the maximum protein content o f  each sample. For NR 
the range protein contents was 23.7 to 149.9 |ig  and for C-RPE, 22.7 to  101.3 fig. 
Occurrence o f specific binding was not obviously related to  higher protein 
concentrations (Table 6.2 ). Increasing the protein concentration by pooling a pair o f  
eyes from the same donor (NR 170 pg, C-RPE 370 pg) and by pooling several N R  
(specimens for which there were no accompanying donor data) (255 pg) also failed to 
reveal evidence o f specific binding.
6.6
6.3.1.1.4 Displacement studies
Displacement studies with cold melatonin (10'^^-10'^ M, radioligand 
concentration = 134-145 pM) were performed on membranes (with or without 
melanin) from two individual eyes and a pool o f  eyes. There was insufficient specific 
binding in either N R or C-RPE tissues to observe an effect o f  the displacing drug. 
Incubation protein contents ranged from 81 to 257 pg for NR and 53 to  121 pg for 
C-RPE samples.
6.3.1.2 Human iris
Preliminary isolated organ experiments conducted concurrently in another 
laboratory indicated a possible contractile effect o f  melatonin on sheep iris sphincter 
muscles (personal communication, Dr. S.M.O. Hourani, University o f  Surrey). 
Binding studies were therefore carried out on this ovine tissue (section 6.3.3). The 
contractile effect observed also stimulated interest in the possibility o f  human iris 
melatonin binding sites and therefore these were also investigated.
6.3.1.2.1 Saturation studies
Pooled human iris sphincter muscle showed evidence o f  specific 2- 
[^^^I]iodomelatonin binding in saturation studies. In 2/2 cases (pools I and II, Table 
6.3) specific binding was observed over the radioligand concentration range examined 
and Scatchard transformation o f the data indicated the presence o f  a single high 
affinity site (Figure 6.3). Binding parameters are shown in Table 6.3. From Figure
6.3 it can be seen that non-specific binding was reduced in pool I as a result o f 
removing melanin, in agreement therefore with the quail findings (section 4.3.2.6.1). 
The corresponding radial muscles were also investigated however these binding data 
could not be Scatchard transformed.
K, ■^ max Hill coefficient
(pM) (fmol/mg protein)
I 293.8 + 83.6 20.7 ± 3 .6 1.01
II 147.2 ± 3 7 .2 13.6 ± 3 .6 0.91
Table 6.3
Binding parameters from human iris sphincter muscle 2-[^^^I]iodomelatonin 
saturation binding experiments. In I, tissues from 6 eyes were pooled and in 
II tissues from 4 eyes were pooled. Incubation protein contents for I and II 
were 12.9 and 19.5 pg, respectively. Data are values ± associated standard 
error usign LIGAND.
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6.3.1.2.2 Displacement studies
A displacement study with cold melatonin (10'^^ to  10'^ M) did not provide 
definite evidence for displaceable specific binding in pooled sphincter or radial 
membranes prepared from 5 irises (radioligand concentration 144 pM; melanin 
removed by pre-centrifugation). There was some effect (30 % displacement) at 10’^  
M in sphincter muscle but at lower concentrations there was little apparent effect and 
consistency o f  the replicates was poor. With radial muscle there was little specific 
binding and no consistent displacing effect o f  melatonin. Incubation protein contents 
were 17.4 and 19.3 |ig  for sphincter and radial muscles, respectively.
6.3.2 Effect o f  tissue storage on 2-[*^^I]iodomelatonin binding
An investigation was undertaken to  ascertain the effect o f  a prolonged pre­
freezing storage period on the “quality” o f specific 2-[^^^I]iodomelatonin binding 
subsequently observed in radioreceptor assays. The chicken was chosen as the 
experimental model as there is much evidence for melatonin receptors within the eye 
o f this species (for example, Dubocovich and Takahashi, 1987 and Chong and 
Sugden, 1991). The exact experimental protocol employed has been described 
(section 4.2.2). In brief, 2-[*^^I]iodomelatonin binding studies (saturation 
experiments) were performed in NR and C-RPE membranes prepared from eyes o f 
freshly sacrificed animals and from “aged” eyes. The latter were subjected to a 
rigorous protocol involving a sequence o f various storage states in order to  simulate 
the worst case scenario that a human eye might be subjected to prior to  analysis.
Preliminary saturation experiments were undertaken to confirm the presence o f 
2-[^^^I]iodomelatonin binding in the particular supply o f birds to  be used. The binding 
parameters obtained were, NR: 81.2 ± 4.3 pM, Bmax 16.8 ± 0.4 fmol/mg protein,
and C-RPE; Kd 55.7 ± 3.6 pM Bmax 3.9 ± 0.5 fmol/mg protein (all values ±  associated 
standard error using LIGAND). Scatchard transformation o f binding data from fresh 
eye N R and C-RPE membranes yielded similar Kd and Bmax values (NR: Kd 72.1 ± 5.5 
pM, Bmax 14.2 ± 1 . 1  fmol/mg protein, and C-RPE Kd 66.1 ± 4 . 1  pM Bmax 4.8 ± 0.3 
fmol/mg protein). In contrast, data from the aged eye membranes (NR and C-RPE) 
could not be Scatchard transformed. Figure 6.4 shows that that in both tissues, at all 
radioligand concentrations the level o f specific binding was greatly decreased by the 
storage process and additionally, at some concentrations there was no specific 
binding.
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Figure  6.4
Effect o f  a prolonged pre-storage period on specific 2-[^^^I]iodomelatonin binding 
in chicken NR and C-RPE membranes. For "fresh" membranes, birds were 
sacrificed and tissue membranes prepared immediately. For "aged" membranes, eyes 
were subjected to an extended period o f storage prior to membrane preparation 
(section 4.2.2). All binding studies were performed on the same day under the same 
experimental conditions. Only saturation data from fresh N R and C-RPE 
membranes were able to be Scatchard transformed.
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6.3.3 Ovine ocular 2-[^^^I]iodomelatonin binding sites
As described in section 6.3.1.2, isolated organ experiments with sheep iris 
sphincter indicated a possible contractile effect o f  melatonin. This, coupled with the 
fact that the sheep is a highly photoperiodic species (Arendt, 1995) indicated that 
investigation o f  2-[^^^I]iodomelatonin binding in membrane preparations from a 
variety o f  tissues within the ovine eye, including the sphincter muscle, might be o f 
interest.
6.3.3.1 Membrane radioreceptor assays
Various ocular tissue membrane preparations from sheep were initially screened 
for the presence o f  2-[^^^I]iodomelatonin binding (Table 6.4). Saturable specific 
binding was observed in NR only (Figure 6.5). Binding was not consistently 
demonstrated in this tissue, however. Data from only 3 out o f  5 membrane 
preparations were able to  be Scatchard transformed. The membrane preparations 
used derived from 5 separate batches o f  eyes obtained on different occasions. The 
absence o f  N R binding in some instances was not related to differences in storage as 
positive binding was obtained in both fresh and frozen membranes.
Saturation studies
NR 3/5
Kd 90.6 ± 3 1 .9  pM; B m ax 1.5 ± 0.5 fmol/mg protein; 
Hill coefficient 0.95 ± 0.04 (mean ± s.e.m., n=3)
C-RPE 0/3
Iris
sphincter pupillae 0/3
dilator pupillae 0/3
Ciliary body 0/2
Table 6.4
-125Frequency o f saturable, specific 2-[ IJiodomelatonin binding in various 
ovine ocular tissues. Each saturation study investigated 7 (NR and C-RPE) 
or 4-7 (iris and ciliary body) radioligand concentrations over the range 9 to  
800 pM.
The iris and ciliary body tissues investigated were taken from batches o f  eyes 
which had previously been demonstrated to possess saturable, specific binding in NR. 
Removal o f  melanin as described in section 4.3.2.3 had no effect on specific binding in 
any o f the tissues investigated.
The ovine NR melatonin binding site was subsequently utilised in various 
methodological investigations. Firstly, because the human membrane studies had used 
low protein contents, ovine NR membranes were employed to determine the effect o f 
protein content on the level o f specific binding. Specific 2-^^^^I]iodomelatonin binding 
at two radioligand concentrations was investigated (Figure 6.6). At the lowest
6.11
*oc
X)
ct-t
I
I— I0)
T 5O
c
I
O)
100 200 300 400 500 600
2-[^^I]iodomelatonin (pM)
.030
.025
9 .020
u.
.015
1
I  *010
.005
2.005
r
0.0
2-[^^I]iodoraelatonin (pM)
Figure 6.5
Representative 2-[^^^I]iodomelatonin binding saturation data in ovine N R  membranes 
(A). Total binding (■), non-specific binding (determined in the presence o f  1 fiM 
melatonin ( • ) ,  specific binding (O). Scatchard transformation o f  the data is also 
shown (B). In this instance = 81.2 ± 16.0 pM, = 1.8 ± 0.2 fmol/mg protein. 
D ata represent values ± associated standard error using LIGAND.
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Figure 6.6
The dependence o f ovine NR membrane specific 2-[^^^I]iodomelatonin binding (finol) 
on protein concentration. Two radioligand concentrations were investigated; 48 ( ■ ) 
and 188 (O) pM.
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protein content (~ 10 pg), specific binding was only observed at the lower radioligand 
concentration. Specific binding at both label concentrations increased linearly 
between 25 and 175 pg protein.
6.3.3.2 Autoradiography
Autoradiographic studies were subsequently performed on sheep N R  and C- 
RPE. On the basis o f  previous saturation studies, other tissues, for example iris, were 
not investigated. Each o f the eyes investigated for the presence o f  specific binding by 
autoradiography was taken from a batch o f eyes which had previously been 
demonstrated to possess saturable, specific binding in the saturation studies.
Preliminary studies to ascertain exposure times indicated that whereas total 
binding in the C-RPE region became apparent at ~ 2 days (127 pM 2- 
[^^^I]iodomelatonin), in the NR, staining was only visible from ~ 3 weeks. At 3 weeks 
there was no obvious difference between total and non-specific binding sections in 
either tissue region upon preliminary visual inspection. Densitometric analysis 
confirmed the absence o f a statistical difference between total and non-specific 
binding in this and two additional eyes (Figure 6.7). Increasing the exposure time (up 
to  12 weeks) in two o f  these eyes also failed to reveal a statistical difference between 
total and non-specific binding. Similarly, increasing the buffer pre-incubation time 
from 15 min to 1 h also did not reveal significant differences between total and non­
specific binding (Figure 6.7).
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F igure  6.7
Effect o f increased exposure time (eyes A, B and C) and increased pre-incubation 
period (eye C) on 2-[^^^I]iodomelatonin binding in ovine N R (N) and C-RPE (R). 
Non-specific binding was defined with 1 pM melatonin. D ata (relative optical density 
(ROD) measurements) represent the mean ± s.e.m. o f 3 to 5 tissue sections. 
Radioligand concentration used was 124 to 150 pM.
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6.3.4 Human autoradiography
Autoradiographic studies were undertaken with human eye tissues in order to 
confirm the N R and C-RPE melatonin binding site data from radioreceptor assays, 
and to further investigate the possibility o f a melatonin binding site in the iris.
Duplicate total and non-specific sections o f  a single eye were exposed for 
variable periods o f time (1 day to 4 weeks). Binding in the C-RPE region was 
apparent after 1 day. NR was faintly visible from 8 days and clearly visible from 2 
weeks. All subsequent sections were exposed for ~ 2 weeks. For each experiment, 
after 2 weeks o f  exposure, 2 test total and non-specific sections were developed to 
ensure that N R was visible before developing the remainder. I f  not, exposure was 
continued. (Autoradiographs o f  the test sections were not included in the 
densitometric analysis.)
Representative examples o f the autoradiograms obtained with the corresponding 
tissues sections are shown in Figures 6.8 and 6.9. It is apparent that 2- 
[^^^Ijiodomelatonin bound extensively throughout both total and non-specific sections. 
Pigmented structures, in particular, were intensely labelled. Visual inspection 
indicated no apparent differences in the staining density between total and non­
specific sections.
Eleven human eyes were investigated for the presence o f  specific 2- 
[^^^I]iodomelatonin in NR and C-RPE tissues (Figure 6.10A). The donor parameters 
o f  these specimens are shown in Table 6.5. Specific binding was only observed in NR 
o f one specimen (eye 165). However the difference between total and non-specific 
binding sections (= specific binding) was not noticeable to the naked eye. To ensure 
that the results obtained in the autoradiographic studies were not artefactual, tissue 
sections from 6 eyes, including eye 165 which displayed specific binding, were re­
imaged under different lighting and focus conditions, etc. and the densitometric 
analysis repeated. In all cases, for both NR and C-RPE tissues, the results were 
identical, that is, specific binding was again only observed in N R o f eye 165.
Iris-ciliary body (ICB) tissues were present in sections from 8 o f  the 11 eyes 
studied. The two components were not easily distinguishable, partly because o f  the 
high level o f staining associated with the pigmented areas o f  each. They were 
therefore analysed together as a unit. There was no evidence for specific 2- 
[^^^I]iodomelatonin binding in ICB o f any o f the 8 eyes (Figure 6.1 OB). In 5 o f  these 
8 eyes, ciliary muscle (M) was distinguishable. Analysis o f this tissue individually 
similarly provided no evidence o f specific 2-[^^^I]iodomelatonin binding (Figure 
6.1GB).
Increasing the exposure period o f sections o f  eye 173 (up to 16 weeks) failed to 
reveal any significant differences between total and non-specific binding in NR, C- 
RPE or iris-ciliary body components (Figure 6.11).
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Figure 6.10
Analysis o f  2-[^^^I]iodomelatonin binding in human eyes: (A) NR and C-RPE; (B) 
iris-ciliary body (ICB) and ciliary muscle (M). Non-specific binding was defined
with I melatonin. Specific binding was only observed in eye 165 N R (* unpaired t- 
test, p < 0.01). Data (relative optical density (ROD) measurements) represent the 
mean ±  s.e.m. o f  5 to 12 tissue sections. Radioligand concentration used was 125 
to  150 pM.
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F igure 6.11
Effect o f  time o f exposure on 2-[^^^l]iodomelatonin binding in human eye 173: N R  
(N), C-RPE (R) and iris-ciliary body (ICB). D ata (relative optical density (ROD) 
measurements) represent the mean ± s.e.m. o f  4 tissue sections. Non-specific binding 
was defined with 1 pM  melatonin. Radioligand concentration was 150 pM.
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6.3.5 Human eye data summary
A summary o f the binding studies undertaken with human eyes is provided in 
Table 6.6
Membrane rai 
Saturation 
studies
iioreceptor assay 
Displacement studies
Autoradiography
N R 2/18 no specific binding, 1/11
0/3
C-RPE 2/18 no specific binding. 0/11
0/3
Iris: no specific binding.
sphincter pupillae 2/2 0/1 NA
dilator pupillae 0/2 no specific binding.
0/1 NA
Iris-ciliary body 0/8
Ciliary muscle NA NA 0/5
Table 6.6
2-[^^^I]iodomelatonin binding studies conducted in human ocular tissues. D ata refer to 
frequency o f  saturable, specific binding in saturation studies; frequency o f  displaceable 
binding in displacement studies; and frequency o f specific binding in autoradiography. 
NA not assayed
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6.4 Discussion
Evidence is steadily accumulating for the existence o f a melatonin binding site 
within the mammalian eye. Furthermore, in the rabbit this site represents a true 
functional receptor which mediates the inhibitory effect o f  melatonin on retinal 
dopamine release (Dubocovich, 1983; 1985). Within the human eye itself melatonin 
receptor genes have been found to be expressed in the retina (Melib, and to a lesser 
extent Melia) (Reppert et al., 1995a) but what has been lacking to  date is a 
comprehensive pharmacological investigation o f  the binding site itself in situ.
In these studies saturable, specific high affinity 2-[*^^l]iodomelatonin binding 
was demonstrated in both NR and C-RPE membranes from post-mortem human eyes. 
Linear Scatchard plots and Hill coefficients approaching unity in all cases indicated 
the presence o f  a single site. The affinity o f the sites for 2-[^^^l]iodomelatonin (mean 
Æd -  250 pM) was much less than that o f  the ocular binding sites described in, for 
example, chicken (Laitinen and Saavedra, 1990a), tree shrew (Lu et al., 1991) and 
frog (Skene et a l, 1993) and was more in keeping with that in rabbit retina 
(Dubocovich, 1988; Blazynski and Dubocovich, 1991) and the chicken N R data o f 
Dubocovich and Takahashi (1987) and Chong and Sugden (1991). The observed Kà 
values were also in the same region as that o f the cloned Melib receptor rather than 
the higher affinity Melia receptor (Reppert et a l, 1995a). Capsoni and co-workers 
(1994) have reported preliminary evidence for two binding sites in the human eye; one 
similar to that described here {K^  340 pM) and the other with much higher affinity 
15 pM). The observed density o f  binding sites in human C-RPE was greater than in 
N R  and both densities were several fold less (over 35-fold for C-RPE) than that 
reported for the low affinity state site in C-RPE (Capsoni et a l, 1994) (Table 1.4 (1)).
Although clear evidence for a specific 2-[^^^l]iodomelatonin binding site was 
obtained with the membrane radioreceptor methodology employed, there was, 
however, only a very low occurrence o f  binding. 3/18 eyes displayed saturable 
binding and the binding was not consistently observed in both eye tissues (NR and C- 
RPE). One reason for these findings is that the data accurately reflect the biological 
situation, that is, perhaps under normal circumstances only a small proportion o f  
individuals possess NR and/ or C-RPE melatonin binding sites. This may be as a 
result o f some common donor parameter: either a known parameter, or some 
combination o f  parameters, but which was not apparent in these studies due to  the 
low frequency o f melatonin binding, or some other factor about which no information 
was available. Donors o f the three specimens which contained a melatonin binding 
site had all died during the day, that is, when ocular and plasma melatonin levels are 
low. These donors were also over 60 years o f age, that is, in the age group in which 
pineal melatonin synthesis is known to decrease (Touitou et a l, 1981). I f  the 
melatonin binding site was being regulated by melatonin itself, then this may partly 
explain the occurrence o f binding sites in these specimens. In the rat pars tuberalis 
and SCN, for example, (Gauer et a l, 1993), melatonin binding site density is 
increased during the light phase when plasma melatonin is low. In the present human 
studies it is apparent that not all the specimens from donors which had died during the 
day and were aged contained melatonin binding sites, however, thus there must be 
other factors involved.
It is possible that the membrane melatonin binding site in the eye is actually o f  
little significance, and represents, for example, some form o f vestigial receptor with
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the main functions o f  melatonin instead being mediated by some form o f  intracellular 
receptor. The studies o f  Cohen and co-workers (1978), although never confirmed, 
indicated the presence o f some form o f cytoplasm binding site in the hamster eye and 
more recently melatonin has been established as a ligand o f the orphan nuclear 
receptor RZRP (Becker-André et a l, 1994) which is also expressed in NR.
Alternatively, if  the assumption is made that under normal circumstances human 
N R and C-RPE do possess melatonin binding sites, and increasingly the evidence 
points towards this, then the question must be asked why were they not consistently 
apparent in these studies. It is unlikely that the negative findings resulted from an 
inherent problem with the method as it had previously been used successfully to 
establish the existence o f  a melatonin binding site in the quail eye (sections 5.3.1 and 
5.3.3). However other methodological factors may have contributed. For example, in 
the quail, removal o f tissue melanosomes by centrifugation prior to membrane 
preparation was found to reduce non-specific binding. It is possible then that in the 
human C-RPE specific binding was present but was masked by a much larger amount 
o f  non-specific binding. However, when melanosomes were removed no increased 
binding was evident in the human tissues. Additionally, this procedure indicated that 
because specific binding was still present in C-RPE from which melanosomes had 
been removed (unlike frog C-RPE (Wiechmann et a l, 1986)), they were not 
responsible for all observed binding.
Throughout the human studies, incubation protein contents were low and this 
would have decreased the levels o f specific binding observed. However, increasing 
the protein content o f the human incubation system failed to reveal an increased 
incidence o f specific binding although coupled with possible low binding site densities 
these protein increases may still have been insufficient to reveal specific binding. The 
studies undertaken with sheep NR indicated that, as expected, protein was an 
important factor in determining binding and that specific binding was not observed 
below a certain level o f protein. Furthermore, other authors describing ocular 
melatonin binding sites with particularly low densities have reported using membrane 
preparations with high protein contents. For example, Vanecek described a binding 
site in rat N R with 0.35 fmol/mg protein and reported using incubation protein 
contents o f  60 to 160 mg compared to the low microgram level used in these studies.
With the membrane receptor assay it was possible that specific binding was 
present but highly localised in discrete areas and therefore not detected when diluted 
with other areas o f ocular tissue not containing the binding site. However, 
autoradiography studies confirmed the low incidence o f specific 2-[^^^I]iodomelatonin 
binding in NR and C-RPE tissues. Serial sections across the entire eye were not 
investigated but this was justified as each tissue section was a cross section o f  the 
entire eye. Although sections were cut from the middle o f the eye, each always 
included N R and C-RPE tissue from the periphery. In addition, binding in N R  has 
been demonstrated to  exist throughout the entire circumference o f the eyeball in other 
species (Laitinen and Saavedra, 1990a; Wiechmann and Wirsig-Wiechmann, 1991; 
quail. Chapter 5). Furthermore, there are no known reasons why the occurrence o f 
melatonin binding sites should be restricted to specific areas.
Binding was not observed in the sheep NR autoradiography studies although it 
was found in the membrane assays. This may have been because the binding site was 
only present in some eyes, and hence could be demonstrated in membranes pooled 
from • several eyes but not in the individual eyes studied for autoradiography.
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Alternatively it is possible that endogenous ligand, that is melatonin, might be 
blocking the binding site and thus affecting the autoradiography binding assay. In 
rabbit N R  and RPE a small increase in specific binding was observed following 
constant light treatment o f the animals prior to sacrifice (Blazynski and Dubocovich, 
1991). However, in chick brain neither treating tissue sections with melatonin prior to 
assay nor increasing the buffer pre-incubation temperature had any effect on the 
resultant binding (Brooks and Cassone, 1992). Similarly, increasing the buffer pre­
incubation period in this study failed to reveal specific binding in sheep NR. In the 
human autoradiography studies it was unlikely therefore that endogenous melatonin 
was responsible for the low frequency o f binding observed. Another possible reason 
for the apparent lack o f  2-[*^^I]iodomelatonin binding in both sheep and human 
autoradiography studies was related to the low density o f binding sites in these 
tissues. Laitinen and Saavedra (1990a) reported that prolonged exposure time was 
necessary to  visualise the low level o f specific 2-[^^^I]iodomelatonin binding in rat 
retina. However, increasing film exposure time, even to 3 months, did not reveal 
specific binding in either human or sheep studies. In contrast, several authors have 
reported that low density specific binding (^nnx ^  5 fmol/mg protein) is visible in 
autoradiography after 3 weeks or less exposure (Blazynski and Dubocovich, 1991; 
Wiechmann and Wirsig-Wiechmann, 1991). Thus it seems unlikely that specific 2- 
[^^^IJiodomelatonin binding was not demonstrated in human and sheep tissues in the 
present studies simply because o f its low density.
Having eliminated these factors as possible causes o f  the low frequency o f 
binding observed in human NR and C-RPE, there remained one in particular over 
which there was no control, that is, the post-mortem nature o f the specimens. The 
time period between donor death and frozen storage o f the specimen (“specimen 
age”) was never less than ~ 20 hours and extended to a maximum o f  68 hours in one 
instance. Furthermore the time between donor death and the enucleation itself was 
also long for several specimens (up to 22 hours). The majority o f  specimens were 
used as tissue sources for corneal transplant. Presumably, therefore, after enucleation 
they were placed in refrigerated storage. Prior to enucleation no information 
regarding the storage conditions was available but obviously at least for a proportion 
o f  this time period the specimens would not have been chilled. Corneal tissue is 
physiologically robust in part because, lacking its own blood supply, it is able to utilise 
atmospheric oxygen. Hence, prior to their removal for transplant the eye specimens 
are not treated with the same degree o f  care, particularly in terms o f  storage period, 
that would be afforded other more delicate tissues (personal communication. D r G. 
Jeffrey, Institute o f Ophthalmology, London).
In these studies, the presence o f 2 -[’^ ^I]iodomelatonin binding appeared not to 
be associated with shorter pre-freezing specimen storage periods, however the 
possible existence o f a relationship between binding and length o f non-refrigerated 
storage period, an essentially unknown variable, could not be precluded. Saturation 
experiments conducted on membranes prepared from “fresh” and “aged” chicken eyes 
indicated a substantial deleterious effect o f storage on specific 2-[^^^I]iodomelatonin 
binding. The pattern o f  specific binding demonstrated in saturation studies in the aged 
chicken eye tissues was very similar to that frequently obtained with those human 
specimens that did not possess a binding site, that is, irregular specific binding that 
could not be Scatchard transformed. Therefore it is likely that storage o f  the human 
eyes prior to freezing could be at least partially responsible for the frequent lack o f
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specific binding. Amongst the various processes which occur upon cell death, two are 
potentially highly significant with respect to receptors; enzymatic digestion and 
protein dénaturation. Enzymatic digestion results from the release and activation o f  
intracellular hydrolytic enzymes which would normally be strictly contained within the 
cell in lysosomes. The effects o f enzyme digestion coupled with protein dénaturation 
on a protein such as a membrane bound receptor are potentially highly significant, 
therefore. It may be then that the melatonin receptor in certain human specimens has 
undergone irreversible damage by the time o f assay such that it is no longer able to 
bind radioligand in the same way. It is unlikely that this hypothesis alone accounts for 
the negative data obtained however as melatonin receptors have been found in human 
SCN 9 to 24 hours post-mortem (Reppert et al., 1988) and in cerebellum 8 to 20 
hours post-mortem (Fauteck et al., 1994) suggesting that the melatonin binding site is 
not particularly unstable. Other membrane receptors have been successfully studied in 
human post-mortem ocular tissues. For example, Dz-dopamine receptors have been 
characterised in NR membranes from specimens up to 24 hours post-mortem 
(McGonigle et al., 1988) and by autoradiography in specimens up to 6 hours old 
(Denis et a l, 1990). However these latter authors have attributed certain 
discrepancies in their data compared with those obtained previously to the time 
elapsed between death and enucleation. Betaz-adrenergic binding sites have also been 
observed in human eyes 4 to 8 hours post-mortem (Elena et al, 1990).
In addition to retinal and choroid components these studies investigated other 
ocular tissues, namely the iris muscles and ciliary body. Despite the contractile effect 
o f melatonin previously observed in isolated organ experiments, membrane 
radioreceptor studies with ovine sphincter pupillae did not identify a 2- 
[^^^IJiodomelatonin binding site. In contrast, preliminary investigations with human 
sphincter pupillae membrane preparations did indicate the possible existence o f  a 
melatonin binding site in this region. Binding was saturable and Scatchard 
transformation indicated a single high affinity site (mean 220 pM) although a cold 
melatonin displacement study did not provide clear evidence o f displaceable 2- 
[^^^Ijiodomelatonin binding. Recently, Osborne and Chidlow (1994) have reported 
the presence o f  melatonin receptors in the iris-ciliary processes o f the rabbit which are 
negatively linked to the adenylyl cyclase system. In this study, discrimination o f 
binding between the iris and ciliary body was not possible. Similarly, in the human 
autoradiography studies conducted here, the macroscopic resolving pow er o f  the 
methodology employed was not sufficient to analyse human iris sphincter pupillae, or 
even iris and ciliary tissues, separately and these latter two were, therefore, by 
necessity, analysed together. This may at least partly explain why autoradiography 
was not able to  confirm the membrane assay data. In addition, the posterior face o f 
the iris is heavily pigmented leading to very high non-specific staining density in the 
region o f  quantification which may have obscured a small amount o f  specific binding.
Evidence for the presence o f melatonin binding sites on smooth muscle has 
already been provided in another location, namely that within the arterial wall. High 
affinity sites {Ka 35-40 pM) have been described in the rat in both caudal and anterior 
cerebral arteries (Viswanathan et al., 1990; Sugden, 1994). In these tissues melatonin 
acts as a direct vasoconstrictor (Evans et al., 1992). It is feasible therefore that 
melatonin does have a contractile effect on the smooth muscle o f the iris. The 
findings o f  Quay (1986) lend support to this hypothesis. Quay showed that in finches 
implanted with melatonin, pupillary diameter was significantly decreased compared
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with control birds and attributed this effect to  an action o f melatonin within the central 
nervous system. The possibility exists however that under normal circumstances a 
similar effect is mediated through locally produced melatonin, or indeed circulating 
pineal melatonin, acting via a local, that is sphincter pupillae, receptor.
The biological function o f a contractile action o f melatonin on sphincter muscle, 
is difficult to  imagine given that in darkness, that is, in the period when melatonin is 
present, the pupil is in a state o f dilation, in order to maximise light reception. Also, 
Liu and co-workers (1996) have reported a circadian rhythm in pupil diameter in the 
rabbit with peak pupil size occurring in the subjective light phase, implying that if 
there is a causal relationship between melatonin and pupil size then it is unlikely that 
melatonin is contributing a sphincter contractile effect. At present, however there is 
no convincing evidence for a direct contractile effect and nor even can the possibility 
o f melatonin as an agent o f relaxation be discounted. M oreover, melatonin may exert 
these effects via a non-receptor mediated mechanism. It is essential, therefore, that 
the putative sphincter melatonin binding site within the human iris, described herein, is 
investigated in much greater detail before its physiological relevance can be 
established. The small amount o f  iris tissue provided by each eye specimen imposed a 
severe limitation on the studies carried out and precludes further use o f  membrane 
radioreceptor assays. The difficulty o f dissecting the sphincter pupillae completely 
from the dilator muscle was also a problem. It is likely that for future studies it will 
be necessary to use the higher resolution liquid emulsion-type autoradiography to 
reveal, if it exists, the exact site o f the melatonin binding site within the anterior uveal 
tissues.
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C h a p t e r  7 
G e n e r a l  d is c u s s io n
Since its identification in 1959, the indoleamine melatonin has been established 
as being o f  immense importance with respect to the phenomenon o f  biological 
rhythmicity. Melatonin was first isolated from the pineal gland o f  the cow but 
subsequently found to be present in this organ in all species that have since been 
studied. The possible existence o f  additional sites o f  melatonin synthesis was initially 
not widely accepted. In 1965, however. Quay (1965 ) demonstrated that, in
several lower vertebrates, HIOMT, the crucial end enzyme o f melatonin biosynthesis 
was in fact present within retinal tissue. In the 30 years since this discovery, interest 
in ocular melatonin and its physiological relevance has grown considerably.
The presence o f  melatonin or melatonin-like immunoreactivity has been 
confirmed in various eye tissues o f  a large number o f  species (Table l .I ) .  The 
biochemical pathway o f  local melatonin synthesis has been elucidated and found to 
parallel that o f  the pineal, that is, it involves the sequential action o f  NAT and 
HIOM T enzymes with 5-HT as the initial substrate (Figure 1.5). Synthesis is 
rhythmic such that melatonin levels are generally higher at night and, in many species, 
production represents a true circadian rhythm. Moreover, in an increasing number o f 
species, control o f  the ocular melatonin rhythm is recognised as being under the 
control o f  an oscillator which resides within the eye itself. In addition to synthesis, 
studies have also considered the potential importance and routes o f  local degradation 
o f  ocular melatonin. N ot surprisingly, a great deal o f the interest in ocular melatonin 
has centred on its actions and their possible physiological relevance. The actual 
mechanisms by which these actions are mediated have attracted similar attention.
This thesis has considered two aspects o f ocular melatonin: its presence and 
quantification, and the existence o f melatonin binding sites. Two species were o f 
primary interest, quail and man.
Despite the existence o f a now considerable number o f  publications concerned 
with ocular melatonin, information regarding melatonin in the human eye remains 
scant. At the commencement o f experimental work for this thesis, few systematic 
attempts had been made to measure melatonin within the human eye and there were 
no reported human ocular melatonin binding site studies. Ironically, it is information 
such as this that would have the greatest potential for future application. In a medical 
context, ocular melatonin has been attributed both pathogenic and protective roles 
(section 1.9). Manipulation o f  the ocular melatonin system in some way, for example, 
via pharmacological means, may represent an alternative therapeutic strategy for the 
treatment or prevention o f  some eye diseases.
A principal aim o f the research described herein was, therefore, to  maximally 
exploit an available source o f human eye specimens in order to firstly ascertain 
melatonin levels and secondly to probe the tissues for melatonin binding sites. In both 
cases interest was centred predominantly upon N R and the C-RPE, that is, those 
tissues which, in other species, had previously been shown to contain melatonin and 
its binding site.
Quantification o f melatonin was undertaken by RIA using methodology which 
was validated specifically for use with human NR and C-RPE tissues. Authenticity o f 
the endogenous melatonin-like immunoreactivity was verified by TLC/RIA. 
Melatonin was found to be present in both NR and C-RPE compartments thus 
confirming the existence o f melatonin within the human eye. Levels were variable 
ranging from about 10 to  490 pg/g wet tissue weight for both N R  and C-RPE. 
Overall, these contents were lower than previously reported (Leino, 1984; Osol and
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Schwartz, 1984). There were no statistically significant relationships between these 
melatonin contents and any o f the known specimen donor parameters, that is, sex, 
age, or month or time o f death. On the basis o f  data from other species these findings 
for sex, age, and month o f death were to a certain extent expected - no definitive 
associations between these factors and ocular melatonin content have yet been proven 
(sections 1.5.2.4 to 1.5.2.6). In contrast it was anticipated that melatonin levels 
would vary in accordance with time o f death as a clear diurnal variation in ocular 
melatonin has been reported in most species studied with higher melatonin levels 
occurring at night. Frequently this day/night rhythm has been shown to  be a true 
circadian rhythm in lower vertebrates and very recently, this rhythm has been shown 
to  be under the control o f a local oscillator in the mammalian retina (Tosini and 
Menaker, 1996). In this human study however, melatonin contents were not 
significantly increased when donor death occurred during the night.
The significance o f human ocular melatonin has not yet been addressed 
experimentally; neither in these studies nor by previous authors. It is anticipated, 
however, that it will be found to  fulfil at least some o f those actions previously 
reported for melatonin in other species (section 1.7). The distribution o f  melatonin, 
that is, within both the N R and the C-RPE compartments, corresponds to  the site o f 
many o f  these actions.
In the present study, not all specimens investigated possessed demonstrable 
levels o f melatonin in both tissues and a large proportion o f specimens (almost 45 %) 
did not contain melatonin in either tissue. The occurrence o f  melatonin was not 
apparently related to any donor parameter. Within the time course o f  this thesis, 
preliminary evidence has been provided which suggests that the human eye, 
particularly the retina, possesses the capacity for melatonin synthesis. Gene 
transcripts o f  both the essential enzymes, NAT (Coon et a l, 1996) and HIOM T 
(Rodriguez et a l, 1994; Bernard et a l, 1995), have been identified in human retina. 
This, coupled with the fact that there is abundant evidence for melatonin synthesis 
within ocular tissues o f  several other mammalian species implies that it is unlikely that 
a biological factor was responsible for the absence o f melatonin in such a large 
proportion o f the specimens. Instead, it is hypothesised that both this finding and the 
depressed levels o f melatonin indicated in the remaining specimens (as compared with 
the human retinal levels reported by Leino (1984) are in fact attributable to the post­
mortem nature o f the tissues. In support o f  this theory, N R melatonin levels were 
found to  be significantly negatively correlated with post-mortem interval (PMI). 
There was no correlation between C-RPE melatonin levels and PM I however, and 
neither were melatonin contents related to  specimen ages, thus suggesting that the 
effects o f  storage are not simply a direct function o f  time. It is probable that 
additional factors relating to the fate o f the specimen prior to being fi-ozen are 
important determinants o f melatonin content. Storage temperature is an obvious 
candidate. Information regarding other aspects o f the donor prior to  death was also 
lacking. The possible implications o f medication and environmental lighting 
conditions, for example, cannot be ignored. I f  such factors are important, then this 
might partly explain the absence o f the expected relationship between time o f  donor 
death and melatonin content.
In conjunction with the investigation o f ocular melatonin contents, an additional 
group o f  human eye specimens was probed for melatonin binding sites. The relevant 
methodology was initially established using quail ocular tissue as the model. This
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species is o f  particular significance with respect to the field o f  ocular melatonin 
research in its own right, however, as not only is the quail eye essential for 
maintenance o f  overall circadian organisation (Underwood and Siopes, 1984), but 
also it exhibits a rhythm o f melatonin synthesis which is under circadian control o f a 
local oscillator (Underwood et a l, 1990b). It was o f  interest therefore to  probe the 
quail eye for a high affinity melatonin binding site, as the mechanism(s) through which 
this ocular melatonin may act locally have not yet been established. Both N R  and C- 
RPE membranes were found to  contain 2-[*^^I]iodomelatonin binding sites, and this 
tissue distribution was confirmed by autoradiography. Subsequent characterisation o f 
the binding sites revealed single sites in both tissues which were pharmacologically 
very similar and which fulfilled several criteria o f  a melatonin receptor, that is, binding 
was saturable, reversible and specific. This 2-[^^^I]iodomelatonin binding site shares 
many similarities with the ocular melatonin binding sites previously described in other 
species including affinity and pharmacological profile. An additional study 
investigated the effect o f maintaining quails under long and short photoperiods on 
ocular 2-[^^^I]iodomelatonin binding. Neither binding site density nor affinity 
appeared to be affected by the photoperiodic conditions. Possible roles for the 
binding site described in the quail eye have been outlined previously (section 5.3).
Having provided definite evidence for the existence o f melatonin binding sites 
within the quail eye it is essential that they are associated with a function before they 
can be termed receptors. Consideration should perhaps be first given to  the inhibitory 
effect o f melatonin on retinal dopamine release, that is, the action already proven to 
be receptor mediated in the chicken and rabbit (Dubocovich, 1983; 1985). Specific 
cellular localisation o f  the melatonin receptor within the retina, for example, by liquid 
emulsion type autoradiography, may also be o f assistance in determining the functions 
o f  melatonin in the quail.
Having established the methodology for analysis o f  ocular melatonin binding 
sites in the quail eye, this was used to probe a group o f  human eye specimens for 
melatonin binding sites. Saturation studies with 2-[^^^I]iodomelatonin indicated the 
presence o f saturable, specific binding in N R and C-RPE membranes, although not 
always both in the same specimen. Linear Scatchard plots and Hill coefficients 
approaching unity indicated a single class o f site with high affinity {Kà ~  250 pM) and 
low density (^max less than ~ 10 fmol/mg protein). This site may represent a 
mechanism through which melatonin mediates its actions within the eye. Its 
occurrence in both NR and C-RPE is in agreement with the distribution o f melatonin 
shown in the quantification studies, and also with its postulated actions. The data are 
reinforced by the findings o f Capsoni and co-workers (1994) who also reported the 
existence o f  melatonin binding sites in C-RPE. In addition, gene transcripts o f  the 
cloned melatonin receptors Melia and Melib have been identified in human retina 
implying that the molecules are expressed in the eye (Reppert et a l, 1995b), although 
the precise localisation within NR and/or C-RPE has not been reported.
Only a very small proportion o f  the human specimens investigated however 
(3/18), demonstrated specific 2-['^^I]iodomelatonin binding in membrane assays, a 
finding confirmed by autoradiography. This low occurrence precluded further 
pharmacological characterisation o f the binding site. A study undertaken with chicken 
N R  and C-RPE tissues indicated that an extended storage period prior to  freezing had 
a deleterious effect on 2-[^^^I]iodomeIatonin binding in both tissues. Consequently it 
is proposed that the human binding site investigations with N R  and C-RPE were
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compromised, as was the melatonin quantification study, by the post-mortem nature 
o f  the tissue and this may explain why binding was observed in such a limited number 
o f  specimens. Because o f  the proteinous nature o f the melatonin receptor molecule, it 
is likely that it would be more susceptible to damage during the post-mortem interval 
than would the melatonin molecule itself and this ties in with the experimental findings 
in that a greater proportion o f specimens lacked melatonin binding sites than lacked 
detectable melatonin.
Melatonin was previously observed to effect contraction o f sheep sphincter 
pupillae in isolated organ experiments (personal communication. D r S.M.O. Hourani, 
University o f  Surrey) therefore membranes prepared from both this tissue and a 
number o f  other sheep ocular tissues were also probed for 2-[^^^I]iodomelatonin 
binding sites. N o evidence was found for the presence o f  a melatonin binding site in 
ovine sphincter muscle. Saturable, specific binding was demonstrated only in NR. 
Human iris tissues were subsequently also investigated. In contrast with the ovine 
findings, studies with human iris muscle membranes provided weak evidence for a 2- 
[^^^I]iodomelatonin binding site that was specific to the sphincter pupillae. The iris 
studies reported in this thesis were intended to  be preliminary only. The iris has 
attracted little, if  any, attention previously with respect to melatonin binding site 
investigations. The possible existence o f a functional melatonin receptor in this 
structure raises several questions regarding its physiological significance. For 
example, if it is found to mediate an effect on pupil diameter what are the 
implications, for circadian photoreception?
If, because o f the post-mortem nature o f the specimens, the findings o f  the 
studies described do not accurately represent the human ocular melatonin system in 
vivo, further use o f  the tissues in similar investigations will not be justified. Ideally, 
future studies should be undertaken on freshly enucleated specimens from live donors. 
These specimens are rarely available however. Given the extreme difficulty in 
obtaining such tissues maximum use has to be made o f  those tissue sources that are 
available, that is, post-mortem specimens. Hence it would be prudent for future 
investigations to address the human ocular melatonin system from alternative angles, 
that is, to study instead those aspects which may be less affected by the post-mortem 
nature o f specimens. Firstly, it will perhaps be o f  benefit to investigate its generating 
system, that is, the synthetic enzymes NAT and HIOMT. This could be done by 
either assessing their catalytic activity or by molecular biology techniques. As 
previously mentioned, gene transcripts o f both NAT and HIOMT have recently been 
located in human retina. It is accepted, however, that neither enzyme studies nor 
molecular techniques would escape the detrimental affects o f  tissue death. In 
conjunction with investigations o f the synthetic system, pathways o f metabolic 
degradation should also be assessed as these may be partially responsible for the low 
melatonin levels observed. The deacetylase route is believed to be absent in mammals 
(Grace et al., 1991), but it has not been investigated specifically in the human eye. 
The possible regulation o f ocular melatonin levels by a cytochrome P-450 mediated 
mechanism is also o f potential significance given that this enzyme is present within the 
eye (Shichi et a l, 1975; Schwartzman et a l, 1987; Zhao and Shichi, 1995). With 
respect to  the deacetylase route, identification o f an active metabolic system such as 
this may be indicative o f a means for rapid termination o f melatonin’s actions. 
Alternatively, it may represent a route by which other biologically active molecules 
are produced. Hence, it may be o f interest to widen the investigation o f  human
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melatonin to  encompass additional methoxyindoles such as 5-methoxytryptamine and 
5-methoxytryptophol. The action(s) o f melatonin within the eye also remain to  be 
considered. There is no reason to  believe that these would be dissimilar to those 
established in other mammalian species (section 1.7), therefore the starting point will 
be to search for evidence o f any o f  these.
With respect to future study o f  the melatonin binding sites in human N R and C- 
RPE, it is unlikely that continued direct investigation as was undertaken in these 
studies will reveal much additional information, given the low proportion o f 
specimens which appear to  contain the binding site. Following the recent cloning o f 
the melatonin receptor, availability o f  probes for the three receptor subtypes will allow 
gene expression to be studied instead. Reppert and co-workers (1994) have 
suggested that post-mortem loss o f  Melia mRNA may be responsible for some o f the 
difficulty in detecting it in human brain. Consequently this is a possibility when 
investigating the eye, although HIOMT mRNA has been detected (albeit at low 
levels) in human retina up to 13 hours post-mortem (Bernard et al., 1995).
Further study o f the putative iris 2-[^^^I]iodomelatonin binding site described is 
essential. The small amounts o f tissue provided by each eye specimen necessarily 
precludes full characterisation o f the site(s) in membrane preparations. The molecular 
methods described above could also be applied to the iris tissues. Given that there are 
no existing reports concerning melatonin binding sites in the iris it will be worthwhile 
for the search to be extended to other species in the first instance, in order that post­
mortem effects are eliminated. I f  binding was found, this species could be used as an 
experimental model for method development prior to further human iris studies.
Cellular responses following melatonin binding were not investigated in the 
human studies. The binding sites described therefore cannot strictly be referred to as 
receptors. Hence, it is also necessary that functional studies are undertaken. W hether 
the human tissues are capable o f  such responses is questionable given their post­
mortem nature. Taking into account all existing animal evidence relating to the ocular 
melatonin system, however, future identification o f  the human ocular melatonin 
binding site as a true receptor is probable, in the appropriate tissue source, that is 
freshly enucleated human eyes, or post-mortem specimens frozen immediately 
following donor death.
In the absence o f freshly enucleated specimens from live donors, human cell 
cultures represent an alternative model for investigation o f  several aspects o f  the 
human ocular melatonin system. The Y79 cell line, derived from a human 
retinoblastoma, is increasingly being used for this purpose (section 1.11). These cells 
possess the requisite synthetic enzymes and are capable o f  melatonin synthesis (Pierce 
et a l, 1989; Deng et a l, 1991). Use o f  an immortal cell line such as this has its 
limitations however, as cellular physiology may deviate from that o f normal NR. 
Useful information concerning the RPE and its relationship with melatonin may also 
be gained from culture systems. Human RPE cultures have previously been utilised in 
a number o f  research areas. Successful primary or secondary cultures can be prepared 
from relatively old post-mortem specimens (up to 72 hours) (Boulton et a l, 1983; 
Miceli and Newsome, 1991; Osborne et a l, 1991) hence the human eye source 
currently available would be ideal for generation o f such cultures. One RPE cell line 
(K-1034) has also been established (Kigasawa et a l, 1994) and this may represent 
another model for investigation.
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The human ocular melatonin system is deserving o f  study for a number o f 
reasons, however, there still exists very little information about it. Limited availability 
o f  appropriate tissue sources for investigation, that is freshly enucleated eyes from live 
donors, has undoubtedly been partly responsible for this lack o f  data. The present 
studies aimed to quantify melatonin and investigate melatonin binding sites in post­
mortem human eyes. Evidence is provided for both the existence o f melatonin and its 
binding sites in N R and C-RPE tissues thus further justifying the need for continued 
investigation in this area o f  research.
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